var title_f37_51_38704="Femoral artery puncture";
var content_f37_51_38704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Femoral artery puncture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Technique of femoral artery puncture. The femoral artery can be palpated just below the midpoint of the inguinal ligament. The needle should be inserted at a 90 degree angle toward the pulsation for a single sampling of arterial blood. For catheter placement, the needle should be inserted at a 45&ordm; angle in a cephalad direction (as shown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from the American Heart Association. Textbook of Advanced Cardiac Life Support 1994.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38704=[""].join("\n");
var outline_f37_51_38704=null;
var title_f37_51_38705="Clavicle fracture displacement";
var content_f37_51_38705=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clavicle fracture displacement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This diagram depicts the mechanisms typically involved in the displacement of a clavicle fracture, which is caused by the upward pull of the sternocleidomastoid muscle and the downward pull of the weight of the arm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eiff MP, Hatch RL, Calmbach W (Eds). Fracture Management for Primary Care, 2nd Edition, W.B. Saunders Company, Philadelphia 2002. Illustration used with permission of Elsevier Inc. All right reserved. Copyright &copy; 2002 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38705=[""].join("\n");
var outline_f37_51_38705=null;
var title_f37_51_38706="Patient information: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)";
var content_f37_51_38706=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82902\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/27/29105\">",
"         Parts of the eye",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?30/52/31554\">",
"         Patient information: Weight loss treatments (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/5/33876\">",
"         Patient information: Weight loss treatments (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/idiopathic-intracranial-hypertension-pseudotumor-cerebri-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H22627930\">",
"      <span class=\"h1\">",
"       What is idiopathic intracranial hypertension?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Idiopathic intracranial hypertension is a condition that causes pressure inside the skull. It is also called &ldquo;pseudotumor cerebri.&rdquo;",
"     </p>",
"     <p>",
"      Idiopathic intracranial hypertension causes very bad headaches and vision loss. These symptoms are similar to symptoms caused by a brain tumor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22627945\">",
"      <span class=\"h1\">",
"       What causes idiopathic intracranial hypertension?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors do not know the cause. But idiopathic intracranial hypertension is more common in women and obese people.",
"     </p>",
"     <p>",
"      Certain medicines seem to make some people more likely to get idiopathic intracranial hypertension. These medicines include",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/16/7429?source=see_link\">",
"       tetracycline",
"      </a>",
"      , high doses of vitamin A, and growth hormone.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22627962\">",
"      <span class=\"h1\">",
"       What are the symptoms of idiopathic intracranial hypertension?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Bad headaches &ndash; Some people say the worst pain is right behind the eyes.",
"       </li>",
"       <li>",
"        Short periods of vision loss &ndash; This can happen in 1 or both eyes. It usually lasts a few seconds and might happen once in a while or several times a day.",
"       </li>",
"       <li>",
"        Dimming of vision",
"       </li>",
"       <li>",
"        Trouble seeing things at the edge of your line of sight",
"       </li>",
"       <li>",
"        Double vision",
"       </li>",
"       <li>",
"        Seeing flashing lights",
"       </li>",
"       <li>",
"        Noises inside your head &ndash; The noise might sound like rushing water or wind. It often pulses in time with your heartbeat and can come and go.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In rare cases, people with idiopathic intracranial hypertension lose their vision forever.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22627977\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eye exam &ndash; An eye doctor will use special tools to look for swelling at the back of your eye, near the optic nerve (",
"        <a class=\"graphic graphic_figure graphicRef70420 \" href=\"mobipreview.htm?28/27/29105\">",
"         figure 1",
"        </a>",
"        ). Most patients with idiopathic intracranial hypertension have swelling of the optic nerve. The optic nerve connects the eye to the brain.",
"       </li>",
"       <li>",
"        Visual field test - This test checks how well you can see things that are at the edges of your line of sight. The test will be repeated from time to time to check your optic nerves.",
"       </li>",
"       <li>",
"        MRI or CT scan &ndash; These imaging tests take pictures of the inside of your brain. Your doctor can use them to check if a tumor or other problem is causing your symptoms.",
"       </li>",
"       <li>",
"        Lumbar puncture (sometimes called a &ldquo;spinal tap&rdquo;) &ndash; During this procedure, a doctor puts a needle into your lower back to measure the fluid pressure inside your skull.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22627992\">",
"      <span class=\"h1\">",
"       How is idiopathic intracranial hypertension treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Weight loss &ndash; If you are overweight, your doctor will recommend a diet or weight loss program. If you are very overweight and cannot lose weight by dieting, your doctor might recommend medicines or weight-loss surgery. &nbsp;",
"       </li>",
"       <li>",
"        Medicines &ndash; Your doctor might prescribe medicines that help lower the amount of spinal fluid your body makes. Spinal fluid is the fluid that surrounds the brain and spinal cord. He or she might also recommend medicines used to prevent and treat headaches.",
"       </li>",
"       <li>",
"        Surgery &ndash; Doctors only do surgery if losing weight and taking medicines don&rsquo;t help enough. The kinds of surgery include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Shunting &ndash; In this surgery, a doctor puts a device called a &ldquo;shunt&rdquo; into a fluid-filled space inside your brain. The shunt is connected to a tube that is placed under your skin and that empties into your belly. The shunt helps drain the extra spinal fluid from your brain and can relieve the pressure.",
"       </li>",
"       <li>",
"        Optical nerve sheath fenestration &ndash; In this surgery, a doctor cuts a tiny, window-like hole in the tissue that covers the optic nerve. This helps lower pressure on the nerve to help save your vision.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22628007\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/52/31554?source=see_link\">",
"       Patient information: Weight loss treatments (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/5/33876?source=see_link\">",
"       Patient information: Weight loss treatments (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/51/38706?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82902 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-00FF42CD0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38706=[""].join("\n");
var outline_f37_51_38706=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22627930\">",
"      What is idiopathic intracranial hypertension?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22627945\">",
"      What causes idiopathic intracranial hypertension?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22627962\">",
"      What are the symptoms of idiopathic intracranial hypertension?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22627977\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22627992\">",
"      How is idiopathic intracranial hypertension treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22628007\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82902\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/27/29105\">",
"      Parts of the eye",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/5/33876?source=related_link\">",
"      Patient information: Weight loss treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/52/31554?source=related_link\">",
"      Patient information: Weight loss treatments (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38707="Alclometasone: Patient drug information";
var content_f37_51_38707=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alclometasone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/15/19700?source=see_link\">",
"     see \"Alclometasone: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/55/28531?source=see_link\">",
"     see \"Alclometasone: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aclovate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin rashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701453",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alclometasone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12464 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-0F5B079826-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38707=[""].join("\n");
var outline_f37_51_38707=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131062\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012690\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012689\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012694\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012695\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012697\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012692\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012693\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012698\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012699\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/15/19700?source=related_link\">",
"      Alclometasone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/55/28531?source=related_link\">",
"      Alclometasone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38708="Chronic pulm thromboemboli";
var content_f37_51_38708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic pulmonary thromboemboli",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic thromboemboli removed by thromboendarterectomy. Note the chronic, fibrotic appearance with extension into multiple lobar and segmental branches.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter F Fedullo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38708=[""].join("\n");
var outline_f37_51_38708=null;
var title_f37_51_38709="Tiludronate: Drug information";
var content_f37_51_38709=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tiludronate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/14/41188?source=see_link\">",
"    see \"Tiludronate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F227853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Skelid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F227884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Bisphosphonate Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F227856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Paget's disease:",
"     </b>",
"     Oral: 400 mg (2 tablets of tiludronic acid) daily for a period of 3 months",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F227857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F227858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tiludronate is excreted renally. It is not recommended for use in patients with severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute) and is not removed by dialysis.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F227829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as tiludronic acid:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Skelid&reg;: 200 mg [equivalent tiludronate disodium 240 mg]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F227815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F227831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer as a single oral dose, take with 6-8 oz of plain water. Should not be taken with beverages containing minerals (eg, mineral water), food, or with other medications (may reduce absorption). Do not take within 2 hours of food. Take calcium or mineral supplements at least 2 hours before or after tiludronate. Take aluminum- or magnesium-containing antacids at least 2 hours after taking tiludronate. Patients should be instructed to stay upright (not to lie down) for at least 30 minutes and until after first food of the day (to reduce esophageal irritation).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F227830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of Paget's disease of the bone (osteitis deformans) in patients who have a level of serum alkaline phosphatase (SAP) at least twice the upper limit of normal, or who are symptomatic, or who are at risk for future complications of their disease",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F227882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Chest pain (3%), edema (3%), peripheral edema (3%), flushing, hypertension, syncope",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety, fatigue, insomnia, nervousness, somnolence, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (3%), skin disorder (3%), pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperparathyroidism (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (9%), diarrhea (9%), dyspepsia (5%), vomiting (4%), flatulence (3%), abdominal pain, anorexia, constipation, gastritis, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (4%), arthrosis (3%), fractures, muscle spasm, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Cataract (3%), conjunctivitis (3%), glaucoma (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis (5%), sinusitis (5%), pharyngitis (3%), bronchitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Accidental injury (4%), infection (3%), diaphoresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Musculoskeletal pain (sometimes severe and/or incapacitating), osteonecrosis (primarily of the jaw), Stevens-Johnson syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F227834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tiludronate, bisphosphonates, or any component of the formulation; inability to stand or sit upright for at least 30 minutes",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F227819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone/joint/muscle pain: Infrequently, severe (and occasionally debilitating) bone, joint, and/or muscle pain have been reported during bisphosphonate treatment. The onset of pain ranged from a single day to several months. Consider discontinuing therapy in patients who experience severe symptoms; symptoms usually resolve upon discontinuation. Some patients experienced recurrence when rechallenged with same drug or another bisphosphonate; avoid use in patients with a history of these symptoms in association with bisphosphonate therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal mucosa irritation: May cause irritation to upper gastrointestinal mucosa. Esophagitis, dysphagia, esophageal ulcers, esophageal erosions, and esophageal stricture (rare) have been reported with oral bisphosphonates; risk increases in patients unable to comply with dosing instructions. Use with caution in patients with dysphagia, esophageal disease, gastritis, duodenitis, or ulcers (may worsen underlying condition). Discontinue use if new or worsening symptoms develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Osteonecrosis of the jaw (ONJ): ONJ has been reported in patients receiving bisphosphonates. Risk factors include invasive dental procedures (eg, tooth extraction, dental implants, boney surgery); a diagnosis of cancer, with concomitant chemotherapy or corticosteroids; poor oral hygiene, ill-fitting dentures; and comorbid disorders (anemia, coagulopathy, infection, pre-existing dental disease). Most reported cases occurred after I.V. bisphosphonate therapy; however, cases have been reported following oral therapy. A dental exam and preventative dentistry should be performed prior to placing patients with risk factors on chronic bisphosphonate therapy. The manufacturer's labeling states that discontinuing bisphosphonates in patients requiring invasive dental procedures may reduce the risk of ONJ. However, other experts suggest that there is no evidence that discontinuing therapy reduces the risk of developing ONJ (Assael, 2009). The benefit/risk must be assessed by the treating physician and/or dentist/surgeon prior to any invasive dental procedure. Patients developing ONJ while on bisphosphonates should receive care by an oral surgeon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with mild-to-moderate renal impairment (not recommended in patients with a Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F227824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: May enhance the hypocalcemic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of antacids containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Magaldrate; Sodium Bicarbonate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: May decrease the serum concentration of Tiludronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Bisphosphonate Derivatives may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indomethacin: May increase the serum concentration of Tiludronate. Management: Separate doses of tiludronate at least two hours before or two hours after indomethacin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral iron supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: May decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Bisphosphonate Derivatives. Specifically, polyvalent cation-containing multivitamins may decrease the absorption of orally-administered bisphosphonate derivatives. Management: Avoid administration of polyvalent cation-containing multivitamins within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Bisphosphonate Derivatives may enhance the hypocalcemic effect of Phosphate Supplements.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: May diminish the therapeutic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: Bisphosphonate Derivatives may enhance the adverse/toxic effect of SUNItinib. Specifically, the risk of osteonecrosis of the jaw may be increased.  Management: Monitor for development of osteonecrosis of the jaw in patients receiving sunitinib and bisphosphonates.  Avoid invasive dental procedures if possible.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F227849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: In single-dose studies, the bioavailability of tiludronate was reduced by 90% when an oral dose was administered with, or 2 hours after, a standard breakfast compared to the same dose administered after an overnight fast and 4 hours before a standard breakfast. Management: Administer as a single oral dose with 6-8 oz of plain water. Should not be taken with beverages containing minerals (eg, mineral water), food, or with other medications. Do not take within 2 hours of food. Take calcium or mineral supplements at least 2 hours before or after tiludronate.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F227826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F227836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic and nonteratogenic embryo/fetal effects have been reported in animal studies. There are no adequate and well-controlled studies in pregnant women. Bisphosphonates are incorporated into the bone matrix and gradually released over time. Theoretically, there may be a risk of fetal harm when pregnancy follows the completion of therapy. Based on limited case reports with pamidronate, serum calcium levels in the newborn may be altered if bisphosphonates are administered during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F227862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F227837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not take within 2 hours of food. Ensure adequate intake of vitamin D and calcium supplements during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Skelid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (56): $642.17",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10143596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alkaline phosphatase; pain; serum calcium and 25(OH)D",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Skelid (AT, AU, BE, CH, DE, ES, FI, FR, GB, HN, HU, LU, NL, NZ, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F227818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibition of normal and abnormal bone resorption. Inhibits osteoclasts through at least two mechanisms: disruption of the cytoskeletal ring structure, possibly by inhibition of protein-tyrosine-phosphatase, thus leading to the detachment of osteoclasts from the bone surface area and the inhibition of the osteoclast proton pump.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F227833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Delayed, may require several weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely to bone and soft tissue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~90%, primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Little, if any",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~6% (range: 2% to 11%); reduced by 90% when given with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Healthy volunteers: Single dose: 50 hours; Cl",
"     <sub>",
"      cr",
"     </sub>",
"     11-18 mL/minute: 205 hours; Pagetic patients: Repeated dosing: 150 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Within 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~60%, as tiludronic acid within 13 days)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Dental Association Council on Scientific Affairs, &ldquo;Dental Management of Patients Receiving Oral Bisphosphonate Therapy: Expert Panel Recommendations,&rdquo;",
"      <i>",
"       J Am Dent Assoc",
"      </i>",
"      , 2006, 137(8):1144-50. Available at file://jada.ada.org/cgi/content/full/137/8/1144",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/16873332/pubmed\" id=\"16873332\" target=\"_blank\">",
"        16873332",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Assael LA, &ldquo;Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2009, 67(5 Suppl):35-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/19371813/pubmed\" id=\"19371813\" target=\"_blank\">",
"        19371813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Author Unknown, \"Safety Update: Bone-Building Drugs: Risks Explained,\"",
"      <i>",
"       Consum Rep Health",
"      </i>",
"      , 2006, 18(5):3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Edwards BJ, Hellstein JW, Jacobsen PL, et al, \"Updated Recommendations for Managing the Care of Patients Receiving Oral Bisphosphonate Therapy: An Advisory Statement From the American Dental Association Council on Scientific Affairs,\"",
"      <i>",
"       J Am Dent Assoc",
"      </i>",
"      , 2008, 139(12):1674-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/19047674/pubmed\" id=\"19047674\" target=\"_blank\">",
"        19047674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Filleul O, Crompot E, and Saussez S, \"Bisphosphonate-Induced Osteonecrosis of the Jaw: A Review of 2,400 Patient Cases,\"",
"      <i>",
"       J Cancer Res Clin Oncol",
"      </i>",
"      , 2010, 136(8):1117-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/20508948/pubmed\" id=\"20508948\" target=\"_blank\">",
"        20508948",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      French AE, Kaplan N, Lishner M, et al, &ldquo;Taking Bisphosphonates During Pregnancy,&rdquo;",
"      <i>",
"       Can Fam Physician",
"      </i>",
"      , 2003, 49:1281-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/14594094/pubmed\" id=\"14594094\" target=\"_blank\">",
"        14594094",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Langston AL and Ralston SH, &ldquo;Management of Paget's Disease of Bone,&rdquo;",
"      <i>",
"       Rheumatology (Oxford)",
"      </i>",
"      , 2004, 43(8):955-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/15187244/pubmed\" id=\"15187244\" target=\"_blank\">",
"        15187244",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lo JC, O'Ryan FS, Gordon NP, et al, &ldquo;Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2010, 68(2):243-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/19772941/pubmed\" id=\"19772941\" target=\"_blank\">",
"        19772941",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marx RE, Sawatari Y, Fortin M, et al, \"Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment,\"",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2005, 63(11):1567-75.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/16243172/pubmed\" id=\"16243172\" target=\"_blank\">",
"        16243172",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mavrokokki T, Cheng A, Stein B, et al, &ldquo;Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia,&rdquo;",
"      <i>",
"       J Oral Maxillofac Surg",
"      </i>",
"      , 2007, 65(3):415-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/17307586/pubmed\" id=\"17307586\" target=\"_blank\">",
"        17307586",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McClung MR, Tou CK, Goldstein NH, et al, &ldquo;Tiludronate Therapy for Paget&rsquo;s Disease of Bone,&rdquo;",
"      <i>",
"       Bone",
"      </i>",
"      , 1995, 17(5S):493-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/8573425/pubmed\" id=\"8573425\" target=\"_blank\">",
"        8573425",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ralston SH, &ldquo;Pathogenesis of Paget's Disease of Bone,&rdquo;",
"      <i>",
"       Bone",
"      </i>",
"      , 2008, 43(5):819-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/18672105/pubmed\" id=\"18672105\" target=\"_blank\">",
"        18672105",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sanson LN, Necciari J, and Theircelin JF, &ldquo;Human Pharmacokinetics of Tiludronate,&rdquo;",
"      <i>",
"       Bone",
"      </i>",
"      , 1995, 17(5S):479-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/8573422/pubmed\" id=\"8573422\" target=\"_blank\">",
"        8573422",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Whyte MP, &ldquo;Clinical Practice. Paget's Disease of Bone,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 355(6):593-600.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38709/abstract-text/16899779/pubmed\" id=\"16899779\" target=\"_blank\">",
"        16899779",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10148 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-71122602D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38709=[""].join("\n");
var outline_f37_51_38709=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227853\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227884\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227856\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227857\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227858\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227829\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227815\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227831\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227830\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227882\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227834\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227819\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300142\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227824\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227849\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227826\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227836\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227862\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227837\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323973\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10143596\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539943\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227818\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227833\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10148\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10148|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/14/41188?source=related_link\">",
"      Tiludronate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38710="Performance and safety risks of sleep deprivation and sleep disorders";
var content_f37_51_38710=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Performance and safety risks of sleep deprivation and sleep disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Richard J Bonnie, JD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Charles F George, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Robert C Basner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Ruth Benca, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38710/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/51/38710/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleepiness refers to an inability to remain fully awake at a time that wakefulness is expected, while fatigue refers to a subjective lack of physical or mental energy. Both reduce alertness, thereby increasing the potential for impairment of occupational and driving performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this topic review, the risks associated with sleep deprivation and sleep disorders (common causes of sleepiness or fatigue) are discussed. Relevant case law regarding driver, employer, and clinician liability for injuries associated with sleepiness or fatigue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8294?source=see_link\">",
"     \"Liabilities of sleep deprivation and sleep disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISKS DUE TO SLEEP DEPRIVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep deprivation makes it difficult to maintain stable performance over time, as measured by response latency, response variability, speed, accuracy, hand-eye coordination, decision-making, and memory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Acute sleep deprivation refers to sleep missed in a 24-hour period, whereas cumulative sleep deprivation is sleep lost over a number of days.",
"   </p>",
"   <p>",
"    Acute and cumulative sleep deprivation are often work-related. Work-related situations that can result in sleep deprivation include compressed work time to obtain more consecutive time off, early start times, long work days, night shifts, extended shifts, shift rotation, consecutive work periods, unpredictable work schedules, or unstable work schedules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most research has focused on the impact of sleep deprivation on the incidence of motor vehicle crashes. As an example, one prospective cohort study followed 2737 medical interns for one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/7\">",
"     7",
"    </a>",
"    ]. Interns who drove after an extended work shift (&gt;24 consecutive hours) were more likely to be involved in a motor vehicle crash (OR 2.3, 95% CI 1.6-3.3) or a near-miss incident (OR 5.9, 95% CI 5.4-6.3) than interns who drove after a normal work shift. Interns who worked five or more extended shifts in one month were more likely to fall asleep while driving (OR 2.39, 95% CI 2.31-2.46) or while stopped in traffic (OR 3.69, 95% CI 3.60-3.77) than interns who had not worked any extended shifts.",
"   </p>",
"   <p>",
"    Other studies have shown that sleep-related crashes are more likely among drivers who have multiple jobs, work night shifts, have unusual work schedules, average fewer hours of sleep per night, report poorer quality sleep, or drive more often late at night [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. Individuals frequently underestimate the degree of impairment caused by cumulative sleep deprivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of sleep deprivation on driving performance is exacerbated by coexisting obstructive sleep apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/13\">",
"     13",
"    </a>",
"    ] and alcohol consumption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Occupational errors are also more common among individuals with sleep deprivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISKS DUE TO SLEEP DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep disorders can be categorized as sleep-related breathing disorders, insomnia, circadian rhythm sleep disorders, hypersomnias of central origin, parasomnias, and sleep-related movement disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/18\">",
"     18",
"    </a>",
"    ]. Most sleep disorders cause fatigue, inattention, and sleepiness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Sleep related breathing disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea (OSA) and central sleep apnea syndrome (CSAS) are disorders that cause nocturnal hypoxemia and disrupted sleep. As a result, patients are frequently inattentive, sleepy, or fatigued.",
"   </p>",
"   <p>",
"    Drivers with untreated sleep-related breathing disorders perform poorly on several types of driving simulators and have an automobile crash rate that is up to six times greater than other drivers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/19-36\">",
"     19-36",
"    </a>",
"    ]. Among patients with severe sleep apnea, the incidence of sleep-related motor vehicle crashes is nearly twice that of patients with mild or moderate sleep apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Excessive sleepiness is probably the reason that patients with sleep apnea are susceptible to motor vehicle crashes. This was supported by an observational study of 38 patients with untreated OSA that evaluated the relationship between sleepiness and driving performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/34\">",
"     34",
"    </a>",
"    ]. Sleepiness was quantified as the mean sleep latency, which was determined from a maintenance of wakefulness test (MWT). Driving performance was quantified as the mean number of inappropriate line crossings during a 90-minute on-road driving test (ie, not in a driving simulator). Patients with a mean sleep latency of 33 minutes or less had a significantly higher number of inappropriate line crossings than patients who had a mean sleep latency greater than 33 minutes or healthy controls. A mean sleep latency of 33 minutes or less categorizes the patient as being sleepy or very sleepy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35095?source=see_link&amp;anchor=H9#H9\">",
"     \"Quantifying sleepiness\", section on 'Maintenance of wakefulness test (MWT)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sleep restriction and alcohol intake appear to exacerbate the risk of motor vehicle crashes among patients with OSA. This was illustrated by a study that found that patients with untreated OSA whose sleep was restricted (to a maximum of four hours) or who ingested alcohol (to a blood level of 0.05",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    had more steering deviation in a driving simulator than individuals without OSA who were subject to the same conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although most research has focused on the impact of sleep-related breathing disorders on driving performance, occupational errors are also more common among individuals with sleep-related breathing disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. This was illustrated by a prospective cohort study of 4957 police officers, of whom 2003 (40 percent) screened positive for at least one sleep disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/40\">",
"     40",
"    </a>",
"    ]. Screening was via sleep disorder-specific questionnaires that were administered either on-site or online. Among those who screened positive for a sleep disorder, most (83 percent) screened positive for OSA, indicating that they had a high likelihood of having OSA. Patients who screened positive for any sleep disorder were more likely to make an administrative error at work (18 versus 13 percent, adjusted odds ratio 1.43, 95% CI 1.23-1.67), to fall asleep while driving (14 versus 9 percent, adjusted odds ratio 1.51, 95% CI 1.20-1.90), to commit an error or safety violation due to fatigue (24 versus 16 percent, adjusted odds ratio 1.63, 95% CI 1.43-1.85), to exhibit uncontrolled anger toward suspects (34 versus 29 percent, adjusted odds ratio 1.25, 95% CI 1.09-1.43), to be absent from work (26 versus 21 percent, adjusted odds ratio 1.23, 95% CI 1.08-1.40), and to fall asleep during meetings (14 versus 7 percent, adjusted odds ratio 1.95, 95% CI 1.52-2.52).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Circadian rhythm sleep disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circadian rhythm sleep disorders affect the timing of sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/18\">",
"     18",
"    </a>",
"    ]. They include jet lag disorder, shift work sleep disorder, delayed sleep phase disorder, advanced sleep phase disorder, and irregular sleep-wake disorder. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11301?source=see_link&amp;anchor=H7#H7\">",
"     \"Classification of sleep disorders\", section on 'Circadian rhythm sleep disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Circadian rhythm sleep disorders can cause fatigue and errors. In a retrospective study, 3436 questionnaires were distributed to the pilots of four commercial airlines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/41\">",
"     41",
"    </a>",
"    ]. Fatigue was reported by 60 percent of the long-flight pilots and was generally attributed to night flights or jet lag. Manifestations included reduced alertness, reduced attention, lack of concentration, increased response times, and small mistakes. This study is limited by its poor response rate (only 21 percent) and, therefore, should be applied with caution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9318483\">",
"    <span class=\"h2\">",
"     Hypersomnias of central origin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersomnias of central origin are hypersomnias that are not due to a circadian rhythm disorder, sleep related breathing disorder, or disturbed sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/18\">",
"     18",
"    </a>",
"    ]. They include narcolepsy and idiopathic hypersomnia.",
"   </p>",
"   <p>",
"    Hypersomnias of central origin can impair alertness, which can predispose an individual to motor vehicle crashes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/37,42,43\">",
"     37,42,43",
"    </a>",
"    ]. This was illustrated by a case-control study that evaluated 70 control drivers and 424 drivers who had untreated sleep disorders including sleep apnea, narcolepsy, another sleep disorder with excessive sleepiness, or a sleep disorder without excessive sleepiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/37\">",
"     37",
"    </a>",
"    ]. Patients with narcolepsy were most likely to be involved in a sleep-related crash.",
"   </p>",
"   <p>",
"    Patients with hypersomnias of central origin are presumably also at increased risk of occupational errors due to fatigue or sleepiness, but this has not been sufficiently studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Parasomnias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parasomnias are undesirable physical events or experiences that occur during sleep or sleep-wake transitions, such as sleep onset or arousal from sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/18\">",
"     18",
"    </a>",
"    ]. When they occur during arousal from sleep, they are sometimes called \"confusional arousals.\"",
"   </p>",
"   <p>",
"    Parasomnias are due to central nervous system activation and often involve complex, semi-purposeful, and goal-directed behaviors that have meaning or importance to the individual. Such behaviors are unconscious; thus, they are sometimes called automatisms. Examples of parasomnias include sleepwalking, sleep eating, sleep sex, night terrors, and rapid eye movement (REM) behavior disorder.",
"   </p>",
"   <p>",
"    In theory, parasomnias may cause fatigue and sleepiness because they are associated with repeated arousals. However, there is a lack of evidence supporting this hypothesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Violence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Violent parasomnias have been described including actual or attempted homicide or suicide. Individuals do not recall their actions. Such parasomnias are usually isolated and rarely repetitive or predictable. Violent parasomnias may be more common in individuals who have another sleep disorder, increased stress, or other extenuating circumstances (eg, extreme sleep deprivation over several days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Neurologic and psychiatric causes have been associated with violent parasomnias, which are often uncovered by a thorough history and physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sleep-related movement disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep-related movement disorders are conditions that are primarily characterized by simple, monophasic movements that disturb sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/18\">",
"     18",
"    </a>",
"    ]. Examples include periodic limb movement disorder (PLMD), sleep-related rhythmic movement disorder, sleep-related bruxism (ie, tooth grinding), and sleep-related leg cramps. Restless legs syndrome is also in this category, primarily because of its close association with PLMD.",
"   </p>",
"   <p>",
"    Sleep-related movement disorders are associated with repeated arousals that may cause fatigue and sleepiness, thereby predisposing individuals to occupational errors and motor vehicle crashes. This has not been well-studied. In one population-based study of 1506 adults, approximately 10 percent of individuals reported symptoms that were consistent with restless legs syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/47\">",
"     47",
"    </a>",
"    ]. Individuals with such symptoms were more likely to drive when drowsy, report daytime fatigue, and make errors at work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT EFFECT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of treating sleep disorders on driving performance is best established among patients with OSA. Successful treatment of OSA improves driving simulator performance and decreases motor vehicle crashes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/19,48-53\">",
"     19,48-53",
"    </a>",
"    ]. This was illustrated by the following two studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective cohort study, 547 patients with OSA were treated with continuous positive airway pressure (CPAP) therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/51\">",
"       51",
"      </a>",
"      ]. During the 12 months following the initiation of CPAP therapy, there were fewer motor vehicle crashes (7 versus 11 percent) and near-miss incidents (6 versus 28 percent), compared with the 12 months that preceded the initiation of CPAP.",
"     </li>",
"     <li>",
"      A retrospective cohort study of 210 patients with OSA found that successful CPAP therapy reduced the crash risk to that found in the population and estimated that 75 motor vehicle crashes would be prevented during three years of therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/53\">",
"       53",
"      </a>",
"      ]. This suggests that treating drivers who have OSA may induce substantial cost savings by preventing motor vehicle crashes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/51/38710/abstract/54-56\">",
"       54-56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are little data about the impact of treating other types of sleep disorders on driving or work performance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sleep deprivation makes it difficult to maintain stable performance over time. Acute sleep deprivation refers to sleep missed in a 24-hour period, whereas cumulative sleep deprivation is sleep lost over a number of days. Both are often work-related and increase the risk of a sleep-related motor vehicle crash. Individuals frequently underestimate the degree of impairment caused by cumulative sleep deprivation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Risks due to sleep deprivation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sleep disorders can be categorized as sleep-related breathing disorders, insomnia, hypersomnias of central origin, circadian rhythm sleep disorders, parasomnias, and sleep-related movement disorders. Most sleep disorders cause fatigue, inattention, and sleepiness, thereby increasing the risk of a sleep-related motor vehicle crash or occupational injury. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risks due to sleep disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Violent parasomnias have been described including actual or attempted homicide or suicide. Such events are usually isolated and rarely repetitive or predictable. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Violence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of obstructive sleep apnea appears to improve driving performance and decrease the likelihood of a sleep-related motor vehicle crash. It is unknown whether treatment of other sleep disorders similarly improves driving performance because it has not been studied. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Treatment effect'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/1\">",
"      Swaen GM, Van Amelsvoort LG, B&uuml;ltmann U, Kant IJ. Fatigue as a risk factor for being injured in an occupational accident: results from the Maastricht Cohort Study. Occup Environ Med 2003; 60 Suppl 1:i88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/2\">",
"      Connor J, Norton R, Ameratunga S, et al. Driver sleepiness and risk of serious injury to car occupants: population based case control study. BMJ 2002; 324:1125.",
"     </a>",
"    </li>",
"    <li>",
"     Kleitman N. Deprivation of Sleep. In: Sleep and wakefulness, Kleitman N (Ed), University of Chicago Press, 1939. p.215.",
"    </li>",
"    <li>",
"     Dinges DF, Kribbs NB. Performing while sleepy; effects of experimentally induced sleepiness. In: Sleep, Sleepiness and Performance, Monk TH (Ed), J Wiley, New York 1991. p.97.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/5\">",
"      Akerstedt T, Fredlund P, Gillberg M, Jansson B. Work load and work hours in relation to disturbed sleep and fatigue in a large representative sample. J Psychosom Res 2002; 53:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/6\">",
"      Akerstedt T, Fredlund P, Gillberg M, Jansson B. A prospective study of fatal occupational accidents -- relationship to sleeping difficulties and occupational factors. J Sleep Res 2002; 11:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/7\">",
"      Barger LK, Cade BE, Ayas NT, et al. Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med 2005; 352:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/8\">",
"      Stutts JC, Wilkins JW, Scott Osberg J, Vaughn BV. Driver risk factors for sleep-related crashes. Accid Anal Prev 2003; 35:321.",
"     </a>",
"    </li>",
"    <li>",
"     Large Truck Crash Facts. Publication no. FMCSA-Ri-02-003. Federal Motor Carrier Safety Administration, 2002.",
"    </li>",
"    <li>",
"     Factors that affect fatigue in heavy truck accidents. Vol1. Analysis. Publication no. NTSB/SS-95/01. National Transportation Safety Board, Washington, DC, 1995.",
"    </li>",
"    <li>",
"     Selective Motorcoach issues. Highway Special Investigation Report, Publication no. NTSB/SIR-99/01. National Transportation Safety Board, Washington, DC, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/12\">",
"      Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/13\">",
"      Vakulin A, Baulk SD, Catcheside PG, et al. Effects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apnea. Ann Intern Med 2009; 151:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/14\">",
"      Vakulin A, Baulk SD, Catcheside PG, et al. Effects of moderate sleep deprivation and low-dose alcohol on driving simulator performance and perception in young men. Sleep 2007; 30:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/15\">",
"      Howard ME, Jackson ML, Kennedy GA, et al. The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance. Sleep 2007; 30:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/16\">",
"      Ayas NT, Barger LK, Cade BE, et al. Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA 2006; 296:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/17\">",
"      Barger LK, Ayas NT, Cade BE, et al. Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med 2006; 3:e487.",
"     </a>",
"    </li>",
"    <li>",
"     The International Classification Of Sleep Disorders; Diagnostic and Coding Manual, 2nd ed, American Academy of Sleep Medicine, Westchester IL 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/19\">",
"      Findley LJ, Fabrizio MJ, Knight H, et al. Driving simulator performance in patients with sleep apnea. Am Rev Respir Dis 1989; 140:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/20\">",
"      Haraldsson PO, Carenfelt C, Laurell H, T&ouml;rnros J. Driving vigilance simulator test. Acta Otolaryngol 1990; 110:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/21\">",
"      George CF, Boudreau AC, Smiley A. Simulated driving performance in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/22\">",
"      Risser MR, Ware JC, Freeman FG. Driving simulation with EEG monitoring in normal and obstructive sleep apnea patients. Sleep 2000; 23:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/23\">",
"      George CF. Sleep. 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004; 59:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/24\">",
"      Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/25\">",
"      George CF, Nickerson PW, Hanly PJ, et al. Sleep apnoea patients have more automobile accidents. Lancet 1987; 2:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/26\">",
"      Alpert, M, Ancoli-Israel, S, Kripke, D, et al. Sleep-disordered breathing and car accidents in the elderly. Sleep Res 1992; 21:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/27\">",
"      Stoohs RA, Guilleminault C, Itoi A, Dement WC. Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep 1994; 17:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/28\">",
"      Findley LJ, Weiss JW, Jabour ER. Drivers with untreated sleep apnea. A cause of death and serious injury. Arch Intern Med 1991; 151:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/29\">",
"      Noda A, Yagi T, Yokota M, et al. Daytime sleepiness and automobile accidents in patients with obstructive sleep apnea syndrome. Psychiatry Clin Neurosci 1998; 52:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/30\">",
"      Horstmann S, Hess CW, Bassetti C, et al. Sleepiness-related accidents in sleep apnea patients. Sleep 2000; 23:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/31\">",
"      Masa JF, Rubio M, Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000; 162:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/32\">",
"      Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/33\">",
"      Ter&aacute;n-Santos J, Jim&eacute;nez-G&oacute;mez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999; 340:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/34\">",
"      Philip P, Sagaspe P, Taillard J, et al. Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk. Ann Neurol 2008; 64:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/35\">",
"      Lloberes P, Levy G, Descals C, et al. Self-reported sleepiness while driving as a risk factor for traffic accidents in patients with obstructive sleep apnoea syndrome and in non-apnoeic snorers. Respir Med 2000; 94:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/36\">",
"      Tregear S, Reston J, Schoelles K, Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. J Clin Sleep Med 2009; 5:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/37\">",
"      Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep 1989; 12:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/38\">",
"      Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001; 164:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/39\">",
"      Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 2000; 26:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/40\">",
"      Rajaratnam SM, Barger LK, Lockley SW, et al. Sleep disorders, health, and safety in police officers. JAMA 2011; 306:2567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/41\">",
"      Bourgeois-Bougrine S, Carbon P, Gounelle C, et al. Perceived fatigue for short- and long-haul flights: a survey of 739 airline pilots. Aviat Space Environ Med 2003; 74:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/42\">",
"      Broughton R, Ghanem Q, Hishikawa Y, et al. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 1981; 8:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/43\">",
"      Arbus L, Tiberge M, Serres A, Rouge D. [Drowsiness and traffic accidents. Importance of diagnosis]. Neurophysiol Clin 1991; 21:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/44\">",
"      Broughton R, Billings R, Cartwright R, et al. Homicidal somnambulism: a case report. Sleep 1994; 17:253.",
"     </a>",
"    </li>",
"    <li>",
"     McCall Smith A, Shapiro CM. Sleep disorders and the criminal law. In: Forensic Aspects of Sleep, Shapiro C, McCall Smith A (Eds), John Wiley and Sons, 1997. p.29.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/46\">",
"      Mahowald MW, Schenck CH, Cramer Bornemann MA. Sleep-related violence. Curr Neurol Neurosci Rep 2005; 5:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/47\">",
"      Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006; 129:76.",
"     </a>",
"    </li>",
"    <li>",
"     Findley L, Presty S, Barth J, Suratt P. Impaired cognition and vigilance in elderly subjects with sleep apnea. In: leep and Respiration in Aging Adults, Kuna S, Suratt P, Remmers J (Eds), Elsevier, New York 1991. p.259.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/49\">",
"      Haraldsson PO, Carenfelt C, Lysdahl M, T&ouml;rnros J. Long-term effect of uvulopalatopharyngoplasty on driving performance. Arch Otolaryngol Head Neck Surg 1995; 121:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/50\">",
"      Minemura H, Akashiba T, Yamamoto H, et al. [Traffic accidents in obstructive sleep apnea patients and effect of nasal CPAP treatment]. Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/51\">",
"      Krieger J, Meslier N, Lebrun T, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. The Working Group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement &agrave; Domicile des Insuffisants Respiratoires. Chest 1997; 112:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/52\">",
"      Findley L, Smith C, Hooper J, et al. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000; 161:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/53\">",
"      George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001; 56:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/54\">",
"      Findley LJ, Suratt PM. Serious motor vehicle crashes: the cost of untreated sleep apnoea. Thorax 2001; 56:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/55\">",
"      Douglas NJ, George CF. Treating sleep apnoea is cost effective. Thorax 2002; 57:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38710/abstract/56\">",
"      Sassani A, Findley LJ, Kryger M, et al. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004; 27:453.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7708 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-4F64B2DDF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38710=[""].join("\n");
var outline_f37_51_38710=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISKS DUE TO SLEEP DEPRIVATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISKS DUE TO SLEEP DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Sleep related breathing disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Circadian rhythm sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9318483\">",
"      Hypersomnias of central origin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Parasomnias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Violence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sleep-related movement disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT EFFECT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11301?source=related_link\">",
"      Classification of sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8294?source=related_link\">",
"      Liabilities of sleep deprivation and sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35095?source=related_link\">",
"      Quantifying sleepiness",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38711="Haloperidol: Pediatric drug information";
var content_f37_51_38711=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Haloperidol: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"    see \"Haloperidol: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/63/37877?source=see_link\">",
"    see \"Haloperidol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6697563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Haldol&reg;;",
"     </li>",
"     <li>",
"      Haldol&reg; Decanoate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Haloperidol LA&reg;;",
"     </li>",
"     <li>",
"      Apo-Haloperidol&reg;;",
"     </li>",
"     <li>",
"      Haloperidol Injection, USP;",
"     </li>",
"     <li>",
"      Haloperidol Long Acting;",
"     </li>",
"     <li>",
"      Haloperidol-LA;",
"     </li>",
"     <li>",
"      Haloperidol-LA Omega;",
"     </li>",
"     <li>",
"      Novo-Peridol;",
"     </li>",
"     <li>",
"      PMS-Haloperidol;",
"     </li>",
"     <li>",
"      PMS-Haloperidol LA",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1053134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antipsychotic Agent, Typical, Butyrophenone",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1053126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"      see \"Haloperidol: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Gradually decrease dose to the lowest effective maintenance dosage once a satisfactory therapeutic response is obtained",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-12 years (15-40 kg): Oral: Initial: 0.25-0.5 mg/day given in 2-3 divided doses; increase by 0.25-0.5 mg every 5-7 days; maximum dose: 0.15 mg/kg/day; usual maintenance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Agitation or hyperkinesia: 0.01-0.03 mg/kg/day once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tourette's disorder or nonpsychotic behavior disorders: 0.05-0.075 mg/kg/day in 2-3 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Psychotic disorders: 0.05-0.15 mg/kg/day in 2-3 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Maximum effective dosage has not been established; doses &gt;6 mg/day have not been shown to further enhance behavior improvement. Preliminary findings of a double-blind, placebo controlled study reported the mean optimal dose in 12 schizophrenic children 5-12 years to be &sim;2 mg/day (range: 0.5-3.5 mg/day or 0.02-0.12 mg/kg/day) given in 3 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6-12 years: I.M.",
"     <b>",
"      (as lactate)",
"     </b>",
"     : 1-3 mg/dose every 4-8 hours to a maximum of 0.15 mg/kg/day; switch to oral therapy as soon as able",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 0.5-5 mg 2-3 times/day; usual maximum dose: 30 mg/day; some patients may require 100 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     As",
"     <b>",
"      lactate:",
"     </b>",
"     2-5 mg every 4-8 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     As",
"     <b>",
"      decanoate:",
"     </b>",
"     Initial: 10-15 times the individual patients' stabilized oral dose, given at 3- to 4-week intervals",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, oil, as decanoate [strength expressed as base]: 50 mg/mL (1 mL, 5 mL); 100 mg/mL (1 mL, 5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Haldol&reg; Decanoate: 50 mg/mL (1 mL); 100 mg/mL (1 mL) [contains benzyl alcohol, sesame oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as lactate [strength expressed as base]: 5 mg/mL (1 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Haldol&reg;: 5 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as lactate [strength expressed as base, concentrate]: 2 mg/mL (5 mL, 15 mL, 120 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1053138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer with food or milk to decrease GI distress; prior to administration, dilute oral concentrate with &ge;2 ounces of water or acidic beverage; do not mix oral concentrate with coffee or tea. Avoid skin contact with oral suspension or solution; may cause contact dermatitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral:",
"     <b>",
"      Decanoate",
"     </b>",
"     product is for I.M. use only,",
"     <b>",
"      do not administer decanoate I.V.",
"     </b>",
"     Although not FDA-approved, haloperidol",
"     <b>",
"      lactate",
"     </b>",
"     has been administered I.V.; however, this may increase the risk of altered cardiac conduction.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F178610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, amsacrine, bivalirudin, cimetidine, cisatracurium, cladribine, dexmedetomidine, dobutamine, docetaxel, dopamine, doxorubicin liposome, etoposide phosphate, famotidine, fenoldopam, fentanyl, filgrastim, fludarabine, gemcitabine, granisetron, hetastarch in lactate electrolyte injection (Hextend&reg;), hydromorphone, lidocaine, linezolid, lorazepam, melphalan, methadone, nitroglycerin, norepinephrine, ondansetron, oxaliplatin, paclitaxel, pemetrexed, phenylephrine, propofol, quinupristin/dalfopristin, remifentanil, sufentanil, tacrolimus, teniposide, theophylline, thiotepa, tigecycline, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, amphotericin B cholesteryl sulfate complex, cefepime, dexamethasone sodium phosphate, fluconazole, foscarnet, furosemide, gallium nitrate, heparin, ketorolac, piperacillin/tazobactam, sargramostim.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Aztreonam, metoclopramide, midazolam, morphine, nitroprusside.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Buprenorphine with glycopyrrolate, lorazepam, sufentanil.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Diphenhydramine, heparin, hydroxyzine, ketorolac, morphine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Benztropine, hydromorphone, scopolamine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1053129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     All dosage forms: Store at controlled room temperature; protect from light",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral concentrate and injection, as lactate: Do not freeze",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, as deconate: Do not refrigerate or freeze",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1053137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, immediate release (lactate): Management of schizophrenia (FDA approved in adults); control of tics and vocal utterances of Tourette's disorder (FDA approved in adults); emergency sedation of severely agitated or delirious patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, extended release (decanoate): Management of schizophrenia in patients requiring prolonged parenteral antipsychotic treatment (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet and solution: Management of psychotic disorders (FDA approved in ages &ge;3 years and adults), control of tics and vocal utterances of Tourette's disorder (FDA approved in ages &ge;3 years and adults), treatment of severe behavioral problems in children displayed by combativeness and/or explosive hyperexcitable behavior and in short-term treatment of hyperactive children (FDA approved in ages 3-12 years); emergency sedation of severely agitated or delirious patients",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F178612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Haldol&reg; may be confused with Halcion&reg;, Halog&reg;, Stadol",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Haldol [U.S. and multiple international markets] may be confused with Halotestin brand name for fluoxymesterone [Great Britain]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F178609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Abnormal T waves with prolonged ventricular repolarization, arrhythmia, hyper-/hypotension, QT prolongation, sudden death, tachycardia, torsade de pointes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, akathisia, altered central temperature regulation, anxiety, confusion, depression, drowsiness, dystonic reactions, euphoria, extrapyramidal reactions, headache, insomnia, lethargy, neuroleptic malignant syndrome (NMS), pseudoparkinsonian signs and symptoms, restlessness, seizure, tardive dyskinesia, tardive dystonia, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, contact dermatitis, hyperpigmentation, photosensitivity (rare), pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, breast engorgement, galactorrhea, gynecomastia, hyper-/hypoglycemia, hyponatremia, lactation, mastalgia, menstrual irregularities, sexual dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, constipation, diarrhea, dyspepsia, hypersalivation, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Priapism, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis (rare), leukopenia, leukocytosis, neutropenia, anemia, lymphomonocytosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice, obstructive jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, laryngospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, heat stroke",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1053141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to haloperidol or any component; narrow-angle glaucoma, bone marrow suppression, CNS depression, coma, severe liver or cardiac disease, parkinsonism",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1053125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with renal or hepatic dysfunction, respiratory disease, thyrotoxicosis, cardiovascular disease, history of seizures, or EEG abnormalities; haloperidol may cause hypotension (particularly with parenteral administration), precipitation of anginal pain, anticholinergic effects (low incidence relative to other neuroleptics), elevation of prolactin levels",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1053124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cases of sudden death, QT prolongation and torsade de pointes have occurred; risk of QT prolongation and torsade de pointes may be increased with the use of any formulation in amounts exceeding the recommended dose and with the use of I.V. administration of haloperidol lactate (not an FDA-approved route of administration). Use haloperidol with caution or avoid use in patients with electrolyte abnormalities (eg, hypokalemia, hypomagnesemia), hypothyroidism, familial long QT syndrome, concomitant medications which may augment QT prolongation, or any underlying cardiac abnormality which may also potentiate risk. If haloperidol lactate is administered I.V., monitor ECG closely for QT effects and arrhythmias. Do",
"     <b>",
"      not",
"     </b>",
"     administer haloperidol decanoate I.V.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is high relative to other neuroleptics, and is dose-dependent; to decrease risk of tardive dyskinesia: Use smallest dose and shortest duration possible; evaluate continued need periodically; risk of dystonia is increased with the use of high potency and higher doses of conventional antipsychotics and in males and younger patients). Use may be associated with neuroleptic malignant syndrome. May be sedating; use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Impaired core body temperature regulation may occur; use with caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects. Safety and efficacy have not been established in children &lt;3 years of age.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     . Use is contraindicated in patients with bone marrow suppression.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     An increased risk of death has been reported with the use of antipsychotics in elderly patients with dementia-related psychosis",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; most deaths seemed to be cardiovascular (eg, sudden death, heart failure) or infectious (eg, pneumonia) in nature; haloperidol is not approved for this indication.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Injection as deconate contains benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; avoid use of haloperidol products containing benzyl alcohol in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F178598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2D6 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (moderate), CYP3A4 (moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Avanafil.  Management: The maximum avanafil adult dose is 50 mg per 24-hour period when used together with a moderate CYP3A4 inhibitor.  Patients receiving such a combination should also be monitored more closely for evidence of adverse effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Haloperidol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ChlorproMAZINE: May enhance the QTc-prolonging effect of Haloperidol. ChlorproMAZINE may increase the serum concentration of Haloperidol. Haloperidol may increase the serum concentration of ChlorproMAZINE. Management: Consider alternatives to combined treatment with these agents. If combined treatment cannot be avoided, monitor for signs and symptoms of prolonged QTc interval (e.g. arrhythmias).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Eplerenone.  Management: When used concomitantly with moderate inhibitors of CYP3A4, eplerenone dosing recommendations may vary depending on international labeling. Consult appropriate labeling for specific recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of FentaNYL.  Management: Monitor patients extra closely for several days following initiation of the combination, and fentanyl dosage reductions should be made as appropriate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FLUoxetine: May enhance the QTc-prolonging effect of Haloperidol. FLUoxetine may increase the serum concentration of Haloperidol. Management: Consider alternatives to this combination when available.  If the combination is used, monitor for evidence of QTc prolongation and increased systemic haloperidol concentrations/effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FluvoxaMINE: May increase the serum concentration of Haloperidol. Management: Monitor for increased haloperidol concentrations/effects when patients are receiving fluvoxamine, particularly when fluvoxamine dose is 150 mg/day or greater.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glycopyrrolate: May decrease the serum concentration of Haloperidol. Management: Monitor patients closely for signs/symptoms of reduced clinical response to haloperidol if concurrent use with glycopyrrolate is required.  When possible, consider avoiding concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: Moderate Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Moderate Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Haloperidol. Specifically including drowsiness and confusion.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Haloperidol may enhance the QTc-prolonging effect of QuiNIDine. QuiNIDine may increase the serum concentration of Haloperidol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Tolvaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1053143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Drug may precipitate if oral concentrate is mixed with coffee or tea",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10869024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal studies. Haloperidol crosses the placenta. There are case reports of limb malformations following first trimester exposure in humans. Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1053133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate, CBC with differential, liver enzymes with long-term use; serum glucose, sodium, magnesium;  ECG (with non-FDA approved intravenous administration; mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1053123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitive blockade of postsynaptic dopamine receptors in the mesolimbic dopaminergic system; depresses cerebral cortex and hypothalamus; exhibits a strong alpha-adrenergic and anticholinergic blocking activity",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1053140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed, undergoes first-pass metabolism in the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses the placenta; appears in breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 92%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver, hydroxy-metabolite is active",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: 60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Adults: 20 hours; range: 13-35 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Excreted in urine and feces as drug and metabolites",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1053131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/63/37877?source=see_link\">",
"      see \"Haloperidol: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause dry mouth. May rarely cause photosensitivity reactions; avoid exposure to sunlight and artificial light sources (sunlamps, tanning booth/bed); use a sunscreen; contact physician if reaction occurs",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Serrano AC, &ldquo;Haloperidol - Its Use in Children,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 1981, 42(4):154-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38711/abstract-text/6937455 /pubmed\" id=\"6937455 \" target=\"_blank\">",
"        6937455",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Spencer EK, Kafantaris V, Padron-Gayol MV, et al, &ldquo;Haloperidol in Schizophrenic Children: Early Findings From a Study in Progress,&rdquo;",
"      <i>",
"       Psychopharmacol Bull",
"      </i>",
"      , 1992, 28(2):183-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/51/38711/abstract-text/1513922 /pubmed\" id=\"1513922 \" target=\"_blank\">",
"        1513922",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13347 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-42B5A9483A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38711=[""].join("\n");
var outline_f37_51_38711=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6697563\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178552\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178553\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053134\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053126\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178524\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178509\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053138\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178610\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053129\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053137\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178612\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178609\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053141\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053125\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053124\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178598\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178518\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053143\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178520\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10869024\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053133\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053123\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053140\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053131\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13347\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13347|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=related_link\">",
"      Haloperidol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/63/37877?source=related_link\">",
"      Haloperidol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38712="WHO weight for length boys 0 to 24 months";
var content_f37_51_38712=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53474%7EPEDS%2F73036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53474%7EPEDS%2F73036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Weight-for-length percentiles, boys 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 508px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Weight-for-length percentiles, girls 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 508px; background-image: url(data:image/gif;base64,R0lGODlhMwL8AeYAAP///+bm5gAAABEREYiIiMzMzPDw8N3d3URERO7u7iIiIru7uzMzMzAwMNDQ0JmZmdfX16qqqmBgYFVVVaCgoHd3d8DAwGZmZuDg4ICAgEBAQFBQUCsrK7q6uhAQEHBwcCAgIFZWVo+Pj7CwsJCQkHNzczk5OaysrMnJyQ4ODmRkZIGBgRwcHEdHR7+/v39/f56enuzs7Pj4+D8/PzQ0NM/Pz29vb+3t7XZ2ds3NzYmJiZaWlvLy8q+vr19fX7Gxsc7OzqKioi8vL76+vsHBwWVlZQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAzAvwBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u740C8vP09fb3+Pn6+/z9/v8AAwocSLCgwYMIEypcyLChQ4XIHkqcSLGixYsYM2rcyLGjvogCMsmzNJJQgEInTaIsFHJQSpcrVcqEORPAS0E3AbSkyRNnTJ81bf4EOmgnUaFBcyodivSoTqZLa0bt2dSp0apTnWatipUl1K9SwVJNebVSSZJlhZ1FyzapWEFG/7fKfbv16tywbvMWHXp3LF2verUG5lqX71vCfwnZPZy1r+CnItNGWkuMMiXLkCg75hqXsWe/ij/33FwYL+jTj62KPkqa6WLUiAffzPkaduPVSCVLwjxZ9y/evdEGGE68uPHjyAMISM68ufPnyJdDn06duvTq2LMXv669e3Xu3sM3By++PHPfmdHHU88LePpCDwbIe0AIQVnNuDvLXl3atuH9QdUWm3+B0YbbbAcCNlqCBSqY2oNdAUhTWQnYJwADCQyygAAEIOKeIx/2EuJ6hVRAHwEDDHKBZfhJCJeLAz7YH4S3wWigaTTy52CMMbYW4H8EBskZgwva+GIhByCQQP8CCnQIQAHyOWnIiItQqYuVivAWQYoAVMAAAfcJyOONORoJm5iO+UiVgGqWqZqZbkLIJpEy7thmhELmpsiXABwwwANNeshelYNeWWiW87xAyAEKRAAAAQoc8IBRLnhk6aWYZqrpppzuo+ggBDDQZ6CBDlIpPZhgiYuqghoCJX0AKFAPS2gepl+eabpG551kskZnj3bqCOeRReKa2F7D4hmnnodcgCEAk9IjpWKHtnoMZtHKs0ABDMhzwSGUQVqAIZNOWetgty6b64/D8hqssS72OiaQ6r5bb7z23qsvUGUdwMC3hpRqriErzgOtfALASitIhwBKyAMVPCnAuAsTIuv/PAqXS6t523Hscccfh0xeyOGNTLJ3Jp+cXcoqd1dWtgIoYPG01BIMsCAmPsplxcZgO8+0CUw8sFnnnpnsumvu+uucR9MLGbz7DonjvPiG1jTU/GpiWcEKLEDIluBWe0s9LpArtCAIRCzIC7MSvfTVqM1IdbFRM401sFZj7W7evsLdN7J3I2im2ILOUzYhF+zMqKODsG3wtegJ4HUC/1p7WdFy+o130u2+PfXedD+9L+jE/h11jYCffjXhYSeyoSCvWl4MZhPQF18CC/yZCKvUitxyeSz/Pl3wwjtHfPHjIe+y8uKxPjQhDIx7AQKPKkBx65AfAqYAuhfs7fOTtJhn/7pzxyl3m6SLrmz55cuLvuehpy946uyjfq/zPA8ygTzRx0qPwkXBnyx4B77dYI5H5JMfupSWLLupbmoHtF/98qVACP5qfvfTmgB1skFYEDB/BvQd87BzvBEap4QmHA4KU6gcFg7PhSTUYKo6+IoP1sxtDdScBN0nrLs5cIIN4hsQH0g/DA6xTkIk3d5oaEO40NAVTXRiW3yoQ6fxsGpU/NwF2aU3+JnuiJsrHRiN6CMmbjCKHuygDcW3rARu0Widy6EW/XZFIaXvhxV8U+BWJ8NLoLGGasSfPEQIw+QV0niHNGQik7NCEzbShWacIcMk+TCE0ScBCGPAAUB4JzfSUf9Xccxi/N6ox9F5cX15lNoeV0khCz1rexyS3eUm6cer5AxFhWCA2gLoxVSiMl/tOyUZSalKU8pxlJ9MIgPh1S8lMWlaERBAhgoYvie2Ao30+NQgwDYIJinsVJ0KpzjHSc5ymjObuZwWpAgBzij+EYppgZnXLHSzGyKpUSoSAPU4mZ8qzrGIPaybFYlZR/MJ05+hi+CxMoiIUA3iANqSJQC8FxJ/zQd7PYunzEClgAT4iXH2HETsCjGBenKwl8T8pTKxKNB/ErGYR7zjQJMJ0FAylGDPIkQBBLBJal6gnhOYAACiOc2QViaePwPABNSGAJqdlBDiGsQDhAoABlCVl8f/HONCYfq+rKp0laWM6UHBisSadnFwhvBXPRHgtWhez6gTlUfXADAAxkmOmmqhx+EeNrGmog1gjnvcIC42H27xr6cBJOQiT7hYRjb2OI8cYWSVN1lHmm0eMoOlU51ouEIkTide04nCAmtNVnxIcktFm1PXqFAuajWInDurKL+YyoIG06vDpKkYlcigSCLidXWFS2jhmtdD1O5gCYCUR4MLwuBk1Ze5NatBcYvQL7YWmeObKVlt21Vm9hF60qNeUIcqTbwGAzPb0x0A6InRair2sS2EL8jkG1/61le+lZXsd/XHv3FZNGHtPWpkptjSl4aRqwEFIx4JCkykFZi2DF6p/2xvWktKZnTAOJwtdBdoUwVr96Xc3WonP/zasPIWrRgmsIAtXE2UVvd8CR6xS0uMYJZ6eMYnlq5YUcziWWavx71572PzWzwi/87IR7bvfZXsWxUPA5uCvG4pNwzHCd8YuyBusIj7ieNl7tbLQGxyhmcXSBXL2MA71DJsH/zVLEt4urNtM41DbGPHfKAFYhyzjy8M5PQIubFIblmgTzZoQjPZvicQgAhUuN89kznFgojPRSvEv6JK8bkpje6X68xlLM9ZzXEbK5qdJuUD38UAHtgAWQxB6QtlSNIADnCLf1xhQtwyRUlaksAureFMc9jKZ4awbtXXXTZr+tNv3jGBNv/gAQOsGknODNStJWpAWhpiQx36r5LMy81B8MmowaZy5jocbDnneNN2FDWND1zqNLtlBAKwALMQ8W1BdLu5ggCT1xZwsV0S97ySgVIsvdQn9VJLHtocFUgfJSpTnfPhEI+4xCdukIQ79KH4dDiqLus1XZIXsVjlM5L+FChAPQCTb+W1SA0+0ZyCu9PrdreOHXxlYW8X1GU1dnXX124SK0UDDTBA1prl8pHKekvR9JqzCsBvS6v8qJ0dVYcCpdYBXJW0V4mqINQqy3D7usrGjPOxz03sGMPc3GDueZcJUQIBOGBCaa0cR1NOq85uaAEQ3fe/Ytm4jYtcqvUgQGrX6+//pxM2YTDbaGI/Vug/A/rQkKdv48PTAQGUIDqXlav/MBZgikouuJhc+NOf7JtATUBUlCv8Ux1dc3EjEMzlHnvaYX922XdY7Z5+iQFAYIKYiHlRdx1AxKAk+tU/OhFU75Y+nW78amP6xaAEdu13bkTcr3vBw7Y+2gUhAQ+gwPeNfuhdcycP1Tef9JB2fq+h71pl65ys7KY9jLB/82QXOzbwHkFUfj/rv+s5yIwXeZIngPhFgCyEAikQAuMRfup3fLXGel7HfrEVdu83ahZEbtMHfxKkfbIHdEKXE9+nPv/XgCv2gP33YK4HY5w2fz43exjIgmtnZRwoGxngdkdBATCQ/2esd4Il6GR+FoD2NXlAOIAG+HgwlGgrgBwdoALEwX8kiH599ghsxD6eVH8T6H41t30yKH/ZFYMUWHYvKAgGkAIbMBMS4Gw6yINqWFxRCCLaV4VudoX3F3vU135zmIEWmFAR1hMbkAJCRxMf8HbP1oZSWFqrAGVmBnMpGH1fSIcaSGpc2EYteHt7SBQkIAAnsBIjQAJDR4huaG0jWIiOt0hC6DGlaB6niIpFWDyVd3nHgQIKeEIM6Fz+RwjYJggLoHwBBmsKE00BFoGPCHZY6Ih5aF2RSIWTuIXDdhK7pwGEcYZwVwit5nL1Zl76lm/ysU/4BnCIIHDZJgAmZVTTtv9emDGFmwGHyCaHZgeDueeC0seONheH6NaIAMBsH1gIJSBv0bgo0dYhG8J3sgYtETUpALSNwIAZfgIoHVIB2hg2CFcI3fY67ERxFFmRFnmR5JRwVSUlfjWRfrdNdXVX1WheB6lXW0cqHYIAmdRTWHcIi6MhaWGOtlKHwniH8KiFX2h9MuWFWDiDVFF5GcATBqBq4NdQDadau2OSd5d3OoEwDUlaoCiQ0jIBTiJ3cGV0ACCR/ASPi2iH69iF7UiJYSiJPHl/PukIL7EBaCgTkuEsltaRnVcPueM1CUmSv1F6HRIqGeJxIKR1MPmLivh14/aOYBmP6TiPtyV2NGliRBL/Lc9SMDmVEhkgb/sXd+EIl+bFlCVVcMX3TteEl4KwP8tXQIdHHxYSa4tniqu4WKnYPEq2ZEN2MjEQNI6iSzuFd7pDHCfgiueReTGTlZhFbX1yV/9lfp5pWmWmZ8BYjCqYbtQVjHo4lshYlgnmkxDlKASgJMKHST0VAEPZExQQAmn4hOTJjZ5IKC4Gna8nneeYjDl5jO1JnTZ2lt5DPRcwAQOwbTahljzhAA0AAeNJi6FYkukHgKoZhK/ZmiWToKsZHjFACEHFTWljEyrQAcgBARxgoYxWoOVJoOeJKOnJnIw4jHgYc5DInjMpn845c7gxKQvgVkwSMSOwAjEhAZw4/4gmuINsmKMC2nqCuZ6ESZZhqYxBOp1D+p5wAyYD4CSiuW0SsBQkIAGdyKMdepccWoghaqI1+ZVCaphkp5Pq1pUsCiOKsJYu4Z9/iKM+2KNQSKWiOIQF2KCHpKALiqAk86CMcKEZClmz+B60tqaf+Hzq2ZxwVoFaGp1FGp9H2pNv5AMbgKeD8KAUUANOYQIUwJZ9iqV/OqAkIqgi6pUrWJg4yago+mte6o6q8wFupxQO8AE9kQEqUJQfip6baosAySgNGXLuBafwRacoI6dzCqzZIQJCkAMycKzIeqzGeqzGAQMc0JtXeo24CJD/5qGuEiWCQDn6tIuWlG+VtpWFKf+mjBmqXTqqZgmfKbqo55osHeABNiCVz3KasJISGAACZjql2epKGfJfBamrgHdXT4KtdukLCElyVflTufp007ZT48KX/rqchwqk9HiTtkekEyuqFYukWGMALNAAAECbVRUxCFCQzNgAlCmrD9WPSiVURHV0IUmXBhuQABd1jDJ1KWmf2tiShwA2F5ed4Nql4lpjK2qoQQumz1mMPEcnGuCHw4md1GMh2ngSNvoYvsEnzAWwdScPZbOUklOzsTItUFmrMMMh9ZCw6IRxTptvitdOGNm2bvu2FDkDcSUP2kh8HDQQFtdwAIuabOtZ9TC2q2WIquAeuzY9sjZSPZurMmn/qkFLZ6F2tBGbtKW6peopufBCAQJAATmxsvXhJCcQdKDRljl1tcP1b0w5WJt1nIcImiqSsM3nlwwbsj9rpJF7bEarmJVbfehqquZanQliAQIQlDnhov6SAFDiNRjAAhiQF/1ilZzbspmJtV8rs9aqYqX5KN/aO7wam8IKSQxqp+GBgC1QHA+qpB3SagDDAScwPL4pM/wqnH5ai2uoqes3qCNqkxi7mEJbqFmYsaSaJxDQAKDLFYpAAnfhhGy6o4DaqfX7qepIrrTbu/O5u5SLtLoLIy3gAcvrFItwwJkaqPJbpYywuGDXuDhnaiVatBQ8mKcqlkIiATZIEzXgAjxQ/wg1XAM9UCYIHL8OuMAj3Hi+qh1BLMTd673gO6yKdqEhAAFKyAJMDB0ausP028Oc+sNZWlv3y6UR7L/rmqjp2sIWSzXAmwFLEZSNkBUSUAIBysM6ap5uCsIo+KOEmphEK8cnLHPlysW+ux8O4AFSqhQfQKln/BMUQJQi2MZs3KY+TCijmEhDvDJFzEKP/B3ZAQEswAFPbBwiIAIP6pgZsj0A0xwngMlN+MEMTMW22iGGBY7Ue8o+KoHjOrT9q7+Om3OznLugShUBbK9HMQJq/LECUJsVQJsfJRj1urxqGorXyIutTLABh60QIzF0x1pXXIn7S8e3bMG5zL/EWLvbzP8VIeABb0cUrZoS1/koCOCL6+UkSmEAJouvIxgtXjOOBmmlaRWz3XQ21boejRyskexI30uE0xECAqChxgEBJkAcD1qfGoMA35IcLbBosligSCe99+avinySNlsfxpkW9dakTkfCLGzC9rdlFEvLd+yeEivBslw0mCsCK2EA0Li5EdoSHZkTKiCl+wiRO8Fv3NOvT8e1w/WSAysiJimVSUU59aSzMMl3ykV4s6uo3lzB3JzCdlzSa5bNUx3LQIG5ZLwSEjDOwys5xMxcN0EBvYephmAhg7CkwMl8d6u1czsPXoOVABC2ISwIgZI7QD1664wzHcVwUf3FJD2mj4u72vz/wLLczSrsFn38xygR1jxhvt66reT8nyhrq9nKd8y1jUzpl0XdHqBJUeF4tkjZJ8o3AEfJtnDb2q792poitz+Mt39Z2fIBUn3rknd1vfXszByKmaF5VU8HsVj8zTTH2Fdt2LaM3LAMhoMAASAwwGdNozJBATYAqYKA3ULhzier1tdWFrEb2rSa14n811Alvc1H3NZcyyh80ris2FXt3onN1QbAAQPcFA7wpCuBpnOxAZcaG5KhlVvHAK57fiJs1On3j7/pPwrQr4O0vUZ4xL0a0HGaHByQAgZdHB0Qi8fRASyAAgPNhMZzCPIqlRMA1waewG68yCDqqRE7x8dt1c19/7t1POM/0X0dENP8mRMBLNZMIQJlGLqmbMW1Or9w/Mr2a9wmnb/vzdXYzNxJXlMw7ADtDI1VUd8jgBojwAF/SLVDPt6obOSurN7LmNIqytWN7cW8q8cTrBKqeqk/N85VsQEwfRr+CaDM++UtTt5THEIQzpoUPuH/LFnHIQJJjBwVmhwhIOLPYckZPuJXWt4rXsVgjuQO7OQxLt9bfc2ZzuTzDVOGzolHIQE5LhMZANmRWgh4agNl48GR3ucZjchjHpjNzd54vMUojdWHXeNRXjqYq9NEkQGauxIU4IwErAiuPqt7HubT6iTsJd6C0s+FNMmULOGCLtCVx+GaLNGFTv/KCh3XMlPi3zGL1/i+0J4LvOGN1bNcnRll1Vzmur7cMt7rzh3fnr7pN/LYS0EBZpwTHXDfm0sAKUmyQ4EBeO6E8vy85dXbCH7PCqlUTBW4iciVyY3pS57Hua7c7X3vKtzHZagUFgDsN+EAyhsUfpIhUHsaqJbW/FfRXkO6574q/YKS5u3QMT/YjFvxnH7xuN7kO5/VUH7pOtHHoOvvrtqfIFDqVHEB02K3seHOmLjGfS7UoAUXDi64qUA2kRZ4g9eRTA09UiKa/aO9ByrQZn/tZz9kKeDtxrGEyYHQj/7tBed0ftUcJnDoyoEI6pyV/VY4cu15uWNXw4XXzK7Xedn/UcUMQv/oJFuySc6b3rRO77au0oSa5heL8T4/8gIA8IPgABqwFO6c5VnB9ANuvAMQWksBw8Krg2wtCB4XTSCH0Vt3V+MFvfvs28jn7N+DVx0JUSlJMyItsYWNmJ2O+Z8++We+v2K6ewLQ5UiBARpwrzbhzv89FSefr7tPGKqq08k8rSoSPU0ns0xp7gwv2pHxkIMAl0HFAJqkcbD9/vAf/xYh24RC296Pi3s3LbnN4rsACAICAISFhoeIhoKJCASEBAyPkYqDhgGHl5aYh5WEmYWfnpuapKClooqjpqcAoaGtqqirhZ2ysKyvubG3tgC1vL26s8G7r7+uxcm4mgYN/w0GxwYSBr0hFMuJ2aEUAs+rv4ULnQMRAAnkiYvZ64jq7O/w8fLs7vPp4ACNjwMHABeTtI4pG+YLG0FhBw0SEqgQGEJirBhCTNgQWaqKsR4C22gs48CJIAM08/YLwrRhEkIMbCBioAMBHKh9yyau0IAKAAqga4fPnq+ePoMKpQfUXj0A4gQpIIRAEIMCnCSC3FhLo9WPGqVy9IgxIleKYENy+rg1bFmCUq92HQbBmcxaBkLIlCVBgloJFNQ68OABxSh8TQU9QDpAEM57QyklXsyYZ+OfiwUFmEy5suXLmAMIyMy5s+fPmDeDHk2atOjSqFNXPq26dWnWrmNThsCBA/8EyqchtLiNOUQI0r5Jo0iRogPnokaRxzv6uHnyx8yfr+1VlazaYVmtf52a/dR17tsLTneo3av38mYzNYt50YAGB7o+SOBel3szAQ7KKpcX3Wd/5wCu8590Qx31HVXjHWgRWujZouAuaTV4loNjJWihedhJeNVIEIzlXn65UDDfVCqMOCEAbQlwjX7NDcjffgHG6OKLkcEmm2Y35piZjTrqyGOPsv0IZGxCDskZbbZdJgAEJhiHmQgtkCbCb6PRJoAIn8EIz4xbahmjc1x2WaOGFYJ34VRaffcghhSeKdZF6YW3Ji1ykmlIW94Y894wFLAHFgUNdBiWBAKQgI2XRDX/FuaXYOJDgCACOHIAA4IgkIBjiRkoYXVuTthdnOd1GmGnD3Xk5pzU1emmAyl4Aww0+c0CqKAUAWrAgnQJoNKhLYIT2AALIKWAYYgxaiym2UQgQAIVRHLAAINFNaaopGIFoZ1mmjUqqNwieCq2C6naLS97+cmLewzZepWtwMRwiLsAUDCDXcogKiBQzQLAAE7K9iPtsQAvVBQBSz2gwAPnQPVvgUWq1rCRr0Hc48MSg0ZxxVlizFkHKSR5GZMd8CiCx5+NzNtk8L7zWq/rTHCBP08toMClCwdsLKSCuGDIAYIEO+kFA0xQyAs426sYteOi+mm2bSZdZtNMn4ireE5X/81gqFaLstczyEhDzTHsngiDq7w8KsjLZr9sptH3QKozIQ8IoEA/CzBwQaSGEA2pzQAPWIAAB0xwGAKHHc0wuFRLDe7SimMdtakZVut44o1HnjXlU6PaytbUuOJ1uIaIQPZDDpgwV9lqmyNABM+W0zjbyCJCMADonOO64Xx/GR0CwSpbwASRJLBv7EFJBuTFGu+YPJHLt4Z885Y9fyPHu2EGQQgns2byaB2YcHJl7prNwAHKMuXIZx2oMBnsNQMwaT8VDEA7TjrdHlDuNzsKqaSUCmAp8YRggCMAEDdILQV3lUvV5dR0rW8hzXKPsxacIrjAp5HHTRRIgYl4gQG5wP9pVspwgAZutQvhVSBuTFEbQhwAgg6ADhHlI8SwIBWt9iVgAkoJ1gIKI4DCIRB/jYLOL5IyQEO4rH2a41QFJwc5CjpRgRBMYAKbKMXMbUpc2eLGrlYhQlqBjgIjvAoLQbQLABAAATHUR1nGmAnAMOdv/mqfUBYFRAJN6xBqDAfgkHjFJYaFcUpD3Lae6CkLBvKBUKsiIbhBL02IkISpyMCIrDLGiSCgAMIjQAJW1zpiYAAEZKScHhGBgNTJsXjsq2M26HgvQbzAEHkMoA9dULRa2vKWuMylLnfJy1768pfADKYwh0nMYhrzmMhMpi9nAIAKOOVSZkOAwIT5SkLUxBD/EeCHIWiJM0WlUpUAnCNgikjAAdAMgUmU3B8bmDXNUdGK6vRWOwWJRal9QEW96MAH0LJB0rEgVlNR2SHaYoGZJOKahVAAOU/pn2+C84fiZEQRE6DQYl1OiYQsFTuf6E5DxrOQE1SkH1+YyAOFAJ+2oIAKTkEol2jALw0RaCEMwIEVoaInCDWjOe/lzYcGsaeGSIrcHjGzewxJetDDUVJRg1ToNdWpFTsplp5Epd6clHveIw3HilMlDkxVSYygoTkGsFCG2tGnd0wrKuk5UpBebZ6IvGBbp5YmCV60nsKQhgdgMAoKXKNrGzBUXcHYuWTsxQMuxEYz8vIXljGGlWhd/6VDIYvOPmbUrlDkKFuj2NHJ1VUhnaUTE5PRDA/AZxMfWJHnGrCiNIWNknw57TIWyyIhAjWyan3E/qzZP4tGFJGhfdNbNRtXeI70nQ0KLuYSVNpQggIvbGGtaAkiurloRASxlRpta3vbQvwqWDr1n29x+9tkLYtnpjTrcp56nKVGzL2mge9o2Ls8+l4GBRxggZMuo4L9WqZ7X1VqZrY3GhEIgKugoU2Ad+TYROQrbjUMJ3nnMaDZVUCaPM3UZ7X1UY2ySaSXDalxQ5xZEJtYniWNBatGN1MNJJaLLfToIgM1EG78Myw0tSl3HwuUIwowURM+XCJ4JoBgIYCH45Mwjf+AizgPD9fEyh3kiZ1MUihvNsWlKNfp1CMB2ZqCjTImwQYgWatueDFlhEAzS+rVYEPEbW6+4CGG1RtkorgNEXCcwADtRgi97U3DR5WvxQQ9aEJ3xr4aQ3QAYJCCrF6mA9gbcJNCY9XSGNhjaF7Hgg/dqzsbYnbAch+0htbNOq+VlL0TQAEgcanh0fkdmhoPRqdczw0Ll5BSVi5dF3dluRKDkRx5ZC+qW+IA1Ic73MhTIcR3qcAIIFpqcShkdpbk+AHgiJ18tanDaTa8XbtS57yfhq+s61rzurgdDo+t3YprvAJ7IyfY5zAyYLonh6CfuzCwqz5xgQVQ1BEIiPCEHLD/UlEKuRA3zKH7+udDcW+bwpNlX6zHNetyc9iBdx1tPJE7nSjXUwWF4tMW6dJIKDajJQohQTesi4gfB2bOK4yxwcs77odD3LYtL+IBAgPegATa0O0FetCFriSiK681Uh3wCjKjG/V5RjQKLs1JSUaZlD2AAeesXys2pl/cmPfThZmztmEtbZ9SlnhETCjWx5vOuZob4+3W+HFl3C2Pa9wAG/AAylcB3Vxsd9ci/KsyCCUBLwLj6nE0HzEq2cawdgLCQM6tzTPMY4kSIpvhrqys0y33Kh8y45xt8oc/H/fQNzc+Bd1IBzRgU7pWUnGEP8s/aDapBOgEvLl4feMP2okf/0e+5pMXkzddCcsBEoCHoSYEN5XJ/OY7//nQj770p0/96guCmTP0XwICozZiVhMpnRCAnLdZtO4Gn/KSV+MZCVGBAzq89LQG7UatjG63e/bcoE9kBzywb0PEBQOlAEYvBjXcsGWxQFMCIG8nIlOE4AA3ZlCIgFCh9iwCJzDmd37jdXDFRwg6ARX5onkUx3mhJ2LJ1WsjFn/FVoL1ZwsrxnINqAGGlwnq8hUk0AAbdh86phEMaAEv1Vi8VwjYthNj93sYmIE0B35KoVsC8BR8tHn2N4LTRVz552somEjrRmUnti0U4AEtYIAAYAEfQGaiUBeFFSr18VksdCUu8YAQMf+DpOBGgrFwxGKEDVWERKiBqPRzRrcae1h0fYgbf8iHJaMrA1ZVlnE9hugZTbc+oLFVm8YZMDBpJUN1kwEBJ7A+bYaHdghR3aZzCiB273dq+WdxUOh5KjiFJxhcHFd3JqgJGZCAHJEBred/NaUQbWFTaWIB2bUuXFMMrzVThVdlwOddgpB84FdW07aJSgYAynIpwiNeyyh8oyh6nbdcHdeKT2iF+Ad/DkEoqnUIKpCDheAADcBXBuEAHDACJBg6AmBayKZsrEBsqOA1u3eBhfCBOuFtQ2hzFXZAdnMBoGiBgHY8gciIBSlgf6hoFSMkupECj6gb/lUZJ9B1ozGREVn/JCsAE9/jGSXgaJ6hApH2XyGJiTiXCEFoMMh4dkHWH0RmZNIEkHS4ZNMogidyhXhFFrlGjSl4jfXXDCkAULcgDV4mCoACgLwohtYIAIRiLhOSEvNQcp4gbLcgbdHxZgdwABVVUdGIgUXzNoYAR0WDYX6mkskIf6SIZVFIf6hIk1Rok9V4IAKBAQ2AWJsgbLnwASPEHR8wZigGC9IgAFB5FnURCs+ybGdDEB1wEjfVaTlzCARTQLvVZ6WmjKfEO8yoaoUAk1tJhG1HYrfWl6SXhTcJd0nJNHYHCpyTC2AoE6EQF/h2CgbQAibyTvcxHxvSAIbyCQVECJvEOjsRCgTn/4Pm9z7NJD8JlZJl91DR0YmGoJn7yBN6mJAHiZB9qJASAxscQ4mTIQJO9zFeJRzfOXST0QEscCWkEXVVRwg8c3mVoA+WMSXHkYkJJzc9BwBa+ZzbRpahWIdMRpOAdIrcmIrbWJpTdGWMxJqG8AF7hwrkOAJ6AQIWsGuFYAEp4AHqOBUd0AAXCgzrSUDtqUKLtE+tKShU+U36iVsnWpaiaJY6iZamyJNrmY1tOaCdqUWl8AEOugkjAEqKAyjOJU/c8JMK4YBASZiVkEYDdAl+JQtyuSslao/KmKLR4Xv2CSmgaDwTc5DWCTFbGp3SGQAntXQfI4mXQWCgoQIeeWiTAf9y2skZIxORKKOeldCbnTQZIbBp2ckbPRFDHgop9bmfK0qZAll5QSUIRXQwkkVuLUqFq2ia2OiZ7EagDEQt3ugQDqCYr3BvLjgMsfma1IF3AjBmalGDSKmbYhVNhaACGwoLqSmM+eAOBkN2ULqJUjpOCeUUiaeinVmFkdqoBbqCvIqFblmKUiQAGmChttABfCkL7lFwYCGXC9qWNjhJyUCGC7gOGzCArTACHsCX9XgICAWZyKiiRyiotWp5hiA8QgOCUVNxLfqfMBqgbCmhcJU10OCOsqBSo0COjIUNFgBKVPYSKHUiELABCqiD6zCUAGBgs+mq4IcIcaMw+LmZwVf/q8TnXWW1fspnfRzbsR77sSAbsiJ7TMxESmLlfaPUDj23fCeaomh1rqQ0QAtgKZnUhCEooyc4rC5arKNZry/KiheyNQLRd5hQlPSBqVxxTzboEiBwAmQBSwL3CYQSrd9aqEA4GA+wUxR7h5QJs3qUhJMCbjbbrvPaEDrLqJa1s6pId45qIdw6QiXRZb2gAss6ITSVAaAFqmP2WSPQAAqbCxhgA44HcwDwl/0KgbB0qsVYgYM6jIJKrma0WwXQP+nVuHlIkAXZpV66h5orGwZGJaxxPXAaAIvIPSwAA6XRARwgAE5HMSvQpo/GAkSwDlpXiRyAYAxWksQofsGStXG4/7X8WBTN+AD0g5kTG4q7epZou45AG6OQKqw0ShYZaSKd0EWkIJeH24bvcR0jUKG4WAzWOiEUYAJAia4Ziq/C8KTZkC8npFMxaYf9mK7GC1E315/ZCK/NK684O3oAmkCVKlojIKKOxKNXgZdlSBGvyIalebcGUYOGVwi1d3sA0IIUob4maUrZ9L5FyJI9A0sNZ7n8OZP3O3+huavLO3fM27bcMrVjQQHy5go+OhUQoAEHWwygCoN0R47mSBH18QoIx32E4AH1VsGZCDdyE0dYaT+AGqU445WFAEfmwGekNpnitLlG17lZmrlARxspcInRowKPGABoupEbE57cs7rdKf+IZcoBo+udJQA+8ZCInCZEnrZsB6QTAjeWjwtRluk7O8S4IHxWybuoORu9Tkisa5vCv5oezfUqApB687gBI3cWgKKtD5FBHvCNJJgB8IiY0tULDAgRFqye1SY/BCOxwPtwy7lbdwMplUuWE0e2+3txPiuabzmgZyughtABIOC3zKoBcclaamHA13FPHABQVFSwDXsKI6DAPswO0SafOESfVSpWx7uSEVcjVkx0WOwjWipoefpo2GMj5OnFn8EkaXzOJiAA1SOeqhvGl/G6ZBwAOxAPK6O7mti12ey4g+yfJNy/JqzLtZzLa6GLQ6w1J/ELohMrGpGhs4gLeyEAeEv/rztqyaNAhq8wwzVgkoe5NkUcqOa6z3jYzyPMv/Fqy4iMy4a8CowUItSboAd9yeTbEBnpAaknoZxcqpjQDIYCDA7QhdkwPn+jMNGMz+Wqz0YtyGmrvIVMmgFdtk9WwpsAbK+wAj0NOngHlQghARsQg6oAqg0AgFboHi+8C7y8oZ8QwA98CJtE1GyW1CG8x15rCFTKFOCApd6sxd+s19ATppgBxtETAPgFz4fIAW+sVWj8GmbsGW+KGSUgpgGQac2pQqbxdYU6ri2bnOA010hITq1MPCT9vGa70rKc0qRJ0GZxUg+NdwqLHxBaUix0oevCF9nra9xQpKrA1TFoADgK/8rNKXZFjUf1kI+YbaKarUqcrXjsJ0B3jdpRyNSj7dRpe8Ke6auTOgvukQKreglCSRW+nEgrENZmYRLd8KMXJA0bUFfNMNGHgAJy69tRnF7BDa6dQIH3ec1LTKsRd7HKTTAHgEKFwLIjO+AEXuAGfuAIjksluzM44wgoa02VgJWOcN8CPqvwK9IbWM1/hrxLTcjRXctPPcs7mb+s2gAAewjx5oJZPSpySQLXsYUpII7eEcMEGt5izQskkAEZLQELHso7ZrV9Gpn4HchMnNSx5KGg3eH+bNIkHuKifX9OzTnAQAGTfAnYW5qXsKMFdRfdYNGnoAJ5+bPS4EGmIA3qGP8KGMABHvA2MnAIbd4VOAUO902/ZxXSicCcryoAlauiQuV+SD62PCviNUnagW7aAz2gJ8B/CEoIsph7r43lOc0dcgmYOn29DVACMkaOLo4Jl8rQhcCtHHDjnQWHz2YIc76f3yWHpZ7K+Sm8y0IwCZBtdL5e2yx03Zwjtx4kFfO5f426ZUqmDNkCctwZjCYAkA0aI2POgLjGowsDKkDGJaAr83wjo3wI+TIBQtOMrG5q8Ss4yj3r0siiSx7VAD3dAi2FP6vCKlflrG0L9HY6DEGOVBsL98SjMszVB+x5+G4LH7ACO53euSk51W5EL7MTRbbtAVIY0VIYajMse04Jdez/Ph2sRqUkmVQcqKEdrB+O7iittirtQN74Cu4t6oQgDYEpED6qFpMO1GGBjlfdRGmOt6vA2q/Ayzbt8bxCx41pxHB28L5QQ3rMDklBN3FIZIA8D03xMkmxFEYvq7QLON6eD2UFy12a68yz14HYpddjnv+VprZ77MteGWMsJSlg7KXxum1skIvGAspOGSfQzpUhAo027RPz0URFO67j8+BOO6WeNn2aq0HxKEvRbQcw9E6PR6m2ajMj6/m9Xoo67iOuwvr75FHk3Cgyl55OCAHs6LL9NAx87+WtOFkthh3B22GECRkg80FJKM6K80SMz8Rpbdh+mZkHucL9MoEx+EPF/xjiID9NofCPEpDcFplAjPCWm/Fnib+S3/HUXYXW7RJqjswhuhFjI/1wwkI7PHCri7S4YAGf7Hq4aQuxCcklbqFYuCbVPp8K4DP9w7gzEvy0MwCFsXP6uBiFsUNkpedNMa57DwgAgoOEgwIChYmKhIeFAY6QhI+MkpGDk5eWgpiblZ6GmgCcopqjpqGjiJ+kq6yZraevoLCogg4eHAaVHxSdgyS5raokDQ6csQAUHim9sr6DJQ0YzqnFshYbEI4jHtKuz9/hyL6qi+aKjefqgunnCwID7wgIAg8DAgvr+vQMAggHAhTcy6eunT5zBg8yEhCgocOHECNKDMBwosWLGP8zRqyosaPHjhw/ihzpMCTJhiJSmIAQUQUMiSFCsLwoAELMmRltCuDQwSMKDiU6QmhRU2KJoC0FyDx5spzCRQmfGnJq7l4/Ag8E9Bsg1RyBQ/UAKDjEdV3UrgDOKkw4Tlwhp23j1nIWjqrcVXfppio1V2/fun/FkRAg4ZsBEw4qGdCQwS2jBiSoOXIAgrCBuxRAWBg3yUIDCnYxbLDwDEMDZrT8pn5FFS271l3VFqJ36ADAQwhcJ3pXG8AF3PpkPxVu1m7gvaqTg3O8HLly5tCjOweXt/nf6dILhRAQ2ZUDCdokOdDQbJwFAaQlE1ohwMMI65IMbNigizOADNaowpD/oMuXsgYdXHdcJLChRVxwBRbyVUCCjCUAAbolco8CgmT1IIIRTqUIAxACkMA9Wh3wlklMlVTiiRmRiOKKJrLoYoskQWBCCiJE1MFSEJ3AQk8ZlcCBihINtRMKHp3AwQod/aQCjBCogCREOi354kcFRlDOgheik+BaWw7C2wWC/IZPhmS+VmZCvHVICAMVjDigMKvB99wxoRgX5zfVRWennHxmR9ee8JnmQYCZUFDYNxRwMI1f8hUG6CSUCaDCXxkoulqi6bFjiwTGFNJBA+71SeedscBGWyJWJqAlmQeW6SpCXR50FgJqCpKAAg+4SWqdu/aq3p9v/ioqr3gFOyyw/7veIs0xGTTjygfZoOLAZ5oWm0F7I9xlWgZyyRctJSR8UB8hg3lz7LnwFfhOIgRQuGqGrb4q70Jnmlrrb7npOiex6PopLGC+UmcswP/mWR12cYFG3zcqvJdJo9HBAEJi1ToDgQYCaDCNXMSQFpcFIPSSygYOsyKfACUYazCBi6w7yG0EJRLvOTPPK2/NsB7yAiG0JjIBmIK4ANbQRBdt9NFIJ6300kw37fTTUEct9dRUV2311VhnrfXTOwviMiEFCCBi0ESzGqvNNp9lzyG5HtCPP6rqy3OHD0wgCAN20xswwf72Oyqy+xa7N8KDq/xWXyc7S4oD9I3SgWaqLfYB4f/3CZBCptCNwELJzFG2gicGfDBYIRB8IMDCKweumrrlIJCPlQW8S0gFhygQ+wIOtinz2WjfDFsFuRLAVQUMAHDAALnKDQBvDBbwNgNja1g4Jar7fSegfacOuMDTK0f5K9MOuo24iHJAsXXTiny4JKZlHF7kH2iAwlz4dZoJNtM45QAHHjirfd+OMRVYggeWWumNEBOI3QTsxiYAWCl60uudBJVXiAhw5QG4+lDsKDgcIDHFg1MiCQhDOJIRktAjJgwADFLAASJBZAVIgYgKVpIREfBkIiZZoQCepJEOsICHGOkAUIKkghhypAQCMIELT9gUV8mmAna7AAMKgLu4HXD/ggoRU5YQBBYXFOIACoiA8RhwgQHkDQAvKJtu2DIwuAzsYPyyXvX0xJfu8el7m7gWf77xAREoZgOFaYsKNNAfvpluYqKqX5+icT5MOCAE50sLADCAMW690Y6s4F1xukiIBQxARAsg4xbRODSFHIA2uLIZPSA0FgPCahEFQJ4gJqA7BOjuirHBXp7ciEn7wMmO/+Mbni4ZJzwagCjdMdkG7LcJ05THEouZ1C+nJYAWFHIcGOBAY5IzLWm+IgOWZAQJupGYYP5NjposCGwwuMEBiPFDYuSgIm6Fj7AJYIOu4o2q8CUr2LQLnxMoXgIaKM9+EnMWcqxeW3QpIEw+6qB3/1yfLKZ1uUqMZ1yDeFymYpG+hSbDAx4gwTldQYwTzKVjpmBcOQmBgUN8YI6+hGnF4NUaBDDAigNoUyzjiUuvaKVBoySTlYhWPAwlwkFscxturBhBA6WQSkxE0VOjShOqlghIKWlhREQQAonYcIkWsSGPMKKUnYwVIzLCEUZQYAIV4OQhJXDrVlMggBNYVapOpMptwHIATx7ilj1dBO2IBlgy8QaCBjVbhNi4N17KtJhxBOBIg/nQXtYRoZ0wXSC1o7hJSOBbeoFWf8bhgEPscZiSGAEIHNaWFTRgo4NgnEkftgEBmA6iqH1sOmm2W9mp4yvu6l0/8kYAoBWnXotl6P/1LAvZXz42ocup7HMjSr1BoABUzxTEYgh1icU0ZhyH2aacximAzq7imAuTEyVVUEhWZEBcx+AG5JSrUGL2Fir3LWghPpSlC7iSTIOFR/KOq9g1ThUkd21KghW8YJGEZIU3hEgHWvDWhgixRkFkwUtyQpQfdcRIQLzICjhgVxuFoMQPYaukZnLgBkMkv7srsD4OMAGwTBGLXEKugXHrWOhCx6PA5PFlfRzTipkuBO19RLjAkahGRoICxYhLpF760NBpLC6UJN8oSiBeVoyTBZijL7rMOdPkyhjHEsQZfs3sUOZ6L7L/I3N1uTfdHx9OUBQYRelKhon4vc8tn8UoXdj/EypJ4mVa3Wnta6+xAe42E2Mf+LOh6zzZN8FYv4lFc5ov3dRcCpnSDd2eZN1c5kqTOhX/WWlsIakYxuRWEBBogHiRcTJzTRocjEzOepMMgNB9txAr6IbHJEpk5nK6007V9ATV7NtBcMhWtLnpiKbU4gZX29ou9ggEDiFXiIig2w/x4YYvIu4eskBSL57IT2KIkRKwAMUPOUEIzmrhH7E73dku4SKsNIi1haXZyVZ275gd404eokOnTMCtDMjYOfZ41M0VdZw/XTDc/g1kAuDcI0KnvvVYg85QdrRbBuMewqFUWg3QMiEMoIJkulcAAHJusUF960GcShDAA4Dw1kxT/4Gvw574NGoh/J28UJ5lVq58Ni4pS2o7yxziM8fsq6FO3WthbDKceoZ8kFwsA0iAP22BQG29gZ2LqbwV0YCtIEawgflJAmQhnbqYs2fflrXGgjyfXe02KDx/APwcQO9d4HOciJzvHCDG3Z3O5qagopJta5CPvOQnT/nKW/7ymM+81rq2PL2GkRBCK2UhEgiABQIgKwMu+EEG7/NXmgPvFchX3hk/CCky1Uxtpvmbnz7x3Fec1MH+eDm8DgNIQFnVzpCY2mUxmBRofH3e+nMs6mcKEpwWE9xwvuCkLueZsw5sspx9IaAIAKWLv/X7PUTQCawIMIoRASCCnupp77bEL/+9jU0vsjB7X2fpRt0XlCQAXaYKFiABGKBngSYnlcJrfwRzbgcsntFxzeEZ28QJGBACzxeA4DFkNdd9VJdJdjcI/8RbLfNJaQEishdY5pAA6tc7LHhPHcRJgxBLyTMBHUJGgpBGouclYEEhFlI70/Yi15ZgQ0iE+fZCLERvDHEUEiFEIRYkbWVu6JYiMwRWE9EkEQYRcVVhAVACKfBuJXSEDqYItBEWSPVvIyKDp2c7ghAPxhN+pAQWT/GC6/cqdNhBijCCgkAA0kZQKphpPvZwHjh1eER3vkdn/wcAKABpdbFMzAcCIpdSqxUdhMZamlBaXXZxDfA5lVCAwzYIFvD/I7PGgXMHR9NzbLjHM9I2S2ByPDyFbOdwh2gji4A4CGeYKzUGN/PnaYc4iPpXiKbYfxzogSSQApDzDYPBa41yGaHgWhRDa2O3KMyBH1UWPwdIOh8wir1mOiYgjU7HfRAlZ6iYFnpFNLbxNoWVivpAi/PCjuzHZq7RcP0iiBa3XEF2iIRITAGYMq8gGufhCCCTXbKwddcUCZHiTdaRZR34dpABDiMQAt74CNzQP8FYauFYdzoGj+vYgrPIkbUYj5d2CNQmhilCkiXpYiuQhBKxAkthEiqgVUHEARiGEeyRAuN2ETZUYh40FEoUETbxhCqmVh9kkiCRV2e2Du5ohx4p/3QayYvCqHvUJXGGg4+mNkefIoDggAIkg1DTwo9+QQzIFw5iB3MbownoVUh2olqcmAnWJ2j3YYzLF5UWeY+6ZZQ9pxBJiX6w6JQB95SJ+IvERnWD6H9Udy0fR1JcNwskMDFhB0ijtQoWcG4vJScgU3xzJgrewoyE0AESoHZw55VjFpgeKI522ZR6eZeo6VQjSZQ4xJoWUYQfYSQp8IQBgAIhcJMNIQBsBW4WoSMzeRFIZJM5UYUbAREwoGFGwZsBoBM9KYSuSValuWOnGZ3SCZIU94EVuX9T6ZeIKFmhkzHXKAng5JZpsWgK2AAPKDCL4T4ol2gSJRrW9ArYwEyCEP9skyiYonmRp0idfTmdqVmd/fmB9HhqcLadgTiMgXECIBB33+AALbB8AciAmbAtP2YBHoCVbZFr0SUIi5kt8ZGNzzAetlWQAQOMBgpx40hwf+ifeHiUUiGPADSgUAlk0zWYCLoaXnc6JGoA4CR9HPpaugRl6TEOSOQBQ2oJuyYMlLRHnAADGyCNG2c6GhCJJ1qKoYZO/MmXLGqdLtpBq/mcDwGbViWmE7FCwhkRJ9AC9NYQu8kSIDQUFJYRP5FEXBgRxwlvOERiEYECLYCbKsQCszmmYPqaWfqi4zidKhpY5udAsAGju5R/NwqOJXqd+QgLJ9M4pCMBycQJJXCMCyn/CJ7hR7TADTuECpnJHBFaCeGimYKAASZgGf9nopO6n4rAb2vyX+rIpVsaAf2gAGORjud3eiAyYGCUgp2WJjZ3dFYqc74YqXNZX1S5NzDgAcfICRQAkZ7Qle1lHFYWnnQBARIgAIwZCifQkPDRMVTRAaPxDBngAWBGoJc5mhg5G+2ArOc3WGzoNUGVq+fQd2/zimTCX7nSD8D6d4ZXFgPld4onAJwHAD3Dg4UQepo3sRRbsRZ7sRibsRq7ePo6GwYksVFBeqYHALG0r+R4EFbySS8IsBnyFWVBsB9JCHhXfhdwAcbKrw5bK19zf40Fqdu3oXR5oD/rGPI1W5nwXuQJ/wPmih0aOo2Ww2eRsC2KlikEuEycMJZPip2kWI80932093c4ZzfHg0H/FS81lhsrKy+0U1Qwy0WH4EWE4H4Omxs2Owg6KIeJ8LAdu4tMB5XfCLQ1SqlVuQknA1+FcAKOWBob0AJQKlGeAZpuEYDyQwsdg6oawF6MEDruyaHGCLXwKqmBS6u7QRV6u7ACALde80lgxEq1cre8A7Np+yrAdTcCULC7OIOytFfAwUGlu7Od1rd/6ayfCq3cWamDMK3VOgihs5a+gB+bASehE2WooAwY2gpid32RcHKMkLWdQE0lIKGxmp9Bi6Ih+LW3u4ax84MHd76KUGNgEruuYk8LQP9PtstBekgIdbuLzOMuZZh65Pilg0oRARymJyEkyhkAItACVtgQRlICdfpiDawRQpKFFnGcfgoRbYrBRAElKpBEa+piZHpXAsQ2nQeEAGdTtycWZcs7wJUAvMGyGbI2CNBKMXuLtXezJwugAuqzvwe6oRmtqlG0jiAalqi8IaAxwmIA4JkcpEo+3GNl6RkOrqV2q+oUI5AC/RO8Q7usu1eXGSkIuis2trjCCjFYuRgz81KydRisWmqo19msQyurXSy0BZOjmEoIXEaiALCYovorqsVQOQoCRiswlBEZyJCkl8A46aEKAZiYWhtxzwpdpPnFuqoQszsvb6MVMMzGbmz/YAA8qCHMRAemI2cabi2Ap/V2wBLBVhRmQjpSTQ8MVxS8knqqheC2hDuByiQZylSVoscWLy+IG4iFqKiYqI4aGDIavrx3osCLiFZHouOpZ/HzjKWQAccIKCyHLXKyP5k4xBpwdgCADSInrh5QgTzcnVwsl+RLyQG6pW3czi3KnXDcw5FsiMU7KuHDvKIwn0zGAub1CZE5gJaAcenlGCXVjOZJCr7mCnbcuH6rf+n8t+vcpZ3Mova0ySRI0bXYzPPcnXKszs08TOMkvcqrAt0MAOOxgbQgGpMbr71WWx5gmXqRZaxaGpebZAW4KJMwTpUhvPLq0uObOr6s0QpyCCkc/7+HgNGu95+G+slgyssk9Kavem8BkKZrCgE+ostGwQEXTCI6pMovVMsWMWJ4+pMS9qpuBdVOPcBDzdSLsCBHXSYX/c50vdH499DCG9GDG6OWcMWeGqW/RghKu6maEIoZ8Jhz5qrieqSfQEnx2Rw07Qpsl54GgETC59P66cP4KbpuXdG/ZdSCdwgXMBYIENfs69laytFcS8/D+8P3vI3VhNOJiwnwGZFRqwFt51zk5cQGvVojNcUTKgHvgQkgkwIuR5gd/dH2jKXsXNdF/SCincbrOxb2t9SEQHQk+zbVncMgudauqdZOLUSl3BBNQtUBMGIX7JPuptUEbCRmJacmEP+nFpHBD8GSbyUkCoxvbD3AG8Gf+Jq+wwq27KJ+9uS/GTLX9HBG6qQIB3t6OgWDHGR+C7KKv3vXWszaet10VMEeSEzcjTYZKUeeoyACIEDYf2I6cTe16qG9rdoCGsfTwy2+F47Oq/3IVVIOSoWGFCSydtPgp/3cqnIPuOoac11jCp7R+1YWtgLhuGSvYRM7fpirqn3ONCrJFLee2giinMByh4kMnoG5wgIaOqpeN40XkY0JJJABf+YAr+rEeNTRclfjk0yv5WB6qSLg5DcIM4tpIgjaQi4vRS4AR54zb/tFn2dzt+S69rKHRUUAxnrM9jjjxlvP2dm3FirI4pF1ruD/Gfp8ChggARpAn6hlARiDHqnhvOMA3N3bmSZzLeazzHi9xXI+r4XwNe7EDmg8FWq4PCYIxoeegzv42QIQ5CarG4E+6GxMg4MwUNtNjhwrCA/r6HsYXCC7sdZ+7die7dq+7ZHHeV8zJmkxYNWuCOyEuwaOs3no58VO5EldeoIes/frSeeOs9He6I+e4XMG53uN74kIc1nMCqIxyKKgWgLJZNoUJyVwoQbY2lzuZJVgzc+7apgDrqdTlrAu6SPF7x5taeULALeeFrnOrygsgvkq4EDu8evuc2dxi1okANWNdILw5OVXWJD+HMn8yH2i8R4IGl2+x4e95S1Q0BylASod/8SVoQFU29ebGAqfctgmk43WisWeK5Wx/i8aP+l+4rWlZzd3vothDEZDY+CJ6s5jn6v7u4eHQOGv4d2sCd4rohMmMRR+asE5EQImwN5nLQAs8JsCvKfxvcAPgYX0ZtUphtaxLBFuzyKJT21kOEBjRMImH7PuTHidbdc9W/UbD9TEaz2U4R5W7MiPQEl3PGghoxwX2B4/L5rOCx+eIVKEUDqE3a6v9ahxPOuab+WcbZrOPfkLTtTvuMOYj/U6/0aDQUiG5nWufwkdSpkN8L2pwaMKr9PEZtiWugEdPggjwLiEUK5Yyde1/7mUzswc39yozfuUr/vnD/wYH+m4Xz3H1P/9koQ/ruCqpxW51u+t1kG9GjDIyAEIGBobKACGhgGHhisgI4eJGBsjiYYGHwIaGI+KAJSbigKcnp2ipYqjpKemiJyhqq+fsayyqbSolK6curu6Arm8wKC/wcTFxse8vsjBysutAgHR0tPU1dYB0Nfa29zd1dne4eLVHSwpJ9MCJSXVKyzo3CUcMOEwLALv3QIQJfnbHSZUQKC2bqA0GClSiBhnDRzDhxAdQpz4cJgzYRd7WczIcRcBAQycNetoaGRGk7Vm2WoFS6XLlDBvtYQ5TObMUTZXAiCBCYIiBwIcnBK0wUBOABZYZDCgE6kGAR4oyEIlAASJlZYaWBhloYX/hUeCBEgwuuol1bJHY5ZVS6vm2rQ438oFsPFk3WUoiU0QUIEksY8h8d4VTBIl3LW/Dt+ca5bl4seNbxrYICBDLRIZhjFyxHayhkKLI0EtwXTqIQsNBJQ2O6LB1VQGMmQYVcIDiK9sm5ZEyziy7rOQfbtUrHMwYb95g+3t65dXBF++JiBLfpH6MV8Ur0nMzr1h9+zlzk2DEIIeOAgtWhjUtmKeN/K+QqzfhsKECRTbp9WXT01ECxTTnMCBOt9Jk1+B3R2IYIHGTddgMdbpUgF0AhDQnEcgifQghBsm41ZwNIFInHBpfahbSiPypMFqAVhQ1G4AjNBIXIp00MAHpeUU/1sKAmygSW4AQCCBVjB+ktUJnHQgAWedGCABJqCdWCJvIvaGomNS9jYiWx0SE+F1XS53IS+AabjLAwP48oAhCPhywS5femmicCFmWWVLU95p2mOTqcOJCq+VNNmLNAJgiQlC6USBBwKYgFtksXEg1SFuUWBVLZaQpsgKHnjgyJZ57mnnqHWSCiSopnTJjEUTCqBAAQAcwICacIbJ15gYBubgLhWsScAAABCgQAIHDBCBRoXNCWSpy6KKJ2JWHnWYAw14sNUhDmzQQSuN7CkjCXBZAEJVk8hFAgizYWnICTfmaAgFPnpiwVM40rnlnM6SCpyp0kab6ph5TQDrBNIRDP/Acwkgi4yYuHJS5nHOATsBcwhY+EyyC2KT8YIKbhyNCClwMJ8IAo3Xwj70pTffNSeYIIBC4YjAQQkrRwMOCi3cR80J5Y0XQqMdeGyg0N91THRFAN9VgXTGlrSAwscw3PAhDwgwQMIOQucCJwcocGzFbL4JwAsUNriXAAhgTamy9+ppL5Vt+fvsTCoI8MEjTnJGCWo8lbUCkZFh8GQKSzUlYwgssmTJbaMYoIJlj5DQqVSFvj0TvnLrq26zWmY+y4MLKGD1mrVqrcgCAxxA19N0kT42hctckOHUirQpgHRg8lLAAKRPzKbFGAUjbMIIMLe258zmazmdbHcOiwENpDD/qSEd+Ij3B5nQZQq1KqwWU2yMShBlY/NKgEHldGUAwqSeZPDB+BYMWPiVbjNLP7/OU4p8v/XjYswAFlqAANQWPE484FWGaNrqoGYMWfkCeLSrzkaEBStDDK9Yx3qGL17AiwoMK1i6ckHZRkjCEprwhChMoQpXyMIWuvCFMIyhDGdIwxra8IY4pCEHdZGACiUwgwAQIew4gQAGqM1gCGNgBJd4MV2IDjprsp3YmggMB1pNVyVpHogSs7/8vUSLvykFT4pCicmU6xAZ4ECiirQu1/gGNeRqyrwcNTdxPYkTJ1gS3jJgmzOKanlfhBsgORe3/gmSkJ940EesJgAgFtAQ/wco2wGs6LpHMvGSdFGVhxaGu+MZEhSf1NzlukgLIVWGFS5iCiUE8YF9TcYEP1KLaDxQArlEQgPXwlP5NJELwdVSESLoFOT4hz9Qzq2YYTQmModDyi4VQAAVpGJH4oTJC1GTQ8f4COs8uUztdXNEoRpk5TDAAU89QjaboACRgCMjCqAPAnwUC1lmggIJ4PKNJrDebpy0FHmlZizJ7CbmQkmizSnvfuJkIzFkhYBNIkeT1ZSgNRskOgVUMosZM9rR9CG0E4QsaNFADzxCqjLt1Ec93LAH0LqBghCYYKTaaNlLqaEOFQBIGvVp1E03qg2N8rSnP02QMap2OwJa0i4Rxf/kNeWULFLq75tetJ/yKDFGnxgiW1Y1RFKmRxPA0c8BT2EBk2QpgRmtBQUbuKcnYiOAWAKgngJYZ1QPOlCoHlOhB0WfsyBaq+YsNalI9Stfs+hUNuZ1rgb1XCKeZBmq3s0TH2jA+GoRFu/hxBK+yEBWXwLPBrBvFYKj4yzgZYFc7Gh9ohToIQ97V2/aNaGvGKw0OfJXwJpJsBjjWFAjsiAIcCAF9Ahpz3A6s2304wQdA5kA/sMNfnBgIdxo6Uz7EwJ4QIMfCWHHbjm63XH4tLsNSRpubRvB2jqUtmBkHkERuaz05sYBKQDBGqsXywCoEze3oFbhPgTWqjzKJupL10z/TqCBe9aCAiF4FF0k54F+KrawrmXmeomJ18KyVrZHlSh5aWfevk7TveFkbUAD+clFmWA1FOjeIQwQghe9pAQNWGNNMEvLt6izcDmZo4ITQQEJ5PJdUJnfVCFcV9iOOMLsPVUzxfvQDXMYw4T9MJEnjFhlJvQSEvCEBNyJrQasYBXU+uVTDxHMHp2vLEkBKPkK/GNDiMDHox1XWwkq4gq/tqBWTjKF9axQKTfZyQ2zDgMsZsW0KVFDGQWvOL6rDfQIALoBQA9Io9GeSVdDHpa2mTQAgg+YWqNlIdgpy+zjaX5Utz/3CDWjFb3q7rZa0dhgMtcGwLrQ+cJ4GQa0nzkh/0AfAqACISnWRTPZ1PVykcqt3RcgyWktRKQSEZMBaH4bMEzFXaLGthCcWlcxrxC4NQCxgXMZKXAP89k5tUY+N5/dpux1/3HdUI6yIhbJOgb05Tmqm62ui70LsAHggA9IwACiyc3AqvbOSh6lnhzgAQ7EcgWQo55naQHjNVJlUWaunONus5JdNq4EH6gv+Dzg7TwP2dirhTD6QFxlO8Wb2HBi3QUYUIDQGRXm+xas6WpHaAZcYACdJNsQ0ZtoWHP3ISJolEEgoILgUpoDmd50cbXRAV/4Qxv9gPSoQ02Nltp0PCXIbs1evV2yB9Xsrk7azp1miAX43NeGEHqHc37oQ//423cAKF7dOXE2ms+Wrsg+crsPkxkJkEJwDijjBiSw2VRkIMY2YespTXPjecai29/GwAdCngrNe4Bw7jL5g1GebJUr/M4XNoatb+XhXrCuaQJ3pLzpvmtd3D0kCbD33g8RgdQBwOd/R96xEa7XxM7ElOyzgLQBQC3KiQIDN2qMjDAxJwKbWy0eVwQGHsciwVWFBJsd/OgP/u46IxTJdU59MXSP79a34vV92Z3scU579O6i166K1azQdvMvRdJC/lZw7mZYpld6otcSBlBOjwJxkRNjL/E3/8UJaBVHHxJaawQT1vcje7MBmqUIFvAzqHV+LGeAplJkA5hwY5Zu57f/V8YwczX3QYe2SALwJqhza+5Xfxr2UBsEDATDAAyQb0GUQ0I4hERYhEZ4hEiYhEq4hDm0Q7rgdrIDQUIEHeOFgwbHb2QSGASARfR3gsOngnsmfq9gAR7QAFY1GYl3VQ0gAqYgI340C9QiAGqUZyJwKWoBVrjEFSHAVfY1Lnl4SCNYfsKXcoEnVRa2ZMUAewqkbzlohbf1Z8DwK6ozc8FXP194gmFofOkkT4mQLaoEAOqUhqfgJIQiCjQGLliCGir2EvVkYJQwAlu2ViRQbhoIiIdIeoJYiGK4TOpHDAMQf4uYaxDjiMNYe7xgO34nDEVndNugUSUgACogDSIQAtMQ/wIoVQ0CsgLaoFLM9Q0BgDM6cw0txQGeJgImoHXYlQJcNxFo91PtuFHveHaqlyast3u7QoyPiIWN6IWFiIIkRgs/Mz0qMD3kFHGjkEbftmKU0S1fpD74pQqxsT6jQAEmwFX1JEyWh2cpOIDmZ4Lmt3IFCIZ9Zn+QiI+5U4VXyI/ER4gbuVbRwxmTsS1aBQJI8gnQJ2CfIDnQaFmKQAECECgp0VmfBYoawGWG4H1WEXpHFogSRn5NKZKtxZT+CG+yZowmyVQouY+At5IkaGfQ4wEy6QDmQ1UNcGbpJFdD8RRaYROocQmrQG7z0wkjUJSo9CQgwIbspomA1JEsCZX/6P+XmDiSKTmYVwkMc8eIDrKMzKgd1tABIXNTPLN0LcAf1IAe13hpPKJd1iBdQZMfMkMzARICWtcyjaJ1DLKY3BCPRKOaPPVyhymAhWmYdzFoh+B2yfGahjGIXJmLLclwDaBKFHA3Ejc9nuAAkgILceiAL9YATDIMGZgKymeUToEJEZiXB4huKsmbgLmL6daLJXkIxbJNv4I2Nxib53U6DwRJMyib+riVgDmV7ZZ0araHhzACLHCBlPB4MvkJmeEBXwYLqKEpYwZWLVBf0YlKT6EBNcmLeslefNmVgVlIqIeIWRksvsA6VTNssGmeu+dvFdBQ7PlhiomaNDUNSUeNkRb/ApMmDzUDAQFxDR0wIOFYDSclapomXTB1Ai0wmi4zXUfDmkIDpBsjpKtZlaBQbxBkjxzahTzHJvT4g0qKlU75kX3pWpfwn06ShtGGgQyJCs/oAa+BCvDEcTShPnoDAJrXgVqVoNXJoNe5l1MGoenXoCdXTK5ZFwLAOoxEnlFqnmWzNU0KABNgMcD3OkOXku4ZoYLnGE/CZWClStA3lIbwAbAUC3GYPS4xAhwQcSmRGRb5ATg2nQoakoZonU65gqTKnRxJoTroC4DKdgBAa7HCO4cgdy+3b9bhb1uYMLqHmCc5paSKqqDgJFEhl8IJACcgXzZJbTTSn/9pk4MwWZRw/2OmJQGriKxsqqhPiX7jp4Iemap02q1UOVHJwDoT8CYY1KexmRz4pwCGcDaG5quGQFS+4K7KqFsk2hC/BVIioJntYaMBYA+eFg0xqlPWwA9XtzMmwB/XVQJfFw2k6aOulq+MSbElarHaYQxPRCsxCB3oun+4tqFLKrL5qBdTNHvZqa3wqQgGABWJIgF4CQASwHiigD1KCQBfGqZ4RG2ygAEtgKnpw3mdMC+YsKDvCZJ0Fqfaqa2qWqew5UwCAITCeI8jW56EeX9RW4kl2I+ZqIZBYSgfcC3Q01jat6mvEBZA6wmRUKlGEllG65OPYgEus21ce3rdqbTbSqUSup2sWv8MCHCyU/urVSuvWSMATsgLvWoIU8iEjNu4jvu4kBu5kju5hhsMvSe1iwtlr1l/m4uyvIAm/SeVyqa3guibLSuWpQEDypkKNiumaimKj0At9YIKqitkB0oXRPuHu7mtotuP36qL4WqqT4sMCpCkgWsMnUt3yRsnCVC8N5iopJu3DLcidOFiJMABljW2mcoj1bZiKrC6xakBJXdVLUCQvuCKdRuVt3iqxQe8b7qqn7Qhv3JzJEu1g3u8yNsgw/O8unm0hySfhjACuTCzjZesTKJ4+NCmrfGsrOAkupumVuV9ArBj6ftuvYtwvzuh7+u040oMAme8+Cul91u/9itBI2r/dCf6MT8TaVM3DfIAsCdwDyVTmekBsAHgDpBmagbRUviQdBibDj8MxEGsMUOcDkZ6tVW7vLKVm5ZYwU3pkyFgCCQgFUExcbCxeLdwbZ9yCudypqehFKuxAtdnAM8YghnMtxvccoN0xkwbvNjJguT6nSOsxO3ZvyrLPz7ZSjI7KVVhccw3caNgnD2ilBhgAmrWeWkVJbBYk+AjPW8avSK4vt5apXOaxsLbwXK8j3Mcb7hJpET6ECvwaNGgAvCQdDYqM1G3AgmhjZdGjtWAsCPFM5AWdikAmkIcxJ+Mr7hcxEYcx/q4ycBAm+CpACBKuCKcspCME41qKC2QKI83DCrg/2Kk0CcNsJ+IILsZCQC1ewgoAKpkBgIN9omPHKxI66bs68SR7L52esSzuk0AIEAgnLw5x67paQi5x6fGvCp4m8yKEJCGoi2GMLOuBT1i5myM8licUHEqIQgFWgkZgDgzKRb1pZf8vLfwe867m84avM6+fAj0dgi7A3chXJi5Cjw+dwHFPNL828QZrWUCIBVOYhQGoAGQ4woOYFaKUDfNVgthBpEOOa3xMp2EAC1yKsncesmJKqwbrW4XPbwdfaSQxDvOq64kTSGv+jts0lAoXatlk1sIksvd8DMLARAD4VuQBg2o3HUDcpkhhWnVAAMtrKPwwMMSC1RDDNanede8bP8gaueqUN01FjLVcXeoI8ykdmchkUQhKe25xQi95CyznhIAqMt8LKBgYuFi08ooDDy06LLQ+fQj2wc5mMWQ7UXJRn3B78nGldySRg3HFcp29FrPKm2SJc0JW03VK721GS0kHiAUHSCcN23NLcup4PYkkMey3+vHAPB4jOw+VsVHHhCz6lXUSWvJi8rSS7vaTM3Brp3JC6QIgj3b+EjP9aoIt53PsnnCRONbKRA00/gxHCBqBUsNBUuZ0hDDmnnfLGDLMKCiH2MOtuxdRYzXRTPge20zRyyDJxveJMyhdLxQtuPOXejYgQc9KSAUwcljv5kKofgLPFGsDRxZsGsoIYD/qWg1KXIr0Wts2tXN2khtx0qNxi5uzk5dDOO52A2OTYWd4zoeDApgRLm94lz5ldtCAZQzs+7yeEzhCn3icKegXyphKXiZKUwhGoiC3XkLrtatkZNM3TR+1F/e3cCQofrs3UnMydBxuIrQezeXuZT75nAe53I+53QuhGp+CMLMCZn72oP74JFIj7JqSRT+TV8pFPQJPQycgFz10lCxxWpY0J3gkNSjRwAQTA3W5dl92q0N4+271GB+t/GLvPSI44xdssDM5x4Noh6ktUL+nhDQABv+AdsCPdJ500bbsnFVizshX1yhFJXwAZoCR/WC6Vmuztutxkmm2ppu7JgMDLIq/2xWa+r36+e6M3C/xoVMrNuAaZy/maWSzZwcrgGwG4eHHACsJM6W8BnvEi/epwHWnLIx3sZbvrJYHu/a/elN3ey8cK6zOn+GLe19juY27gvJuDbq/R2OKTIuGjTlYGksaqIJIREikLABywKs3FL0gF0s4HS6/MMEniAGfuAPYkUhy+NlvuP/DvCCi8yk5JsQkKWgeOWGICSGxwqXEGOmtQEt4D1o9SJkXC8yQjgYzOJfjtoqq+wtfuwvfid3iuojS+1aaceHZbpCwhTqlFUJCJQokBov4griIp07IVZaJQHbEhbi47tED+ozDqe4WOyebvT2PhdNb+ZPP5sWUwD7B/+4pQ4mB08RCQ8BZB0AJWAC6xGjHO9RAsDKGqMCM/qNATEQLaWNTCeHAzukIa/XmL/Xcz9rGEqPGirPuLoRvWYxDxB/0ITbSjTog9QBHlAUWCWzNZ8IMgK7PHHhoMCzrEAC60QC9UIBKQCmmb5FaZ/vRv+gwV/0Ws7RFfrRv+YrwIL6430XAWjPp4/e58nybjMCKWB4DnA3NP8I6vSJ1LxZPHGBKKAB9eIAXsF8T3GtcS/8Xq72Sn/d2u72Mj7/bK/83p2nnAAIEQMAhIUAAgKGiouMjY6PkJGIky6KCASWFYUvk4iRj56GAYqjoqSKiYWlqqemhBQCIQAUHwAGHBT/hiESBoQBDg0CtaUGGxKphCQcFrYfGQEGHwIaDqu+rqzY19qHrdvZ4N/iANbk3Mjj5erc6+yo3ubu8uHx4+j16fD47fTt95+NOgmoVEjAAkMHFEQwxGkSwIcQI4L6V+hSoQQMLgSk+BBRgI8gQ4ocSTKAgJIoS4qIFUBEiAAQOIgACcGEipAwUqSYCfIEi5knA6CwCSHAiRAdWurkmbKp05JBn0qd+jQq1atYQ1rNylXq1q5gq0rcGPAgoQIDHpAdy7YtpFCMLAJYkNYR3LF38enlRwgd372zBEgAICKXAxAWSmFoQGFVBgEgHKjK0ABDXwAkGjCDIIEEAAwaBPfK/9dP39971v6qNn2O9TzAr/Wijr36dbnZtOHVLt3NbUGOBgkRUFDALkffyCPmJbRgkgIAFzppRHX8U97d9nKLgpUBwAcRAA5LHiXeXDEBJkZ/NlGroIYPvUaEwGDgcYMTrknzpodbv3/Y4dyWn3/YAXiZNgUm2Jp2+xnoYCnVQbQcAZNopEAnalGX3IZtLYdXhG99FZaIU4UgwEwhzCSCCUl9JAIHLQbQAQsC3AQSDCycENIKAuiIQgswGMVCCiuEZaRJRyY5EolKjtjkk0w+OeKGHioHIodYaohclYZciAgCWjbooF8DHpPLB5KJ0IB6JaxZiAgeeDBCPB9oYIBi7/8lQgIvGLQgwAaWPcjgf/0JOug+7xya2oBj6saogvw9OiCk2Vz5QCdmhdnhlVl2yqWEICqQ4SLXSWoImfMcI4IB1HjXgnoSyFKINA1IRs5i3ZkzAghzCjYnCR6wwIyYiyqaaICmErugsggmm12zxtp27H/YUbqNpc9NtCWnnWL5aUehIsLAAZoaGqmyrHpgAWeSSSABMQ2QQExorxYCA2KFQLDBBr2QIIABDoSWAQTOWiubo9E2KGDC5hKKMLMQH8wwotFaOgkmjHxrHbfdUsmxcYi8AAlGExTigkAop6zyyiy37PLLMMcs88w012zzzTjnrPPOPPecs8iPXFocISf/d7Jtx0hn/PFanxAA5qmFNtzbfyg04IEDDmwAgQGM+bKrrQFQEOec5DXwDCHRaIACZhkYYIEAHnhG7cNzLyuOwdVOK3WxEUuM7MR8Ldx34M7G83FwpC6deNKM/5bctwsgkABGGDs+MarhOJDCmiPU0gG+hKipngoC1OoLBaaX7RkKElgQDSKB1v334HrzLfvtgt9OMe2n0r33pLUXbvvvUz8ygVoPDJCA0kc3zrjGG0NyAANfLg81lFKdkAIHEIhwk08xhhBCUTCZIEAL5EMQAvoglQBjACuUAEFOKcAQpZRY3Y//VPrv75X/RuofAL3SNETUhXm+gZ7z3KLAEDEw/2oFwtw2YCEBCGQgF6gjmC00cLbwgEAAJSgEMFZQCAywxwAY2MC6NiCa4hFPd6fxHd58B0HgXU6GwqNhDqHFO8Uh8IELTBqXGFA5BCBiOuWy0g4L4o7HDEYFc/oAv8qWi1HAQk6lQF01CLEr/OzJACNIAehcaK0Z9o6HMLQhExlmxjXOLo3SOiPv3kg8Hy5uEQcYgFmmh4hRQS2ISPNQcwSAseEkII8LSSKolnigdJiJVR0wgLt8YYHI+OIYlSGHJPmlyX0ZQF8jAE2N1EPGgjGylHPEXfAG1cZG3u2UhJMjHOkIKTsmkUKIm0DJIiAA6/0RkN3iklwmoAkAyOWXbP/xSJOYFJP6dWB8MWHKCrj3kZjEgnwd4ECRPnICbQYABuNbQQpytKQBOsmcXBEgOkmiznVqxZ1gsSUyUWGWASQScfMEJocEQpCKYEwuCJhOQxyyqVNiDhgpcIAFeOEAFsyJELEajQU8IAC5zYIDtgJABjhAHwlQAAWhgY/fZvnCZ9ESlnYraStRSdKG5a6ku4OjPH9DiVOZBXECGNVAZ6rPO8YFY8QkxDEtl8waxgZVE20ABGgxiwZ0AG1mK4W/PIAfW0hAa4TAVQBGACgSiHFYI1WpQXEIuJSWcaxohGks3djS4dXSY2UhhD37kimi9hSujZCLIRHp0w9hTyQ8Gl//igJQAhNgkwVBgomJqCkjb35kmieAQAlWMJQakQ8q8MxfZqnSzs12Fp6f3axJ8Eoqs+gSALz0pV3v2jxFDFIA2TKiAJCYTyXeMF/HIAEki9GesJkOAB0IxmDIoUVC6ItfFtgACoBVqxiyEa0nLeu5UrnSQq10ra5Uq3R5eoh/4HK2AOBjTn/I2tYCsaC3/QwH5JQ1AwQ3F4QIASdnkQIPwNcA8pWoQ72TARMKIFfOpS50XyldOhpVYQOOqXbTemBVVoy06C2veSP8IbSOwAMcpcBgKIDRrDYghISQRofD0wAShlhtDpCAA4A14kY9N70ETqWBXnpWGCv4umZlpBm5/9tA40j4cTztceKwV4JYoEAFM1GBYblJTqFw4Hzkm2aLslkCwqqgslXmrGj5t+WqdNnLX05JaD0L4aL+eMJm/oQR+wrTaQiAAg4IgQNwZQ7KWGarFPUMNIzRiwCQIDIpPAFzx3NUHSfYrSidLkmrS1YZD6/BLt0ht5pTOUXa9swUznQjovOPUg3qbZGhBQR2NSwIvKcQpLMkAE7QNVuckAQZcID5cnXjVUaM0WnFsaLFamNEFzisrdwxQNBCSKZpGtOL3FbIHFEBIqKjaD6LtrSnTe1qW/va2M62tnkGNDymRQGVhraQyYvsS5/XEcM5wKXYrCBg2Fcwc/5wISiztv9ZUNTEoPnAKDZpgBWoWGDYBbYpe/3rGdvawTK2bqINvPAFgyghmAC3sdNcbomMm9yL8BJBV5sg5mLAXwZAXWI+04BhnKe5ACA1OSwQL0nCYNAGzzErD13wgEM64AZTeM1lLuAHQ+JSnaj0aitccYtfSbySY7Mj1l0u7Pi3vyr8Eyd9O6wTfFCkx+2FAVSgAQyMQMWzRjDPEd5SnTtahy9OeKPbOnZe9xAiEsf4IhbgpWJauujaikSzw3vA2jaC6dfjijhZ0IEVjO8EAkgsBFrAPsIKoH7clMlHqKw+GJRgezEKYJibMmZ0dt7zm0fJ593JsbgrfREM0AQvyXV3vE///O+iSsAAhuZ3cElKlB/owAZGkLZU7AoGhAAGerRep3pTxgEwUGEwOij2XddY7bluOI0HDv3ont35hvY5mhdxAQYUgO6q7Qt3ywu96V1gACU7ve1pAyzEkCAEbovXISTZ9VE8Jm6jqKSegdE2CYjAPoQWR9g3cwR3fc2XXc9Xdmu3YCbFdtfHYyCyABlRbOrnehtRU40QVMZUTDtlS8okFR1gPiXwIzCweCaAAh8hACywTdmEHigIASrwPoQFI+AEAxxAJPszegOkg/7Dgz0YepgFhGLmMRi4CHMle4kEADtlgesHCRPAAACAEXY3dMnGG/UhABiVAW1DAftlCywU/yj3JzcWwAK5wnIlkEK0gB6xE2ltlzcF6IAHyFJk12YLGGwH53YyVWaMMACagBZJSIVMKHd4RD0CkHStJwk1VElxcwKtAxoVlAy8kgiVpIbNoDbNUCv+RgEggH/U14B4SIfR92vTR4DVF2NwaIpy+IlvBWSRQBeIMIWAGIiHCBAXx3GKoC9/4gAfUAL1gS+/8B69IBhw0xgpJ38BwHIkkGLJ9yd91okCR4oKGIoG+Iy3RnPTGHNsxYAOp4dGJ4uIyIqbkhKDBwOGhwI2mGUwyAE60hKIwD4/0gIv2AIsUgL0OE7raE4+mINCWE77KBL5KCX/2IPcaG7eKIgESZClIP98JcBVFgAaLRAommhiAYMIw7JRD5UZMPB1mQFCpJSA1DiHOVeH2ZeNHhmS0niKo9hzbweO51aQBlmFRKcKr6MBFqACbUMZI2cBGsAL0HAMHvAYAFBJAxOUJRdnezINGGCHbahG0Wh9KHmHbliKtSaKUOmMq7h9B+mSsQiTRicSIrAU5SgCK/gRKBACLPIRl2dkJiGPL2iWJ1ACKnB5OyFaAflX/ZiCd/lOeYkke6kVA8mVWrmVTdgIsicurEdUuMeQFsABIlUfHPBQmjgNzHCFFfmYGvlBbTONAbZo1niK2IiAVlk4ZueZjyZ9klZAiCB0ghk9gVmBgOkIqachV9j/ACLwASSQQpY4CyAgL0EZGiAAHrrpL02VATAgARnAQrmpmfpwcyJZaCepjSkJkqLZnCoJmmmXhw+RWi9Ji+PHWrU4i4SQAKJCHbsSNxmgAhiQAb64K5nZAaHxk8QFApk5Da3zASpwDL5omkspgE2JirrmiSU5nc+plCQ5ktgJEMPxet3YmuCJiMvmCNHxNESzbRRaoRZ6oRiaoRq6oZ3QbXiECHUlbjP1ncimQBLoIQ00AbTVXRpGASynAr2Am0+FAccQC5ahkxKwNjSqASMgDBkQJ7y4c2LCnAPKKKOpjQpGpE4pNUf6nx+piqbCMQUgAIdZe4pAAANQiNvpjeUH/14KaggPkH4MkH6/gSYbUH87ygysgwgSkJQ6SZMAwDq8QgIsdHV30nBTWaDQCIpLSqDWWY1viKQ2p58rCQkIcBC8RHtWWgiX4kcNyoTQUwESup0FQIjjQh0lQE6SJXlliQghgIInYAIm4CMh8BMuUapqeZd1uUx9uapK4qpHAqvLhJoU6JqEQER5x6A0hQj9tAgIkKUCcKlKKBAP5Bm9CB5XiB6S8ab4QaO7KQLu8kHHIKRLqqT+KaB9aqCpGJX9madPKUvQeZpAVoSoAKyTuoS6upoAMAEYkxG26kCo0zYWRFE0eYw7yQwdIAEaQAHHGQLSahkSJKjOWZ18eq1UCf+uAXooTUqof8qZ2pdAIKJHfOeo3ZWu6koADLA8sfmoSgMC8FEfKSCZs2ACbdqbJsCv7uIBKVCyruSk3rqtTFmwL+unMMufMutryomw2nqVEBsJKsp3fyh+Fiu0nzAB1fOuE4ECkhWyo9oSLPCpLWECIQADKiCPOiE//tiqfcmXeSmrmreXXpskEBgJ4gWLRGuxJKquxvGjkulbH0AfauJR+mo+IEABzShLLouzDcuGUqm34aqze2qS2XqdNQuohdqziIu2QeaBiECT9UGGBtCLJUCnGhAMJ2s3eTuwDtu31IqK1jqzRkqdm7u3CcssY5u46Zq2Z/shkeU+8lOWK1j/WCYQskjhFGHbFbeLu1q7u127tSBxui2pq6pbsZvyAV1jASbAQcbrm5npYqS5gJ/rtxEkup8YvQW3sAerpwTLs8Ebk6m7uA+EQQ0gASWwAQ3wQRoAnEPauS9rvdeIvTmrvdKpsNTrke47uLwBvMcWmMNLoohAGRJQJyxAUSrGpOzrt/eLpPD7rfLLt90qvdqawKArD/pLcd/Lkh+iAiHAATTCAlibTrzbu2C7tbmbFSUcT385mMILvo+QALKVsdSxidMwAoIrsM+ZwLiGv6NbuATSmTbMcNl7oEEDrBS7uha8wg+REJMqmAcgOeIpdIjgASxbw5m7voRbwxNMsDjs/8NVDKA7G6WfUAFqgaVfOne1uqgFqUAYoaWJ86CPgKsTyqFyPMd0XMd2fMfV5qGMIAiGIKKfQGyqSbyKCxAZcQFLbMToBoVNh60/bLANzK03e8D7GYdYDMGEK8GWnL9JrBBlXAh59ACmh8ZceiUIACaGvKXQAcOLTL/XiHNVabOVLMkDaLgPLMtefMVg/Md9Z6sQBwChrLaQ2gm9ihAC8TQdKD3uSm5UjKcI/MWsrMPV68x9s8B/+8ihqR1XMhyK2sa8yghAdzGbYDRD22OnbKvfDFvUYZeqSsIhvM4j7LujFQkaN15ISwi/jMitSc6HLMjeW7Bd7Lw7HMutjHbby//IWbzDmLxdKawI98zPSIyV3Dlg/7yZUPrMjszApBuzAv28DMawdbTQrDnIEL0x6tyPJ6xZ75zS7uy7FdzPDNq/jCvRzKy5FT3N9euMWxyoE/3KtPzRGHzEL83CR7zMnUvRpas71EyzOc25A93RQezTIx3R4yzU/UzUTe0wuGzRBx3NWW3TRXrJHs29+/ua/EvVXcmqKr3Sar3W+3jS6QTS3zjVP42QjLzTk9zDOj3Tszy/Xg3N9hvWuRzVIX3Bgp2r/WnXe+3AkXzVnivNSH3Te5rQDwjXDiTXhW0cJd3W7JzWJt3OYEvZhv3QqOsIvKTMda3XWF3QWp3JCO3YBvz/1VoM2Nj8EHCMypUt0pBQqUe0pbJl2haN2Lfc0xvdyEnq2tML26391GLNCIMUyPisCMnTR7YdzJ/wAH0oANvcXW7M3Pcgonj83eAd3uI93hWqx5YgdH4MCWIMAGRcz9T9EAmA3UjbHL7d18TdzF392MjN1apt31v918od2JEwVI/Kx+5tgfw04HZ3zK1IEZ5m38D9pJA83BG+1LXM2MUd4LMNEAQONeSKR5wczhtH2JGAESuqrvTNbqdd1Mtp3KG73wDe3/rt1zgt26b7EB2urmhRxA4d1J9AFzze4746CY76gWLr2ZrN2Ukuwiz9487RycJBHD5m2ZDAabvNsSr+/9uoDdA1PeMXXc0ZDcsGzdr8jdFQPdqMMM8UO7wSBtPBa9UcndoBPea2LOEaTecYXpoafuNzvaC4Hby8RKYhktlC6NZapuSFjuSqStoCIOih7dL5bNaBLtWlGOHRqdgUvuWXPuF4HueNved1cxyTPthAHemOMACDUAFnzGajHteVruktnt+vTeOR7eI0TeYxbubLTQitftuKgOoAoOrO/dxaySXALuyhHegJMXtNLACo3ku2qOUsftefudienuEyPutfrtQ2HuqMPgHLXgDN/uw3AIjHvupYjnfGnuronk+BzgCzt67FlqW+ZOSxquhAaOj/g++bp+9XIeqNDu/FYf+0mJCl5f7c5z7sQl7Wp87uv+ql5cJL4iJX8k3v0Q7hsE7trrzadb7pd87xea7xH8/nezwJipylxWHw5u7wWXriC1/sx5HwAEA9dWXEvIQAqq4RRrQQFm/EcN7IRn3N/o3rNS7rx03rPS3ZDgjwOA9eOw8AKo/w7I4JNH/grrfuwV5sRhu0Dj3pNJBTBfD1NNDz3UXo+b7ZTJ72nQ3PAF8yX/8AYS8AYw/tUp/1mLD1Vq/uMT/14infj9oc2eLzK87YQR+4nX7fIg/jsY70c6j02ygRgF97Cd/32c3m5Lf3WU/kWyrxwaqoD+7lls7TeM3U167n2X702x7B3W4oHMP/+d4n+eyu+XlfdG6eaT/vpIUv3Idf4bZuxYyv2I4vbH2elWVN3sZ//Mif/Mq//BU6tNrN/NAf/dI//dSP/B7g/PsU0+BKKm8BCt3v/Xbx/eEP/gEh/uU//uh//unP/eSv/hlj/u+//uwv/3pT//a//fif/9l42dgPCACCg4SFhoeIggICiY2Di46RkpOUlZaXmJmam5ydnp+goaKjkKOmp6almaqora6vsLGys7S1p6y2ua24lqwHhAWFv4IFCYQJBcmCB8PEycYAwYMHyc3NANQFzdLOxcSGzILI4MPjhdzYhebfwNDhg8nK2Nfxw97L8YTb1fCDyM/splm7FjAa/zRiB9P5Q/euH7yEDRvOE2jo3rJzCS2uWwcgAbQFxhIs8PfRGDWSgkBOE1cyJUoAKk+yvIgNHSZeunKGUvVAwSIGCQQMQCBAAQGfEwipijAgGNMBBAYxDTZhwIAIg6paPUDAatRoVgdUOGBVAbSwDARNHYQWwNOvBcJWSKBggIJmCAakXWA16aC8aR/0lepVbdNBFaw6LYyt7gUAXcUuC9s08lfBYQEwsDpSc9iviQVhtuqWceK+dO0Oi1wBMuOOde96HtBZK9bS0vgOFQTYX+xftgWdjmpZeOHhhPLSNsxN+cgDjg0PSKobATEExHcTjVoAu2sEBRY9iOa9q3UAFf+sd89unejI9d/jChgPP4ICkAMEdAbQ82cEAQwwIAB2i3ylCCM6JShKKeEBJY5QkAnwmE/NlEJWUwkcNo1icUHmFwATGNhUh2ABA4B3AGiIjWJsSZMhOiR6eCJoj/E23n3C1YiNMYe9uKGGETjYkYqajSdIU3ydo0CKyQxQCAHUyUiIAsFg9uQEPhoSIpQzHllAkiM6KQiX3o3EZYdcXihNiExWoOOYSWGHZlJkrfhih3WSNU6SolkX5IoaPuBnWgwYKQiODETA5mH2RXWXAhY86pZRADwKRAER+Enpowfwpamj0AUhZKOVQocDAZlOmt0CD1zQKjEAQvNfe/MdUJT/UggqqGsnpRAgQGsPOulrawJyAwldU/VkF1bIHoZAgLeBaBcBJB4W13TNUHmkXiApsNa2DLAa223XTnBAhs9Co8BmSR3GZqXswrMkf+M2K80FdTFwgLLerlgXcQqgOAgD1IqpYpYgGogedd6KKU5T/EY76ZDpjhlwwV4+XLEg7z6bqL2GTWDdutP5M5SDHmNF1gJ8VasNbS3DOcgDDBQgGMj81SwYWf8e+kABBDMl8iAERMUIAjpYh2DRABw90quQGX1iD0adx/TRKrAYddMn7qDXbUyfuEDRC1j9q1QCJDWBABEE5XDTue4q900INgiN2xESK4CxjBQx3QAXEKDz/5IX/H0B0Atc8OECmDZlsDQRFDBBjQgA61YBRxVelY6RHyW4zfNePjkBF2T61QA/F+ru6amPBx3Yg2sOOMcVFHBB4IODxfIAB4R7FCF/uoyY5ekdM4AxCihQlYEVtPZ5T4QkClnpKPpO5eNjUg/aeYgrLnuNEzzQU1ytZ2969351VZfw6vM+6TVVMaDA91npdf3uv9hn1wPhjz+m1EhT2v+4hoBurQaAWdsMVq52IhUELn0A/MAEJgCssBWQbNyLlVrSBiK24e0RcZubCCfBE5/ECkLD0szeQAiTokHlTwtY0ti6UjTr8AkmQyJLk5bxC9KdyHI4jOEMoTKIkcQQhv/zCgfp2MSlIp1IUDfqTKGe+Dqp7OU+LqTR9JCYQyYdj0kDu02YNgSN4hHiAsB6gAs7oye3XHFmaUmYjOLCo7jskGPESYoZIWND2mTxSCPBzhQRYCQmhqiPhKAZk2KUs/cdAo1DVBgA0JihX7iPGMdbDoqY9qhIQWeAnCIk0UClgB+QTlucNBX1QGmqCqRqa2JrFdTo5R8Orq1tEGLhCHcpCZxQghXusorEnCXMgVnFeYzBzF0iI5kLXaVFkylmcPhTFmb8JiVW6WPJsLkbraCOY8XMGGxUI61nukYyp7Gc4Ij2GgrCyipxpCMwHOZOcJqzUreBDjnRc8xzGkifdwn/Dzx5E04wlmY31ZnGNZVzm8LJpjiTJCdlsrUbaB6qoqwZUzGfYjYBuJBWxCmQeRawCGGJtKJli5BHzZMhtqn0o2Rxqa88ujYBDCE/+6EbL3faCF+SMG7bSIhCDHKOgRyDG/E4iEWGipCHHNVETxWHTczxDxhB5Bzt0IdRX8JDfQCDHzTxalib6pCydvWsUI0GWIm6koW4FatOlapW31oTeaB1rBKRCDo2wjJjqEQk4ugrTPzKuI4IViUXEYlK/uqiw5qksSDp1HNscgmf8pSXlo1EZi/L2c569rOg5VUIQyvCzfY0hKMtRGqV0lNHrPYRrY1tIl6rCNkigrZcm61r/3drW0Pg9re99S1vbztc4gaXtcdFrnF1m1xNmJa0uliEdKdL3epa97rYza52t8vd7nr3u+ANr3jHS97ymve86E2vetfL3ulCF7Ptja9850vf+tr3vvjNr373q9337vK5t40bbmvbSxIauMAI1uyBFZzg4jZXtQt2MHMlvFwKH2LABGawhh+sXFJg2L+1APCFBdxgDsO2xBO2sHBRXGETZ1jFEGbxhSOcYhfndsM2/jCGdYwKEYM4Fj5W7Yd/TOQiG/nInwgykj28CSUv+clQjjKRnSxlTvjyg7PNlVKFKo60YoQih1hqIiwiZrmaOcxXDTM8AFKRjCACqWulazTG7P/lqBZEH3tFhEwmcoiNUDauY52Gi/JhCI5wJKrZoOyeJYJnOQsD0IX2RyPu9uew7lkSWA5wlUM85BFj43fllBhXkhgboW5mORCNHmf4IzBVL+fUOaVmyZRJkNl05ls/Msu1JFMIWB9Ukhcyy2jeJuukpEY2+ihLAgAqVFofW6insc6oDxFtfhKxELSmtTDCchtcG6ebYSGItk9DWVqf+trftk5GC1Htp3yIEKEpZ6x5QydQHwIBScHMuwkTjGrvpNOb9oRPSSOgmioMEguoSomamBKFTzIqzSuEmdp1R0JMHD2UMsTFL66POp6rSxKXkZoqMiNGhhxKCMOqwBi+jDr/kkmSc8ZO4NADxB3NyIczhyqSHA7XEcGE2DbHzsdb/Y00ac0hTXkXOIyBnSBxueUgrxSMvIQkoEujKYiSmKxhsiRBGUJzMOF5IcD+cSIBKhhXr/QhCJ62AuEq4LMYuJMExLJcHgiTvIHWOcR0uwJUYN94FJ6WvqL0wWcF5tGYV9nOc4gQ4cwQVCpXrfEYMURoa0h/LsCS0CUkyNvucH/XOAKsY0hDCA5YJicaA9QJeJiMPiWvL/QE7vJ41bemKhmX+OvxpZfJLx4xgD89ZC52COErIHUKO6KwkmJyAmDHL6nnI8M1r46GSUP4lGB73d9GZbhX9rVsL4bd4YZ39O19/xmbmZ8hiid4eDO+8O5HDOP10a9P42j91qGfISqnFsm9Sf6QkTv7Rzw1twz9Qjqmc2+t0Tt28X/2l3B5pHFHYQzR10Jm4UjgcBTPoYHFJ3OGI4FmwThMUWujlnC1czuHUIJDwmVjYxbWcwgtmAD6c3xTojxQcSZvQxbPgiOpp4Py8xz1Nwj6F4PZN3d7k2nd532VIHcqJH7cVzfCgkjzdAzSE39eknp7JEf4B4DgUH/eQHTocR6RNIBd5UPsdh5cVAj8NxlcVkVyxHK8AUQJUIVOhR04J0kj4SPRl4dNYR+T94XUwnTA1kMTMIYWh3l8SBCA6CbT02ZdgkYah3lfZP92fCgN8jQzaxRDrPYkpKMvJWJ6nWhNWtdCNIRDKecI4YeEAKeEqwB+RuiEbzcaB8BQiRRu11JzAqUX/nQOQqGLp4aLvVgzwVgI3vQA/gYMwyhO7HRM2oaMAzVNyygZ9USMYfEAAEUQzFQ7/cRu2TROF+hqrSGLvdZPE8WNu3GMM1NNFmVMkvGL69eNx1Zr1XaJ4GhtBeiOkTGKn6gV8yYj4mh6alONaxcM7liETaiKrPgK3ccg8lBmhFZmaqUNd7VmEpkNXFYPEUkQVYUPb7ZWfwgQh0aR9vB0ScVUR2VXlVaSEFkTdQYP+5B5w5BoKcgNl2ZngUYM2zB5LGlWwkD/k2+2VRWxDY0QVIkADYTWZx1xlI+Gk0yWkLuwim/nlFI5lVQpC0lYlZ7mXCSGYzXWlS3mlTMmYyvGlV9ZlmFJlmcJYx0GlmOplieGlm3pYjx2C1CJlafVZFvpli+WYzTGljEGl3+plzcmmHMJmGtplnHpl4eJmIEpl30JCldpl7jCX5RZmZZ5mZiZmZq5meUlmaAAApwZmqI5mqRZmqZ5mh7gmaq5mqzZmq75mrAZm7I5m7RZm7Z5m7iZm7q5m7zZm775m8AZnMI5nMRZnMZ5nMiZnMq5nMzZnM75nNAZndI5ndRZndZ5ndiZndq5ndy5ZPlRgN0ZnuJ5WfmBeJsQ/x4CcBZnM57s2Z67VJ6igJ7qCZ7uWZ/2SQvwCTwCMiDBMFMzpSMX8BOLEBTS5ST5ITJFoXb3uaAM+gn5mRJFkQC+siQzlQzigR4A4hYDKp9HYku30qAgGqKe8KAncja2oh8zxSMelSIr+h/pyaEs6jzjJ6I0WqOSQKL7OV0RkKIsSgAEihUuigwD2qEyCnQ2eqRI2qEKQxT/x6PwmR/jEaQw+p0RYqRJeqUiSqL/cRiziDlDCp9ro24DeqJidDa+YqVYmqYLmh/TFRWZIl0IIKFfuqIJQBRtJyYzZaBmOqNq2qd+2ghr03p/OqiEmgguuggOWKiKuqiM2qiO+qiQGi6pkjqplFqplnqpmJqpmrqpnNqpnvqpoBqqojqqpFqqpnqqqJqqqrqqrNqqjhoIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38712=[""].join("\n");
var outline_f37_51_38712=null;
var title_f37_51_38713="Principles and overview of nail surgery";
var content_f37_51_38713=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles and overview of nail surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Phoebe Rich, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Julie A Jefferson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Stanley J Miller, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/51/38713/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/51/38713/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H120459077\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nail surgery is performed to remove benign and malignant nail tumors, alleviate pain secondary to ingrown and traumatized nails, and diagnose clinically ambiguous lesions and dystrophies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Because of the propensity for scarring and inadequate sampling, nail surgery is best performed by clinicians with appropriate training and experience. Prerequisites for a successful nail biopsy include a thorough understanding of nail anatomy, adequate anesthesia and hemostasis, and proper patient selection and preparation. Nail avulsions, biopsies, and excisions can be safely performed in the office setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the surgical anatomy of the nail apparatus, preoperative patient evaluation, anesthesia techniques, basic surgical procedures, and surgical treatment of specific nail lesions.",
"   </p>",
"   <p>",
"    Nail disorders, nail biopsy techniques, nail plate avulsion, and chemical matricectomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link\">",
"     \"Overview of nail disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=see_link\">",
"     \"Nail biopsy: Indications and techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H6#H6\">",
"     \"Nail surgery\", section on 'Nail avulsion'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H9#H9\">",
"     \"Nail surgery\", section on 'Chemical matricectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459084\">",
"    <span class=\"h1\">",
"     SURGICAL ANATOMY OF THE NAIL UNIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nail unit is comprised of the nail matrix, the nail bed, the proximal and lateral nail folds, and the hyponychium (",
"    <a class=\"graphic graphic_picture graphicRef85578 \" href=\"mobipreview.htm?35/18/36132\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef85616 graphicRef76994 graphicRef83965 \" href=\"mobipreview.htm?32/60/33738\">",
"     figure 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nail matrix is the germinative epithelium from which nail matrix keratinocytes differentiate to ultimately form the nail plate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. Although most of the nail matrix is hidden beneath the proximal nail fold, the distal third of the nail matrix is sometimes visible through the proximal portion of the nail plate as a half-moon shaped structure called the lunula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. The proximal nail matrix forms the dorsal (superior) portion of the nail plate whereas the distal nail matrix forms the ventral (inferior) surface of the nail (",
"    <a class=\"graphic graphic_figure graphicRef85617 \" href=\"mobipreview.htm?39/48/40706\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3-5\">",
"     1,3-5",
"    </a>",
"    ]. The proximal portion of the nail matrix is responsible for the production of approximately 80 percent of the nail plate, allowing the nail plate to achieve a natural convex curvature as it grows distally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nail bed extends transversely between the lateral nail folds and longitudinally from the distal lunula to the hyponychium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. The nail bed possesses a rich vascular supply that results in the pink color visible through the tightly-adherent and translucent nail plate. The epithelial cells of the nail bed contribute to the undersurface of the nail plate forming a tight seal (",
"    <a class=\"graphic graphic_figure graphicRef85617 \" href=\"mobipreview.htm?39/48/40706\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]. For this reason, nail bed surgery is sometimes complicated by mild onycholysis and rarely by permanent nail dystrophy.",
"   </p>",
"   <p>",
"    The dermoepithelial interface of the nail bed is composed of longitudinal rete ridges and papillary body ridges. Each papillary body ridge contains three to five longitudinally-oriented capillaries, explaining the longitudinal orientation of splinter hemorrhages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. No subcutaneous tissue separates the dermis of the nail bed from the periosteum of the distal phalanx.",
"   </p>",
"   <p>",
"    The proximal and lateral nail folds are collectively known as the paronychium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. The nail folds serve to protect the nail plate and direct its growth in the correct orientation. The lateral nail folds of the toes are often very pronounced, making patients susceptible to the development of ingrown nails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/4\">",
"     4",
"    </a>",
"    ]. The skin of the dorsal aspect of the proximal nail fold has a thin dermis; it lacks hair follicles and sebaceous glands, but contains some sweat glands in its most proximal part [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/6\">",
"     6",
"    </a>",
"    ]. The ventral surface of the proximal nail fold, also called the eponychium, is thin and lacks all skin appendages. The stratum corneum of the tip and ventral surface of the proximal nail fold extends onto the nail plate as the cuticle, which protects the proximal nail plate from environmental pathogens and irritants. During nail surgery, it is important to remember that the insertion of the extensor tendon of the digit is located approximately 12 mm proximal to the cuticle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]. Although the tendon is usually proximal to the nail surgical field, it may be compromised in extensive nail surgery.",
"   </p>",
"   <p>",
"    The hyponychium, located at the distal free edge of the nail plate just proximal to the distal groove, is contiguous with the volar skin and functions to seal and protect the distal nail unit from the environment. Disruption of the hyponychium may result in onycholysis and subsequent bacterial invasion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. The paronychium plus the hyponychium and nail bed is called the perinychium.",
"   </p>",
"   <p>",
"    The distal phalanx possesses a rich blood supply. Two proper digital arteries, the smaller dorsal and larger volar arteries, run alongside each digit and anastomose approximately at the level of the distal interphalangeal joint to form arcades at the levels of the proximal nail fold and the nail bed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/3\">",
"     3",
"    </a>",
"    ]. Capillaries that arise from these vessels run obliquely in the proximal nail fold and nail matrix and parallel to the surface of the longitudinally-oriented papillary ridges of the nail bed. Distal phalanx circulation is complemented by glomus bodies connected to the small muscular arterioles. At lower temperatures, glomus bodies dilate and supply warm blood to the digital capillaries.",
"   </p>",
"   <p>",
"    The venous system of the digit is more variable. The blood is collected into deep and superficial systems that drain into larger veins that run subcutaneously on the dorsal and volar aspect of the digits.",
"   </p>",
"   <p>",
"    Paired palmar and plantar nerves run alongside the proper digital arteries and the flexor tendon sheath (",
"    <a class=\"graphic graphic_figure graphicRef52608 graphicRef82236 \" href=\"mobipreview.htm?2/43/2745\">",
"     figure 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,4,7\">",
"     1,4,7",
"    </a>",
"    ]. The nails of the second through fourth fingers are innervated by the volar proper digital nerves, whereas the first and fifth nails and all digit tips are innervated primarily by the dorsal digital nerves (",
"    <a class=\"graphic graphic_figure graphicRef50552 graphicRef52461 \" href=\"mobipreview.htm?23/1/23577\">",
"     figure 4A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/3\">",
"     3",
"    </a>",
"    ]. Just distal to the distal interphalangeal joint, the digital nerves divide into three main branches, one innervating the nail bed, one the digit tip, and the other the pulp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459091\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659297\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete history and targeted physical examination are necessary before nail surgery. The history should focus on potential causes of neurovascular compromise, altered hemostasis, cardiovascular disease, and the use of drugs that could interfere with anesthesia or coagulation (",
"    <a class=\"graphic graphic_table graphicRef85839 \" href=\"mobipreview.htm?9/11/9403\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should also be questioned about history of allergy to latex, antibiotics, and topical anesthetics such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/38/7782?source=see_link\">",
"     ropivacaine",
"    </a>",
"    , or parabens (a preservative commonly found in anesthetics) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical examination should include palpation of peripheral pulses, evaluation of fingernails and toenails, and inspection of skin, mucous membranes, hair, and scalp, looking for signs of neurovascular compromise or evidence of associated conditions (eg, systemic sclerosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H130502806\">",
"    <span class=\"h2\">",
"     Ancillary tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;When infection is suspected, appropriate mycology, bacteriology, or virology studies should be performed. If a space-occupying lesion or any underlying bony defect is suspected, radiographic studies should be obtained before nail surgery. Clinical photographs of the preoperative nail are recommended for baseline comparison.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H130502813\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be fully informed of the procedure, alternatives, and risks. The discussion must mention the possibility of inconclusive diagnosis, time needed for nail regrowth, and potential risks of permanent nail dystrophy, bleeding, pain, and infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659429\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics are generally not necessary. &nbsp;However, antibiotic prophylaxis is indicated in the following situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Procedures performed on the lower extremities",
"     </li>",
"     <li>",
"      Procedures that are at increased risk of postoperative infection (eg, excisions of mucous cysts that drain preoperatively or procedures involving the bone)",
"     </li>",
"     <li>",
"      If the surgical site is infected before the procedure",
"     </li>",
"     <li>",
"      If there is an increased risk of methicillin-resistant Staphylococcus aureus (MRSA) infection (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/48/21258?source=see_link\">",
"       \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recommended antibiotic regimens for dermatologic surgery are illustrated in the table (",
"    <a class=\"graphic graphic_table graphicRef69096 \" href=\"mobipreview.htm?8/56/9101\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659443\">",
"    <span class=\"h2\">",
"     Premedication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nail surgery can be an anxiety provoking experience and premedication may be required in some patients. Preoperative anxiolytic medication with short-acting agents is preferred (",
"    <a class=\"graphic graphic_table graphicRef71754 \" href=\"mobipreview.htm?23/28/24012\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/24/391?source=see_link\">",
"     hydroxyzine",
"    </a>",
"    25 mg taken orally the night before surgery and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    1 to 2 mg sublingually one hour before the operation are generally effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Some surgeons prefer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    for its short-acting hypnotic, retrograde amnestic and anxiolytic properties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link&amp;anchor=H17#H17\">",
"     \"Procedural sedation in adults\", section on 'Benzodiazepines (midazolam)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15765030\">",
"    <span class=\"h2\">",
"     Surgical field preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately before a nail procedure the surgical field that includes the relevant digit should be washed with a surgical soap, such as povidone-iodine or 0.5% chlorhexidine-alcohol preparation, and draped in conventional fashion to create a sterile field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. A sterile glove placed on the hand also may provide a sterile field.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659304\">",
"    <span class=\"h1\">",
"     INSTRUMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to standard surgical instruments used for routine cutaneous procedures, nail surgery may require special instruments (",
"    <a class=\"graphic graphic_picture graphicRef85732 \" href=\"mobipreview.htm?25/22/25956\">",
"     picture 2",
"    </a>",
"    )[",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Freer septum elevator has thin curved blades that facilitate nail avulsion.",
"     </li>",
"     <li>",
"      The English nail splitter is composed of a cutting blade opposed to a flat anvil-like surface and aids partial longitudinal nail avulsion.",
"     </li>",
"     <li>",
"      Double-action nail nippers are used for excising thickened nail plates.",
"     </li>",
"     <li>",
"      A bone rongeur may be needed for removing bone tumors and trimming thickened toenails [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Standard instruments used in nail surgery include hemostats, surgical blades, blade holders, iris- or Gradle-type scissors, needle holders, suture-cutting scissors, excavator-type curettes, skin hooks, and suture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/11\">",
"     11",
"    </a>",
"    ]. Forceps are not recommended for handling surgical specimens because of their potential for causing crush artifacts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For digital anesthesia, Luer lock syringes or dental syringes with needles tightly secured through the screw-on system are usually needed because the nail and dorsal aspect of the digit is highly resistant to tissue dilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659290\">",
"    <span class=\"h1\">",
"     ANESTHESIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659824\">",
"    <span class=\"h2\">",
"     Anesthetic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    1 to 2% with epinephrine 1:100,000 is safe in most patients undergoing nail surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13-18\">",
"     13-18",
"    </a>",
"    ]. Advantages of epinephrine include local vasoconstriction, reduced bleeding, and prolonged duration of anesthesia. However, epinephrine should be avoided in patients with peripheral vascular disease who are at increased risk for digital ischemia or infarction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=see_link&amp;anchor=H6#H6\">",
"     \"Digital nerve block\", section on 'Use of epinephrine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One-half to 1 mL of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    0.5% is often administered after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    to provide longer lasting pain relief (ie, up to eight hours). However, because of increased burning and pain associated with the injection of bupivacaine, it is generally not used to induce initial topical anesthesia and is typically administered after lidocaine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=see_link&amp;anchor=H2693871#H2693871\">",
"     \"Infiltration of local anesthetics\", section on 'Choice of anesthetic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/38/7782?source=see_link\">",
"     Ropivacaine",
"    </a>",
"    in a concentration of 5",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    or less is preferred over",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    by many nail surgeons because it has the same quick onset of action as lidocaine, produces vasoconstriction, provides up to nine hours of postoperative pain relief, and is less cardiotoxic than bupivacaine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13,19-21\">",
"     13,19-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659844\">",
"    <span class=\"h2\">",
"     Reduction of injection pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thin needles cause less pain on injection, allow slow anesthetic flow, and gradual tissue swelling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/10,13\">",
"     10,13",
"    </a>",
"    ]. Thirty-gauge (30 G) needles are recommended for anesthetizing fingers, 27 G for toes, and 30 G for children in all cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional measures to reduce the discomfort associated with the needle puncture include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13,22-26\">",
"     13,22-26",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=see_link&amp;anchor=H540550#H540550\">",
"     \"Infiltration of local anesthetics\", section on 'Methods to decrease injection pain'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Application of EMLA (an acronym for eutectic mixture of local anesthetics) cream under occlusion for one hour before injection.",
"     </li>",
"     <li>",
"      Application of topical cryogen spray, ice packs, or vibration.",
"     </li>",
"     <li>",
"      Alkalinization of acidic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      by adding one part of 1",
"      <span class=\"nowrap\">",
"       mEq/mL",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      to 9 or 10 parts of 1 percent lidocaine or lidocaine with epinephrine. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=see_link&amp;anchor=H2693192#H2693192\">",
"       \"Infiltration of local anesthetics\", section on 'Anatomy and physiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Warming the anesthetic to 37&deg; C.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659835\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Luer lock syringes or dental syringes with needles tightly secured through the screw-on system are usually used for anesthetizing the nail unit, since this site is highly resistant to tissue dilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anesthesia can be administered by digital nerve block or wing block procedure. Most nail surgeons prefer the wing block because it is less painful, requires a smaller amount of anesthetic, and is more rapid than the digital nerve block [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=see_link&amp;anchor=H12#H12\">",
"     \"Digital nerve block\", section on 'Digital block procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anesthesia administered by wing block acts immediately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13\">",
"     13",
"    </a>",
"    ]. The injection site is a point approximately 5 to 8 mm proximal and lateral to the junction of the proximal nail fold and the lateral nail fold. The needle is introduced at a 45&deg; angle and directed distally to the bone (",
"    <a class=\"graphic graphic_picture graphicRef74358 graphicRef85733 \" href=\"mobipreview.htm?0/10/164\">",
"     picture 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/13\">",
"     13",
"    </a>",
"    ]. Approximately 0.5 mL of anesthetic is needed for each side of the digit to distend and blanch the nail folds and anesthetize the three branches of the dorsal nerve. Sometimes blanching of the lateral part of the lunula is noted.",
"   </p>",
"   <p>",
"    Increased resistance to injection may suggest that the needle has penetrated the periosteum. In this case, careful withdrawal of the needle should result in free flow. To ensure complete anesthesia, the anesthetic must also be injected into the lateral nail fold. The needle may be bent at 120&deg;, reinserted at the initial injection site, and pushed distally to the end of the lateral nail fold. The anesthetic is injected in a retrograde fashion, while pulling the needle back. For complex nail procedures, the ventral nerve branches should also be anesthetized by inserting the needle at the initial puncture site on each side and injecting 0.5 mL of anesthetic into the digit pulp. Following complete anesthesia, the digital tip should appear white and swollen.",
"   </p>",
"   <p>",
"    A digital tourniquet (",
"    <a class=\"graphic graphic_picture graphicRef71108 \" href=\"mobipreview.htm?10/23/10623\">",
"     picture 4",
"    </a>",
"    ) may be required to achieve hemostasis. A flat Penrose drain wrapped around the base of a digit with its ends clamped together using a hemostat may be used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/11,27\">",
"     11,27",
"    </a>",
"    ]. A sterile glove with the tip of a glove finger removed and the remainder rolled back to the base of the finger may provide hemostasis and also a sterile field (",
"    <a class=\"graphic graphic_picture graphicRef85734 \" href=\"mobipreview.htm?20/29/20944\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,11\">",
"     1,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Digital tourniquets should not be left in place for more than 15 minutes to avoid prolonged digital ischemia. If necessary, the tourniquet can be removed for one to two minutes during the procedure to allow the digit to reperfuse before retightening the tourniquet.",
"   </p>",
"   <p>",
"    As an alternative to the application of a digital tourniquet, hemostasis may be achieved by having an assistant apply pressure to the sides of the digit during the procedure (",
"    <a class=\"graphic graphic_picture graphicRef85735 \" href=\"mobipreview.htm?11/62/12259\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459098\">",
"    <span class=\"h1\">",
"     BASIC SURGICAL PROCEDURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459107\">",
"    <span class=\"h2\">",
"     Nail plate avulsion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete or partial nail plate avulsion is indicated in most nail surgeries to achieve maximum exposure of the nail bed and matrix (",
"    <a class=\"graphic graphic_picture graphicRef83964 \" href=\"mobipreview.htm?12/4/12353\">",
"     picture 7",
"    </a>",
"    ). When possible, partial nail plate avulsion is preferred to complete avulsion because it minimizes trauma to the adjacent tissues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/28\">",
"     28",
"    </a>",
"    ]. Partial nail avulsion is performed using the same principles used for complete nail avulsion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H6#H6\">",
"     \"Nail surgery\", section on 'Nail avulsion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459114\">",
"    <span class=\"h2\">",
"     Full nail unit excision or en bloc excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;The en bloc excision of the nail unit is a treatment modality for primary malignant nail tumors such as melanoma in situ and squamous cell carcinoma (SCC). In patients with SCC, en bloc excision is generally preferred if the bone is not involved or if Mohs surgery cannot be performed. (See",
"    <a class=\"local\" href=\"#H120459158\">",
"     'Squamous cell carcinoma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Before en bloc excision, the planned excision margins should be marked. Proximal margins generally include a line drawn transversely at about 50 to 75 percent of the distance between the distal interphalangeal joint crease and the cuticle to ensure that the nail matrix is fully excised (",
"    <a class=\"graphic graphic_picture graphicRef85736 \" href=\"mobipreview.htm?4/48/4865\">",
"     picture 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/29\">",
"     29",
"    </a>",
"    ]. This line should form a 90 angle with the lateral nail folds bilaterally. Lines should also be drawn along each of the lateral nail folds and meet at least 2 mm distal to the hyponychium on the distal digital tip. These margins may be widened on a case-by-case basis.",
"   </p>",
"   <p>",
"    Although surgical techniques vary, one approach is to start the incision at a lateral edge just dorsal to the distal transverse line to simplify access to the correct plane of dissection, which is at the level of the periosteum, and proceed dorsally to reach the dorsal surface of the phalanx [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/29\">",
"     29",
"    </a>",
"    ]. The procedure is then repeated on the other side (",
"    <a class=\"graphic graphic_picture graphicRef85737 \" href=\"mobipreview.htm?41/63/42994\">",
"     picture 9",
"    </a>",
"    ). Blunt tipped scissors angled &ldquo;tips down&rdquo; can be used to cut proximally to the level of the extensor tendon located approximately 12 mm proximal to the cuticle (",
"    <a class=\"graphic graphic_picture graphicRef86590 \" href=\"mobipreview.htm?0/8/142\">",
"     picture 10",
"    </a>",
"    ). Once removed, the tissue specimen should be marked with single sutures placed on the proximal and distal aspects and the radial and ulnar aspects inked to ensure correct orientation of the specimen during pathologic processing.",
"   </p>",
"   <p>",
"    Several options exist for tissue repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/29\">",
"     29",
"    </a>",
"    ]. Some surgeons perform a full-thickness skin graft with potential graft donor sites including the hypothenar eminence, clavicular area, pre- or post-auricular areas, or upper inner-arm area. Others surgeons prefer to allow the defect to heal by secondary intention alone. However, secondary intention healing may require up to several months. A split-thickness skin graft offers reliable graft survival but less-than-ideal color and texture match and less protection of the distal phalanx than full-thickness skin graft. For the thumb or index finger, a cross-finger flap can be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459121\">",
"    <span class=\"h1\">",
"     SPECIAL SITUATIONS IN NAIL SURGERY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459130\">",
"    <span class=\"h2\">",
"     Longitudinal melanonychia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation and surgical management of longitudinal melanonychia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H549604#H549604\">",
"     \"Overview of nail disorders\", section on 'Longitudinal melanonychia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=see_link&amp;anchor=H190722931#H190722931\">",
"     \"Nail biopsy: Indications and techniques\", section on 'Nail matrix biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459137\">",
"    <span class=\"h2\">",
"     Longitudinal erythronychia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Longitudinal erythronychia limited to a single digit is usually caused by a tumor of the nail matrix",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nail bed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H429302#H429302\">",
"     \"Overview of nail disorders\", section on 'Longitudinal erythronychia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A full thickness longitudinal elliptical (fusiform) excision is generally considered the technique of choice for longitudinal erythronychia, since the relevant pathology lies in the distal matrix and usually extends into the nail bed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=see_link&amp;anchor=H4656084#H4656084\">",
"     \"Nail biopsy: Indications and techniques\", section on 'Longitudinal elliptical excision'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following complete or partial nail avulsion, a longitudinal elliptical biopsy is performed, starting at the mid to distal matrix, extending through the nail bed to the hyponychium (",
"    <a class=\"graphic graphic_picture graphicRef85739 \" href=\"mobipreview.htm?3/4/3144\">",
"     picture 11",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The defect may be left to heal by secondary intention. However, undermining and side-to-side suturing of the matrix with absorbable suture material minimizes the risk of postoperative nail dystrophy. (See",
"    <a class=\"local\" href=\"#H120459200\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459144\">",
"    <span class=\"h2\">",
"     Onychomatricoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Onychomatricoma is a rare benign fibroepithelial tumor that originates from the nail matrix. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H176463734#H176463734\">",
"     \"Overview of nail disorders\", section on 'Onychomatricoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical removal of an onychomatricoma begins with two releasing incisions at a 45&deg; angle at the junction of the proximal and lateral nail folds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/32\">",
"     32",
"    </a>",
"    ]. The proximal nail fold is then reflected backward using skin hooks or suture. To expose the tumor, proximal plate avulsion or lateral curled avulsion is performed (",
"    <a class=\"graphic graphic_picture graphicRef85740 \" href=\"mobipreview.htm?21/6/21601\">",
"     picture 12",
"    </a>",
"    ). During nail plate avulsion, it is important to avoid tearing the tumor digitations. Using a scalpel blade, the tumor is excised from the matrix. Following tumor removal, the releasing incisions of the proximal nail fold are sutured or approximated and secured with steri-strips.",
"   </p>",
"   <p>",
"    A nonadherent dressing can be placed under the proximal nail fold and secured with sutures to avoid any adherence between the ventral nail fold and the matrix [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/32\">",
"     32",
"    </a>",
"    ]. The nail plate should be sent along with the tumor for pathologic examination since tumor digitations are typically found within the nail plate. (See",
"    <a class=\"local\" href=\"#H120459186\">",
"     'Managing the surgical specimen'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The sutures of the releasing incisions can be removed after approximately seven days. The sutures securing the nonadherent dressing should be removed after three weeks. The excision of an onychomatricoma is usually followed by the regrowth of a normal nail. However, nail plate dystrophy, usually mild, may occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459151\">",
"    <span class=\"h2\">",
"     Digital myxoid cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;A digital myxoid cyst (DMC) typically presents as a translucent nodule on the dorsum of the digit between the distal interphalangeal joint and the proximal nail fold. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H176463741#H176463741\">",
"     \"Overview of nail disorders\", section on 'Digital myxoid cyst or myxoid pseudocyst'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A wide range of therapies are used to treat or remove digital myxoid cysts (DMCs) including cryotherapy, intralesional corticosteroid injection with 3 to 5",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    solution, and surgical removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Although surgical removal achieves cure rates of over 90 percent for fingernails, it is associated with a risk of septic osteoarthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459158\">",
"    <span class=\"h2\">",
"     Squamous cell carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Squamous cell carcinoma (SCC) of the nail bed and lateral nail groove is the most common malignant tumor of the nail unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]. The clinical features of this tumor are often minimal and nonspecific, causing a long delay in the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,36\">",
"     1,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H176463785#H176463785\">",
"     \"Overview of nail disorders\", section on 'Squamous cell carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of choice for SCC of the nail apparatus without bone involvement is Mohs surgery or en bloc excision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,37\">",
"     1,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=see_link\">",
"     \"Mohs surgery\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H120459114\">",
"     'Full nail unit excision or en bloc excision'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In cases involving invasion of the underlying bone, amputation may be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459165\">",
"    <span class=\"h2\">",
"     Glomus tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glomus tumor is a rare benign tumor composed of cells resembling the smooth cells of the normal glomus body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/38\">",
"     38",
"    </a>",
"    ]. It presents as a red to purple or blue lesion under the nail plate (",
"    <a class=\"graphic graphic_picture graphicRef77094 graphicRef72924 graphicRef61115 graphicRef51899 \" href=\"mobipreview.htm?34/21/35162\">",
"     picture 13A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H176463763#H176463763\">",
"     \"Overview of nail disorders\", section on 'Glomus tumor'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/34/553?source=see_link&amp;anchor=H14616899#H14616899\">",
"     \"Overview of benign lesions of the skin\", section on 'Glomus tumor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of glomus tumors is surgical excision. The location of the glomus tumor under the nail plate must be marked before anesthetic injection or tourniquet application, since exsanguination precludes the visualization of the tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/41\">",
"     41",
"    </a>",
"    ]. To expose the tumor, a partial nail plate avulsion, such as a trap door avulsion or a lateral curled nail avulsion, is preferred (",
"    <a class=\"graphic graphic_picture graphicRef86591 \" href=\"mobipreview.htm?17/41/18066\">",
"     picture 14",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the trap door avulsion, the nail plate remains attached proximally over the proximal nail matrix, with full access to the underlying hyponychium, nail bed, and distal nail matrix [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/28\">",
"     28",
"    </a>",
"    ]. This avulsion technique is less frequently associated with postoperative complications, such as paronychia and pterygium than complete avulsion.",
"   </p>",
"   <p>",
"    When complete exposure of the proximal matrix and eponychium is necessary, the lateral curled nail plate avulsion is ideal. The lateral curled avulsion is best performed using a hemostat, first to undermine the isolated lateral portion of the nail apparatus and then to clamp and roll the loosened nail plate away from the nail sulcus.",
"   </p>",
"   <p>",
"    Following nail plate avulsion, the tumor is dissected from the surrounding tissues with blunt curved scissors (",
"    <a class=\"graphic graphic_picture graphicRef85741 \" href=\"mobipreview.htm?5/52/5954\">",
"     picture 15",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/41\">",
"     41",
"    </a>",
"    ]. The nail bed defect can be closed with absorbable sutures if larger than 3 to 4 mm. The avulsed portion of the nail plate is often replaced and secured to the lateral and distal nail folds to protect the surgical site (",
"    <a class=\"graphic graphic_picture graphicRef86421 graphicRef86786 \" href=\"mobipreview.htm?1/12/1223\">",
"     picture 16A-B",
"    </a>",
"    ). Although the nail plate will not reattach permanently, it will protect the wound for several weeks until it is pushed out by a newly growing nail plate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/28,41\">",
"     28,41",
"    </a>",
"    ]. The entire glomus tumor must be enucleated to prevent recurrence. Glomus tumors that occur in or under the nail matrix are the most difficult to excise and have the highest risk of recurrence because of incomplete removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459172\">",
"    <span class=\"h2\">",
"     Subungual exostosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subungual exostosis is a benign osteocartilaginous tumor that most commonly occurs on the dorsomedial aspect of the tip of the great toe in adolescents or young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=see_link&amp;anchor=H176463770#H176463770\">",
"     \"Overview of nail disorders\", section on 'Subungual exostosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete surgical excision of the lesion, including its cartilaginous cap, provides definitive treatment. After appropriate anesthesia by proximal or distal (wing) nerve block, a tourniquet is applied to achieve exsanguination. A complete or partial nail avulsion by trap door or lateral curled avulsion techniques is then performed. These procedures are discussed above (see",
"    <a class=\"local\" href=\"#H120459165\">",
"     'Glomus tumors'",
"    </a>",
"    above). The nail plate is preserved and replaced as a surgical site cover at the end of the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nail bed is then incised and the bony proliferation dissected at the base with a bone rongeur or sterile dual action nail nippers. The distal phalanx cortical bone is vigorously curetted to remove any remaining tumor cells. The surgical defect in the nail bed can be closed with absorbable suture. Defects &gt;4 mm should be undermined to allow the approximation of the lateral margins and sutured. Following defect closure, the nail plate can be replaced and secured for protection.",
"   </p>",
"   <p>",
"    If the nail plate is distorted by the underlying tumor, a v-cut in the middle of the plate may flatten it and allow the distal edge be secured to the distal fold with sutures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should be encouraged to apply adhesive tape to the nail plate to keep it in place for as long as possible to prevent distal embedding. Typically, a normal appearing nail grows following surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459179\">",
"    <span class=\"h2\">",
"     Pincer nails",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pincer nail is characterized by a transverse overcurvature of the nail plate that can cause significant pain and tenderness (",
"    <a class=\"graphic graphic_picture graphicRef85742 \" href=\"mobipreview.htm?11/8/11393\">",
"     picture 17",
"    </a>",
"    ). Toenails develop this deformity more frequently than fingernails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44,46,47\">",
"     44,46,47",
"    </a>",
"    ]. Pincer nails may be genetically inherited or occur as a consequence of trauma, surgery, foot deformations, chronic dermatoses, or osteoarthritis. In some instances, the deformity is caused by an enlargement of the distal phalanx secondary to lateral osteophyte formation. As the distal phalanx enlarges, the proximal nail plate flattens and causes an increased curvature of the distal nail plate.",
"   </p>",
"   <p>",
"    Treatment of pincer nail deformity may be conservative or surgical. Nonsurgical methods include nail thinning (by mechanical abrasion or long term use of keratolytics such as 40% urea paste) or nail braces (steel or plastic devices adapted to the curvature of the nail plate and gradually adjusted to exert a counter tension on the nail plate) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44,47,48\">",
"     44,47,48",
"    </a>",
"    ]. However, recurrence is usual after nonsurgical treatments.",
"   </p>",
"   <p>",
"    Surgical treatments of pincer nails include selective resection of the nail matrix horns; chemical ablation of the matrix horns with phenol, which is applied to the nail matrix with a cotton swab for one minute three times and then rinsed with alcohol or water phenol; or a combination of the two.",
"   </p>",
"   <p>",
"    Chemical matricectomy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H9#H9\">",
"     \"Nail surgery\", section on 'Chemical matricectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Matrix horn resection plus nail bed plasty is complex procedure. Under digital block anesthesia, lateral nail strips or the entire nail are avulsed. The digit is exsanguinated by using a tourniquet and the matrix lateral horn dissected and removed or phenolized. The nail bed is then incised along the median line from the lunula to the hyponychium down to the bone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44\">",
"     44",
"    </a>",
"    ]. The pinched nail bed is dissected from the terminal phalanx and reflected laterally. Any underlying osteophyte of the dorsal end of the distal phalanx is removed by using a bone rongeur or sterile dual action nail nippers. The nail bed flaps can be closed with absorbable suture. Several variations of nail bed plasty have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/49-52\">",
"     49-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nail bed plasty is associated with severe postoperative pain requiring appropriate analgesic medications. (See",
"    <a class=\"local\" href=\"#H120459193\">",
"     'Postoperative care'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Healing is typically complete after approximately four weeks regardless of the surgical technique used. Patients should be warned that oozing generally appears after three days and remains for one to two weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459186\">",
"    <span class=\"h1\">",
"     MANAGING THE SURGICAL SPECIMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following a surgical excision, the tissue specimen should be correctly oriented and marked so that the pathologist can appropriately evaluate the histology. A requisition form that thoroughly describes the clinical picture to the pathologist should be completed at the time of biopsy. Additionally, a nail map can help the pathologist identify the biopsy site and orient the epidermal surface (",
"    <a class=\"graphic graphic_picture graphicRef83981 \" href=\"mobipreview.htm?26/44/27329\">",
"     picture 18",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,53\">",
"     1,53",
"    </a>",
"    ]. A record of the biopsy should be maintained in the office and signed at the time the result is relayed to the patient to ensure adequate patient communication concerning diagnosis and management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459193\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate dressing can minimize postoperative pain and complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]. Many nail surgeons apply the initial dressing themselves to determine the appropriate level of pressure needed to maintain hemostasis without causing a tourniquet effect. A layer of antibiotic ointment is usually applied to the surgical site before dressing. Patients should be instructed to loosen the original bandage if pain due to pressure worsens, since postoperative edema may cause the original bandage to tighten, thereby functioning as a tourniquet. The patient should elevate the digit above the heart to minimize swelling and painful throbbing.",
"   </p>",
"   <p>",
"    The original bandage should be kept dry and left in place for 24 to 48 hours and changed daily thereafter until complete healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1,12\">",
"     1,12",
"    </a>",
"    ]. Dried blood may cause adherence of the bandage to the surgical site. Soaking the dressing in warm tap water before its removal can minimize discomfort. The wound should be cleaned with half-strength",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    (3% over-the-counter hydrogen peroxide diluted with an equal amount of tap water) before reapplying antibiotic ointment and a clean padded dressing. On average, fingernail regrowth takes approximately 6 months and toenail regrowth about 12 months and up to 18 months for the great toenail [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postoperative analgesics such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    , or NSAIDs may be necessary for adequate pain control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/1\">",
"     1",
"    </a>",
"    ]. Pulsating pain beginning 36 to 48 hours after surgery may indicate infection and prompt appropriate antibiotic treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120459200\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common nail surgical complication is permanent nail plate dystrophy (eg, nail splitting, ridging, or pterygium formation), which results from nail matrix damage. Nail dystrophy occurs more frequently when the biopsy site is located within the proximal nail matrix [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Midline nail unit biopsies are associated with a high risk of split nail plate deformity (",
"    <a class=\"graphic graphic_picture graphicRef83966 \" href=\"mobipreview.htm?32/1/32784\">",
"     picture 19",
"    </a>",
"    ). The deformity results from scaring within the nail matrix, most frequently after biopsies that are &gt;3 mm. Closing the matrix defect with absorbable suture may prevent the split nail complication. A nail split may also occur as a consequence of pterygium (adherence between the proximal nail fold and the nail matrix after nail plate removal). Pterygium may be prevented by separating the proximal nail fold from the nail bed with nonadherent gauze, a stent, or the original nail plate.",
"   </p>",
"   <p>",
"    Nail plate misalignment is typically associated with the lateral longitudinal nail biopsy technique, particularly when the biopsy is &gt;3 mm in width [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Nail misalignment can be treated by surgical realignment of the matrix or total matricectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=see_link&amp;anchor=H2729113#H2729113\">",
"     \"Nail biopsy: Indications and techniques\", section on 'Lateral longitudinal excision'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Partial or total chemical matricectomy may be associated with nail spicule recurrence due to incomplete destruction of the lateral or subproximal matrix. Chemical ablation is associated with the risk of tissue necrosis, pain, persistent exudative drainage, and periostitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54\">",
"     54",
"    </a>",
"    ]. Surgical matricectomy is thus preferred by some surgeons because of the lower risk for nail spicule formation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H9#H9\">",
"     \"Nail surgery\", section on 'Chemical matricectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A distal nail fold may form when an overlying nail plate is lacking for an extended period of time, as in the case of a great toenail avulsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/3\">",
"     3",
"    </a>",
"    ]. Although a distal nail fold is usually pushed down by the regrowing nail plate, when present for a long period of time it may become fibrotic, fixed, and interfere with further outward nail plate growth. Under these circumstances, compression of the distal nail fold by taping or removal of the distal nail fold by crescentic wedge excision may be necessary.",
"   </p>",
"   <p>",
"    A pyogenic granuloma may develop following nail surgery (",
"    <a class=\"graphic graphic_picture graphicRef85753 \" href=\"mobipreview.htm?39/15/40176\">",
"     picture 20",
"    </a>",
"    ). It may be removed by cautery, scalpel excision, laser, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/53/42834?source=see_link\">",
"     silver nitrate",
"    </a>",
"    application [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/5/29785?source=see_link&amp;anchor=H3446840#H3446840\">",
"     \"Pyogenic granuloma (Lobular capillary hemangioma)\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nail bed scarring results in persistent onycholysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54\">",
"     54",
"    </a>",
"    ]. Epidermal inclusion cysts can occur during suturing when needle trauma causes invagination of a small piece of epidermis into the subcutaneous layer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54,56\">",
"     54,56",
"    </a>",
"    ]. Other nail surgical complications include anesthetic allergy, bleeding, infection (including superficial infection, acute purulent tenosynovitis, osteomyelitis, and septic arthritis), hematoma formation, persistent pain and swelling, and reflex sympathetic dystrophy due to traumatic nerve injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54,57\">",
"     54,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15764861\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nail surgery is performed for diagnosing clinically ambiguous lesions and dystrophies, removing benign and malignant nail tumors, and alleviating pain secondary to ingrown and traumatized nails. (See",
"      <a class=\"local\" href=\"#H120459077\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The preoperative evaluation of the patient undergoing nail surgery includes a complete history (",
"      <a class=\"graphic graphic_table graphicRef85839 \" href=\"mobipreview.htm?9/11/9403\">",
"       table 1",
"      </a>",
"      ) and targeted physical examination. Antibiotic prophylaxis is generally not necessary, but may be indicated in patients at increased risk of postoperative infection (",
"      <a class=\"graphic graphic_table graphicRef69096 \" href=\"mobipreview.htm?8/56/9101\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H120459091\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4659429\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       Lidocaine",
"      </a>",
"      1 to 2% with epinephrine 1:100,000 is used for local anesthesia in most patients. However, epinephrine should be avoided in patients with peripheral vascular disease who are at increased risk for digital ischemia or infarction. (See",
"      <a class=\"local\" href=\"#H4659824\">",
"       'Anesthetic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anesthesia can be administered by digital nerve block or wing block procedure. The wing block is preferred because it is less painful, requires a smaller amount of anesthetic, and is more rapid than the digital nerve block. (See",
"      <a class=\"local\" href=\"#H4659835\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complete or partial nail avulsion is indicated in most instances to achieve maximum exposure of the nail bed and matrix (",
"      <a class=\"graphic graphic_picture graphicRef83964 \" href=\"mobipreview.htm?12/4/12353\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=see_link&amp;anchor=H6#H6\">",
"       \"Nail surgery\", section on 'Nail avulsion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The en bloc excision of the nail unit is a treatment option for primary malignant nail tumors such as melanoma in situ and squamous cell carcinoma (SCC). (See",
"      <a class=\"local\" href=\"#H120459114\">",
"       'Full nail unit excision or en bloc excision'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nail conditions requiring specific surgical approaches include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Longitudinal melanonychia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=see_link&amp;anchor=H190722931#H190722931\">",
"       \"Nail biopsy: Indications and techniques\", section on 'Nail matrix biopsy'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Longitudinal erythronychia (see",
"      <a class=\"local\" href=\"#H120459137\">",
"       'Longitudinal erythronychia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Onychomatricoma (see",
"      <a class=\"local\" href=\"#H120459144\">",
"       'Onychomatricoma'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Digital myxoid cyst (see",
"      <a class=\"local\" href=\"#H120459151\">",
"       'Digital myxoid cyst'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Squamous cell carcinoma (see",
"      <a class=\"local\" href=\"#H120459158\">",
"       'Squamous cell carcinoma'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Glomus tumor (see",
"      <a class=\"local\" href=\"#H120459165\">",
"       'Glomus tumors'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Subungual exostosis (see",
"      <a class=\"local\" href=\"#H120459172\">",
"       'Subungual exostosis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Pincer nails (see",
"      <a class=\"local\" href=\"#H120459179\">",
"       'Pincer nails'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following surgical excision, the tissue specimen should be correctly oriented and marked so that the pathologist can appropriately evaluate the histology. A nail map is helpful to identify the biopsy site and orient the epidermal surface (",
"      <a class=\"graphic graphic_picture graphicRef83981 \" href=\"mobipreview.htm?26/44/27329\">",
"       picture 18",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H120459186\">",
"       'Managing the surgical specimen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures to control postoperative pain include appropriate dressing, digit elevation above the heart level, and oral analgesics. The original bandage should be kept dry and left in place for 24 to 48 hours and changed daily thereafter until complete healing. (See",
"      <a class=\"local\" href=\"#H120459193\">",
"       'Postoperative care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complication of nail surgery is permanent nail dystrophy (eg, nail splitting, ridging, or pterygium). Other complications include nail misalignment, nail spicule recurrence, distal nail fold, pyogenic granuloma, and onycholysis. (See",
"      <a class=\"local\" href=\"#H120459200\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rich P. Nail Surgery. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Mosby, New York 2006.",
"    </li>",
"    <li>",
"     Abimelec P, Dumontier C. Basic and Advanced Nail Surgery (Part 1: Principles and Techniques). In: Nails: Diagnosis, Therapy, and Surgery, Scher RK, Daniel RC, et al (Eds), Elsevier Saunders, 2005. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/3\">",
"      Haneke E. Surgical anatomy of the nail apparatus. Dermatol Clin 2006; 24:291.",
"     </a>",
"    </li>",
"    <li>",
"     Haneke E. Surgical anatomy of the nail apparatus. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/5\">",
"      De Berker D, Mawhinney B, Sviland L. Quantification of regional matrix nail production. Br J Dermatol 1996; 134:1083.",
"     </a>",
"    </li>",
"    <li>",
"     Fleckman P. Structure and function of the nail unit. In: Nails: Diagnosis, Therapy, and Surgery, RK, Daneil CR III, et al (Eds), Elsevier Saunders, 2005. p.13.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/7\">",
"      Richert B. Anesthesia of the nail apparatus: techniques and tips. Dermatol Online 2005; 11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/8\">",
"      Wright TI, Baddour LM, Berbari EF, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008; 59:464.",
"     </a>",
"    </li>",
"    <li>",
"     Richert B. General considerations. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.16.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/10\">",
"      Richert B. Basic nail surgery. Dermatol Clin 2006; 24:313.",
"     </a>",
"    </li>",
"    <li>",
"     Richert B. Instrumentation. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.11.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/12\">",
"      Jellinek NJ. Nail surgery: practical tips and treatment options. Dermatol Ther 2007; 20:68.",
"     </a>",
"    </li>",
"    <li>",
"     Richert B. Anesthesia of the nail apparatus. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.24.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/14\">",
"      Denkler K. A comprehensive review of epinephrine in the finger: to do or not to do. Plast Reconstr Surg 2001; 108:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/15\">",
"      Mohan PP. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Epinephrine in digital nerve block. Emerg Med J 2007; 24:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/16\">",
"      Krunic AL, Wang LC, Soltani K, et al. Digital anesthesia with epinephrine: an old myth revisited. J Am Acad Dermatol 2004; 51:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/17\">",
"      Lalonde D, Bell M, Benoit P, et al. A multicenter prospective study of 3,110 consecutive cases of elective epinephrine use in the fingers and hand: the Dalhousie Project clinical phase. J Hand Surg Am 2005; 30:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/18\">",
"      Chowdhry S, Seidenstricker L, Cooney DS, et al. Do not use epinephrine in digital blocks: myth or truth? Part II. A retrospective review of 1111 cases. Plast Reconstr Surg 2010; 126:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/19\">",
"      Moffitt DL, De Berker DA, Kennedy CT, Shutt LE. Assessment of ropivacaine as a local anesthetic for skin infiltration in skin surgery. Dermatol Surg 2001; 27:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/20\">",
"      Keramidas EG, Rodopoulou SG. Ropivacaine versus lidocaine in digital nerve blocks: a prospective study. Plast Reconstr Surg 2007; 119:2148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/21\">",
"      Kuthiala G, Chaudhary G. Ropivacaine: A review of its pharmacology and clinical use. Indian J Anaesth 2011; 55:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/22\">",
"      Browne J, Fung M, Donnelly M, Cooney C. The use of EMLA reduces the pain associated with digital ring block for ingrowing toenail correction. Eur J Anaesthesiol 2000; 17:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/23\">",
"      Serour F, Ben-Yehuda Y, Boaz M. EMLA cream prior to digital nerve block for ingrown nail surgery does not reduce pain at injection of anesthetic solution. Acta Anaesthesiol Scand 2002; 46:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/24\">",
"      Smith KC, Comite SL, Balasubramanian S, et al. Vibration anesthesia: a noninvasive method of reducing discomfort prior to dermatologic procedures. Dermatol Online J 2004; 10:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/25\">",
"      Cornelius P, Kendall J, Meek S, Rajan R. Alkalinisation of lignocaine to reduce the pain of digital nerve blockade. J Accid Emerg Med 1996; 13:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/26\">",
"      Davidson JA, Boom SJ. Warming lignocaine to reduce pain associated with injection. BMJ 1992; 305:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/27\">",
"      Hixson FP, Shafiroff BB, Werner FW, Palmer AK. Digital tourniquets: a pressure study with clinical relevance. J Hand Surg Am 1986; 11:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/28\">",
"      Collins SC, Cordova K, Jellinek NJ. Alternatives to complete nail plate avulsion. J Am Acad Dermatol 2008; 59:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/29\">",
"      Jellinek NJ, Bauer JH. En bloc excision of the nail. Dermatol Surg 2010; 36:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/30\">",
"      Collins SC, Jellinek NJ. Matrix biopsy of longitudinal melanonychia and longitudinal erythronychia: a step-by-step approach. Cosmet Dermatol 2009; 22:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/31\">",
"      Jellinek NJ. Longitudinal erythronychia: suggestions for evaluation and management. J Am Acad Dermatol 2011; 64:167.e1.",
"     </a>",
"    </li>",
"    <li>",
"     Di Chiacchio ND, Richert B, Haneke E. Surgery of the matrix. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.103.",
"    </li>",
"    <li>",
"     Abimelec P, Dumontier C. Basic and Advanced Nail Surgery (Part 2: Indications and Complications). In: Nails: Diagnosis, Therapy, and Surgery, Scher RK, Daniel RC, et al (Eds), Elsevier Saunders, 2005. p.291.",
"    </li>",
"    <li>",
"     Richert B. Surgery of the distal interphalangeal joint. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.165.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/35\">",
"      De Berker DA, Lawrence CM. Treatment of myxoid cysts. Dermatol Surg 2001; 27:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/36\">",
"      Lumpkin LR 3rd, Rosen T, Tschen JA. Subungual squamous cell carcinoma. J Am Acad Dermatol 1984; 11:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/37\">",
"      de Berker DA, Perrin C, Baran R. Localized longitudinal erythronychia: diagnostic significance and physical explanation. Arch Dermatol 2004; 140:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/38\">",
"      Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med 2008; 132:1448.",
"     </a>",
"    </li>",
"    <li>",
"     Richert B, Haneke E, Di Chiacco N. Surgery of the nail bed. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.55.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/40\">",
"      Bhaskaranand K, Navadgi BC. Glomus tumour of the hand. J Hand Surg Br 2002; 27:229.",
"     </a>",
"    </li>",
"    <li>",
"     Richert B, Haneke E, Di Chiacchio N. Surgery of the nail bed. In: Nail Surgery, Richert B, Di Chiacchio B, Haneke E (Eds), Informa Healthcare, New York 2011. p.55.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/42\">",
"      Lin YC, Hsiao PF, Wu YH, et al. Recurrent digital glomus tumor: analysis of 75 cases. Dermatol Surg 2010; 36:1396.",
"     </a>",
"    </li>",
"    <li>",
"     Haneke E, Di Chiacco N, Richert B. Surgery of the bony phalanx. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.149.",
"    </li>",
"    <li>",
"     Haneke E, Di Chiacchio N, Richert B. Surgery of the bony phalanx. In: Nail Surgery, Richert B, Di Chiacchio N, Haneke E (Eds), Informa Healthcare, New York 2011. p.149.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/45\">",
"      Starnes A, Crosby K, Rowe DJ, Bordeaux JS. Subungual exostosis: a simple surgical technique. Dermatol Surg 2012; 38:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/46\">",
"      Baran R, Haneke E, Richert B. Pincer nails: definition and surgical treatment. Dermatol Surg 2001; 27:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/47\">",
"      Di Chiacchio N, Kadunc BV, Trindade de Almeida AR, Madeira CL. Treatment of transverse overcurvature of the nail with a plastic device: measurement of response. J Am Acad Dermatol 2006; 55:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/48\">",
"      Lee JI, Lee YB, Oh ST, et al. A clinical study of 35 cases of pincer nails. Ann Dermatol 2011; 23:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/49\">",
"      Kosaka M, Asamura S, Wada Y, et al. Pincer nails treated using zigzag nail bed flap method: results of 71 toenails. Dermatol Surg 2010; 36:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/50\">",
"      Mutaf M, Sunay M, Ik D. A new surgical technique for the correction of pincer nail deformity. Ann Plast Surg 2007; 58:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/51\">",
"      Hatoko M, Iioka H, Tanaka A, et al. Hard-palate mucosal graft in the management of severe pincer-nail deformity. Plast Reconstr Surg 2003; 112:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/52\">",
"      Fern&aacute;ndez-Mej&iacute;a S, Dom&iacute;nguez-Cherit J, Pichardo-Vel&aacute;zquez P, Gonz&aacute;lez-Olvera S. Treatment of nail bed defects with hard palate mucosal grafts. J Cutan Med Surg 2006; 10:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/53\">",
"      Collins SC, Cordova KB, Jellinek NJ. Midline/paramedian longitudinal matrix excision with flap reconstruction: alternative surgical techniques for evaluation of longitudinal melanonychia. J Am Acad Dermatol 2010; 62:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/54\">",
"      Moossavi M, Scher RK. Complications of nail surgery: a review of the literature. Dermatol Surg 2001; 27:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/55\">",
"      De Berker DA, Baran R. Acquired malalignment: a complication of lateral longitudinal nail biopsy. Acta Derm Venereol 1998; 78:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/56\">",
"      Wadhams PS, McDonald JF, Jenkin WM. Epidermal inclusion cysts as a complication of nail surgery. J Am Podiatr Med Assoc 1990; 80:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/51/38713/abstract/57\">",
"      Ingram GJ, Scher RK, Lally EV. Reflex sympathetic dystrophy following nail biopsy. J Am Acad Dermatol 1987; 16:253.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16202 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-FA0D210239-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38713=[""].join("\n");
var outline_f37_51_38713=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15764861\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459077\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459084\">",
"      SURGICAL ANATOMY OF THE NAIL UNIT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459091\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659297\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H130502806\">",
"      Ancillary tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H130502813\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659429\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659443\">",
"      Premedication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15765030\">",
"      Surgical field preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4659304\">",
"      INSTRUMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4659290\">",
"      ANESTHESIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659824\">",
"      Anesthetic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659844\">",
"      Reduction of injection pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659835\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459098\">",
"      BASIC SURGICAL PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459107\">",
"      Nail plate avulsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459114\">",
"      Full nail unit excision or en bloc excision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459121\">",
"      SPECIAL SITUATIONS IN NAIL SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459130\">",
"      Longitudinal melanonychia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459137\">",
"      Longitudinal erythronychia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459144\">",
"      Onychomatricoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459151\">",
"      Digital myxoid cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459158\">",
"      Squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459165\">",
"      Glomus tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459172\">",
"      Subungual exostosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120459179\">",
"      Pincer nails",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459186\">",
"      MANAGING THE SURGICAL SPECIMEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459193\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H120459200\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15764861\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/16202\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16202|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/11/43187\" title=\"figure 1A\">",
"      Nail anatomy 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/43/25267\" title=\"figure 1B\">",
"      Nail anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/30/4583\" title=\"figure 1C\">",
"      Nail biopsy diagram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/48/40706\" title=\"figure 2\">",
"      Nail growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/55/16244\" title=\"figure 3A\">",
"      Palmar hand anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/1/7188\" title=\"figure 3B\">",
"      Plantar foot anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/59/24501\" title=\"figure 4A\">",
"      Dorsal hand anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/8/20612\" title=\"figure 4B\">",
"      Dorsal foot anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16202|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/18/36132\" title=\"picture 1\">",
"      Nail anatomy 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/22/25956\" title=\"picture 2\">",
"      Instruments nail surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/2/7201\" title=\"picture 3A\">",
"      Wing block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/36/22080\" title=\"picture 3B\">",
"      Wing block 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/23/10623\" title=\"picture 4\">",
"      Digital tourniquet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/29/20944\" title=\"picture 5\">",
"      Glove finger tourniquet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/62/12259\" title=\"picture 6\">",
"      Pinching tourniquet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/4/12353\" title=\"picture 7\">",
"      Partial nail avulsion 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/48/4865\" title=\"picture 8\">",
"      Nail excision en bloc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/63/42994\" title=\"picture 9\">",
"      Nail unit en bloc excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/8/142\" title=\"picture 10\">",
"      Defect following nail unit excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/4/3144\" title=\"picture 11\">",
"      Longitudinal erythronychia excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/6/21601\" title=\"picture 12\">",
"      Onychomatricoma surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/25/2449\" title=\"picture 13A\">",
"      Glomus tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/39/43636\" title=\"picture 13B\">",
"      Glomus tumor subungual 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/34/5667\" title=\"picture 13C\">",
"      Glomus tumor subungual 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/34/44578\" title=\"picture 13D\">",
"      Glomus tumor nail dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/41/18066\" title=\"picture 14\">",
"      Glomus tumor excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/52/5954\" title=\"picture 15\">",
"      Glomus tumor surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/53/40784\" title=\"picture 16A\">",
"      Nail plate post-surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/46/22242\" title=\"picture 16B\">",
"      Nail plate post-surgery 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/8/11393\" title=\"picture 17\">",
"      Pincer nail",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/44/27329\" title=\"picture 18\">",
"      Nail map paper and cassette",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/1/32784\" title=\"picture 19\">",
"      Split-nail complication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/15/40176\" title=\"picture 20\">",
"      Pyogenic granuloma toe",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16202|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/11/9403\" title=\"table 1\">",
"      Nail surgery history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/56/9101\" title=\"table 2\">",
"      Antibiotic prophylaxis derm surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/28/24012\" title=\"table 3\">",
"      Common benzodiazepines for treatment of procedural anxiety",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=related_link\">",
"      Digital nerve block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=related_link\">",
"      Infiltration of local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=related_link\">",
"      Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36869?source=related_link\">",
"      Nail biopsy: Indications and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12758?source=related_link\">",
"      Nail surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/34/553?source=related_link\">",
"      Overview of benign lesions of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/15/36090?source=related_link\">",
"      Overview of nail disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/5/29785?source=related_link\">",
"      Pyogenic granuloma (Lobular capillary hemangioma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/48/21258?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_51_38714="HSV primary";
var content_f37_51_38714=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61107%7EOBGYN%2F76083%7EOBGYN%2F80959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61107%7EOBGYN%2F76083%7EOBGYN%2F80959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary genital herpes simplex infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Recurrent herpes simplex virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 368px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Herpes simplex virus (HSV) folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 356px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38714=[""].join("\n");
var outline_f37_51_38714=null;
var title_f37_51_38715="Urinary patterns associated with different kidney diseases";
var content_f37_51_38715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F56160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F56160&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Urinary patterns associated with different kidney diseases",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Urinary pattern",
"       </td>",
"       <td class=\"subtitle1\">",
"        Kidney disease suggested by pattern",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematuria with dysmorphic red blood cells, red blood cell casts, varying degrees of albuminuria",
"       </td>",
"       <td>",
"        Proliferative glomerulonephritis (eg, IgA nephropathy, ANCA-associated vasculitis, lupus nephritis)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Heavy albuminuria with minimal or absent hematuria",
"       </td>",
"       <td>",
"        Non-proliferative glomerulopathy (eg, diabetes, amyloidosis, membranous nephropathy, focal segmental glomerulosclerosis, minimal change)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Multiple granular and epithelial cell casts with free epithelial cells",
"       </td>",
"       <td>",
"        Acute tubular necrosis in a patient with underlying acute kidney injury",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Isolated pyuria",
"       </td>",
"       <td>",
"        Infection (bacterial, mycobacterial) or tubulointerstitial disease",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Normal or near-normal urinalysis with few cells, no casts, and no or minimal proteinuria",
"       </td>",
"       <td>",
"        In presence of acute kidney injury: pre-renal azotemia, acute tubular necrosis, hypercalcemia, urinary obstruction, vascular diseases with glomerular ischemia (eg, systemic sclerosis, malignant hypertension), or extra-glomerular vascular disease (eg, cholesterol emboli, polyarteritis nodosa)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In presence of chronic kidney disease: ischemic nephropathy, hypertensive nephrosclerosis, urinary obstruction",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38715=[""].join("\n");
var outline_f37_51_38715=null;
var title_f37_51_38716="Comparison of aerosol devices";
var content_f37_51_38716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of pressurized metered dose inhalers with holding chamber, dry powder inhalers, and nebulizers as aerosol delivery devices",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        pMDI/HC",
"       </td>",
"       <td class=\"subtitle1\">",
"        DPIs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nebulizer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Performance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Majority of aerosol particles &lt;5 &micro;m in size",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        High pulmonary deposition",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Low mouth deposition",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Reliability of dose",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenced by humidity",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Physical and chemical stability",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breath actuated",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Risk of contamination",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Convenience",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lightweight, compact",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Multiple doses",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dose counter",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Easy and quick operation",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Suitable for all ages",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DPI: dry power inhaler; pMDI: pressurized metered-dose inhalers; HC: holding chamber.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin, BK, Fink, JB. Aerosol therapy for children. Respir Care Clin N Am 2001; 7:175. Copyright &copy; 2001 Elsevier Science (USA).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38716=[""].join("\n");
var outline_f37_51_38716=null;
var title_f37_51_38717="RBC size sideroblastic anemia";
var content_f37_51_38717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Red cell size distribution curves in congenital sideroblastic anemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 430px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Top panel) Size distribution curve from a 28-year-old man with autosomal recessive congenital sideroblastic anemia (Hb, 6.7 g/dL; MCV, 65 fL; RDW, 35). The pattern indicates a broad population of red cells, varying markedly in size, with the majority of the cells being microcytic.",
"    <br>",
"     (Bottom panel) Size distribution curve from a 60-year-old woman with X-linked sideroblastic anemia (Hb, 9.9 g/dL; MCV, 93 fL; RDW, 14). It indicates the presence of two populations of red cells: one is comprised of normocytic to macrocytic red cells (black arrow) derived from precursors expressing the normal ALAS2, while a lesser population contains only microcytic red cells (red arrow) derived from precursors expressing the mutant ALAS2.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38717=[""].join("\n");
var outline_f37_51_38717=null;
var title_f37_51_38718="Burn costs cost US";
var content_f37_51_38718=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73840&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 632px\">",
"   <div class=\"ttl\">",
"    Cost of burn injuries compared by age and type of burn in the US between 1998 and 2008",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 612px; height: 369px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control. Web-based injury and statistics query and reporting system (WISQARS&trade;) 2009. Available online at: webappa.cdc.gov/sasweb/ncipc/mortrate9.html (Accessed on April 2, 2010).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38718=[""].join("\n");
var outline_f37_51_38718=null;
var title_f37_51_38719="Anterior laryngeal web";
var content_f37_51_38719=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior laryngeal web (type 3 laryngeal atresia)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A perforated membrane (*) partially obstructs the glottis (G).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_51_38719=[""].join("\n");
var outline_f37_51_38719=null;
